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Abstract 
Nuclear pore complexes (NPCs) and nuclear lamins are major constituents of the nuclear 
envelope (NE) in metazoan cells. NPCs are embedded in the NE and they mediate all 
nucleocytoplasmic transport events. NPCs are built of around 30 nucleoporins, which, 
besides being involved in nuclear transport, have been shown to be engaged in a number 
of other cellular processes, such as transcriptional regulation, kinetochore organization 
and cell division. Here, we provide an analysis of Nup153 function in mitosis in Chapter 
2. We show that overexpression and deletion of Nup153 leads to mitotic defects due to a 
misregulation of the spindle assembly checkpoint protein Mad1. In Chapter 3, we identify 
Nup88 as novel lamin A-binding protein. Using interaction assays and 
immunofluorescence microscopy, we characterize the direct interaction of Nup88 with 
lamin A. We show that the interaction of lamin A with Nup88 is mediated by the lamin A 
Ig-fold, and that the interaction between the two proteins is abrogated in the presence of 
laminopathy-associated mutations lying in the Ig-fold domain of lamin A. Finally, in 
Chapter 4, we show that Nup88 is implicated in cell cycle regulation due to an interaction 
with the lamin A-LAP2α complex.  
Our results presented in this thesis contribute to broaden the current knowledge of 
cellular functions of the nucleoporins Nup153 and Nup88, as well as to increased 
understanding of the interaction of nucleoporins with the nuclear lamina and the impact 
of laminopathy-associated mutations on the interaction of lamin A with Nup88. The 
finding that Nup88 is involved in gene regulation and proliferation is a key step in 
understanding Nup88’s implication in cancer development. 
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1.1 Nuclear pore complex architecture 
The structure of the NPC has been studied since almost 40 years, and distinct 
electron microscopy (EM) and cryo-electron tomography (CET) have nowadays provided 
high-resolution images of this fascinating and most distinctive structure of the NE. Three 
substructures of the NPC are easily distinguishable: a cylindrical core known as central 
framework or spoke complex, eight cytoplasmic filaments and a nuclear basket (Figure 
1.1). Early EM studies used negatively stained and frozen-hydrated NPCs from Xenopus 
laevis oocyte NEs (Akey and Radermacher, 1993; Hinshaw et al., 1992) or frozen-
hydrated yeast nuclei (Yang et al., 1998) to reconstruct the central framework of the 
NPC. Accordingly, the central framework is composed of eight multi-domain spokes and 
found embedded between the inner and outer nuclear membranes (Figure 1.1) (Akey, 
1989). Each of the spokes consists of an inner domain, a central domain and a luminal 
domain (Akey, 1989). Only recently it became evident that, at least in yeast, each spoke 
can be divided into two parallel columns, suggesting that the NPC is made of a 16-fold 
repetition of columns, each with a similar architecture (Alber et al., 2007b). A 
cytoplasmic and a nucleoplasmic ring are integrated moieties of the central framework 
and associated with the outer and inner nuclear membrane, respectively. Recent 3-D 
reconstruction of NPCs from Xenopus laevis or Dictyostelium discoideum nuclei 
increased the resolution of the central framework to now 5-6 nm and revealed the first 
reconstruction of the peripheral and flexible cytoplasmic filaments and the nuclear basket 
(Beck et al., 2004; Beck et al., 2007; Stoffler et al., 2003). In Dictyostelium discoideum, 
the NPC has an outer diameter of 125 nm and a total length of ~150 nm, whereof the 
cytoplasmic filaments are ~35 nm in length, the nuclear basket about 60 nm and the 
central framework ~50 nm (Beck et al., 2004; Beck et al., 2007). This overall 3D 
architecture appears evolutionary conserved, while the linear dimensions of the NPC can 
vary among different species (Fahrenkrog et al., 1998; Kiseleva et al., 2004; Yang et al., 
1998).  
Embraced by the central framework is the central pore of the NPC, which 
mediates all trafficking between the cytoplasm and the nucleoplasm (Feldherr et al., 
2002). The central pore is hourglass shaped with a diameter of 60-70 nm at its 
cytoplasmic and nuclear periphery and ~45 nm at its narrowest point at the midplane of 
1.1 Nuclear pore complex architecture 
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the NE (Beck et al., 2004; Beck et al., 2007; Pante and Kann, 2002; Stoffler et al., 2003). 
Small molecules and ions with a diameter of up to 9 nm can pass the NPC by passive 
diffusion (Kiseleva et al., 1998), while larger molecules depend on a translocation signal, 
which is recognized by nuclear transport receptors of the importin β/karyopherin β 
family. Receptor-facilitated transport allows passage of macromolecules with diameters 
up to 39 nm (Pante and Kann, 2002).  
Peripheral channels, about 8 nm in diameter, are formed at the interface between 
the nuclear membrane and the central framework and their function is still controversially 
discussed (for review see: (Fahrenkrog and Aebi, 2003)).  
 
 
Figure 1.1: Schematic representation of the nuclear pore complex architecture.  
The main structural components of the nuclear pore complex include the central framework (or 
spoke complex) embedded in the nuclear envelope, the cytoplasmic filaments and the nuclear 
basket. 
 
1.2 Nucleoporins at the atomic level 
At the molecular level, the NPC assembles from a set of ~30 different proteins, 
called nucleoporins or Nups (Cronshaw et al., 2002; Rout et al., 2000). A minimum of 
eight copies of each nucleoporin is present per NPC (or multiples of eight) and only 
recently it has been shown that each NPC, at least in yeast, is made up of ~456 individual 
1.2 Nucleoporins at the atomic level 
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nucleoporins (Rout et al., 2000). Structural knowledge of nucleoporins at the atomic level 
thus far was limited, but computational analysis has indicated that most nucleoporins 
consist of a small number of protein folds, such as α-helical solenoids, β-propeller, 
coiled-coil and unstructured, natively unfolded phenylalanine-glycine (FG)-repeat 
domains (Table 1.1) (Devos et al., 2004; Devos et al., 2006; Schwartz, 2005). Less 
frequent structural motifs found in nucleoporins are transmembrane helices as in the 
integral membrane protein POM152 and gp210 (Wozniak and Blobel, 1992; Wozniak et 
al., 1994), zinc-finger domains as in Nup153 and Nup358/RanBP2 (Higa et al., 2007) or 
an RNA recognition motif in Nup35 (Handa et al., 2006) (Table 1.1). 
Besides these predictions, a growing number of crystal structures of nucleoporin 
domains are available and the crystal structure is not always consistent with the previous 
prediction. The first crystal structure of an α-helical nucleoporin domain was solved for 
Nic96p, the S. cerevisiae homologue of vertebrate Nup93 (Jeudy and Schwartz, 2007; 
Schrader et al., 2008). Nic96p is located at the cytoplasmic and nuclear side of the NPC 
(Figure 1.2) and is composed of two structural predicted domains: an N-terminal coiled-
coil domain of about 150 residues and a C-terminal helical domain of about 600 residues. 
Crystallization of this C-terminal domain revealed that it folds into an elongated mostly 
α-helical structure with strong deviation from the predicted α-solenoid fold (Jeudy and 
Schwartz, 2007; Schrader et al., 2008). 
About one third of the nucleoporins contain a predicted β-propeller or α-solenoid 
domain or a combination of both. Seven-bladed β-propeller domains have been 
determined by X-ray crystallography for the N-terminal domains of the human 
nucleoporins Nup133 and Nup214 and Nup214’s yeast homologue Nup159p (Berke et 
al., 2004; Napetschnig et al., 2007; Weirich et al., 2004). β-propellers have the ability to 
interact with several partners, making this fold ideal to organize dynamic multiprotein 
complexes. The β-propeller found in Nup214 differs from the β-propeller of its yeast 
homologue Nup159p or the one found in Nup133 by an additional peptide segment 
attached to the N-terminal β-propeller. The crystal structure analysis revealed that the N-
terminal seven-bladed β-propeller of Nup214 is followed by a 30-residue C-terminal 
extended unique peptide segment (CTE) that binds to the bottom face of the β-propeller 
1.2 Nucleoporins at the atomic level 
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and has been proposed to play an autoinhibitory role in NPC assembly (Napetschnig et 
al., 2007).  
The autoproteolytic, NPC targeting domain of Nup98 was the first crystal 
structure obtained for a nucleoporin (Hodel et al., 2002). This domain contains a six-
stranded β-sheet sandwiched against a two-stranded β-sheet, flanked on both sides by α-
helical stretches, similar to the structure of its yeast homologues Nup116p (Hodel et al., 
2002; Robinson et al., 2005). This domain adopts multiple conformations and is 
stabilized only when bound to a ligand, i.e. to Nup96 and Nup145-C, respectively 
(Robinson et al., 2005). Conformational diversity might allow Nup98 and Nup116p to 
bind to multiple binding partners within the NPC or to associate and dissociate from the 
NPC to increase the mobility of the two nucleoporins, as it was described for Nup98, 
which shuttles in transcription-dependent manner (Griffis et al., 2002; Griffis et al., 
2004). More recently, a high-resolution crystal structure of this autoproteolytic fragment 
of Nup98 revealed that autoproteolysis of Nup98 might occur due to an energetically 
unfavorable, so-called N-O acyl-shift (Sun and Guo, 2008). Nup98 may therefore utilize 
autoprocessing to control its biogenesis pathway and intracellular translocation. 
The crystal structure of protein complexes for two nucleoporins have been solved 
for human Sec13 and yeast Nup145Cp as well as human Nup107 and Nup133 (Boehmer 
et al., 2008; Hsia et al., 2007), all members of the Nup84p subcomplex of the NPC, and 
its vertebrate homologue the Nup107-160 complex (see below). Sec13p and Nup145Cp 
form heterodimers and four of these heterodimers assemble to build a heterooctamer 
(Hsia et al., 2007). The heterooctamer forms a slightly curved, rigid structure of sufficient 
length to span the entire height of the central framework (Hsia et al., 2007). In contrast to 
that, the C-terminal domains Nup107 and Nup133 each form elongated α-helical 
structures and also the complex of both exhibits a largely extended overall structure 
(Boehmer et al., 2008). It remains to be seen how these four nucleoporins assemble with 
their other complex partners to form the central framework, or part of it. 
The attempt to crystallize the Nup62 complex, i.e. Nup62, Nup58 and Nup54, 
yielded the α-helical core structure of rat Nup58/45, whereas Nup62 and Nup54 did not 
crystallize (Melcak et al., 2007). Nup58/45 forms tetramers, each consisting of two 
antiparallel hairpin dimers, in which two α-helices are connected by a short loop. The 
1.2 Nucleoporins at the atomic level 
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dimerization interphase is hydrophobic, whereas the dimer interaction occurs through 
hydrophilic residues. These residues are laterally displaced in various tetramer 
conformations, which suggests an intermolecular sliding mechanism (Melcak et al., 
2007). Recent immunogold localization studies of different domains of the Nup62 
complex showed that it is anchored to the cytoplasmic side of the NPC, probably through 
the coiled-coil structures of Nup62 and Nup54 (Schwarz-Herion et al., 2007), so that 
intermolecular sliding of Nup58/45 could contribute to a flexible pore diameter (Melcak 
et al., 2007).  
1.2 Nucleoporins at the atomic level 
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Table 1.1: Secondary structures found in nucleoporins. 
Based on secondary structure predictions, nucleoporins can be grouped into three classes (Devos 
et al., 2006). The transmembrane group contains transmembrane helices. A transmembrane helix 
is a hydrophobic helical segment spanning the membrane. The second group of nucleoporins 
contains β-propellers and α-helical repeats. β-propellers have seven blades arranged around a 
central axis, each blade consisting of four-stranded antiparallel β-sheets, α-helical repeats consist 
of antiparallel α-helices and can fold into a solenoid or similar structures. The third class of 
nucleoporins harbors conserved sequence motif of phenylalanine-glycine (FG)-repeats. Those FG-
repeats adapt no secondary structure, but are natively unfolded. Another frequent structure 
observed in nucleoporins is a coiled-coil fold, which is formed by α-helices twisting together. 
Other less frequently observed secondary structures are the cadherin domain, which is a seven-
1.2 Nucleoporins at the atomic level 
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stranded β-sandwich structure; the autoproteolytic domain exhibiting a β-sandwich structure with 
helices capping the two ends; RRM is a two layer α/β sandwich involved in RNA binding; a zinc-
finger DNA-binding motif consisting of two antiparallel β-strands and a α-helix and the Ran-
binding domain folds in a β-barrel topology with pleckstrin-homology (PH-like domain). 
* indicates proteins with folding domains which have been crystallized: Nup116p: β-sandwich like 
fold (Robinson et al., 2005); Nup145Cp: α-solenoid domain (Hsia et al., 2007); Sec13p: β-
propeller (Hsia et al., 2007); Nic96p: α-helical structure (Jeudy and Schwartz, 2007); Nup159p: β-
propeller (Weirich et al., 2004); RanBP2/Nup358: Ran-binding motif (Vetter et al., 1999); 
Nup214/CAN: β-propeller (Napetschnig et al., 2007); Nup107: α-helical repeat (Boehmer et al., 
2008); Nup133: α-helical repeat (Boehmer et al., 2008); Nup153: Zinc-finger (Schrader et al., 
2008); Nup98: autoproteolytic domain (Sun and Guo, 2008); Nup58/45: coiled-coil (Melcak et al., 
2007); Sec13: β-propeller (Stagg et al., 2008); Nup35/53: RNA recognition motif (/RRM) (Handa 
et al., 2006). 
 
1.3 NPC subcomplexes 
Nucleoporins are typically organized into distinct biochemically defined 
subcomplexes, which consequently build up the NPC (Figure 1.2) (Alber et al., 2007a; 
Schwartz, 2005). A well-studied and conserved subcomplex is the vertebrate Nup107-160 
complex, which consists of nine nucleoporins (i.e. Nup107, Nup160, Nup133, Nup96, 
Nup85, Sec13, Nup43, Nup37 and Seh1) (Belgareh et al., 2001; Harel et al., 2003; 
Loiodice et al., 2004; Vasu et al., 2001). The Nup107-Nup160 complex localizes to both 
sides of the NPC’s central framework (Belgareh et al., 2001; Krull et al., 2004) and its 
conserved homologue is the Nup84p complex in S. cerevisiae (Allen et al., 2002; 
Lutzmann et al., 2002; Siniossoglou et al., 1996). Depletion of any nucleoporin of the 
Nup107-160 complex in nuclear reconstitution assays from X. laevis egg extracts or by 
RNA interference (RNAi) in HeLa cells results in NE devoid of NPCs or nuclei with 
severe deficiencies in NPC formation, indicating that the complex is needed for NPC 
assembly at least in situ (Boehmer et al., 2003; Harel et al., 2003; Walther et al., 2003). In 
mice, however, NPCs assemble into the NE in the absence of Nup133 (Lupu et al., 2008). 
Besides its central role for NPC assembly, the Nup107-160 complex is essential for 
anchoring the nuclear basket protein Nup153 to the nuclear side of the NPC, which, in 
turn seems to anchor the nucleoporin Tpr to the nuclear basket (Hase and Cordes, 2003; 
Krull et al., 2004; Vasu et al., 2001). In mitosis, the Nup107-160 complex is recruited to 
kinetochores (Belgareh et al., 2001; Loiodice et al., 2004) and its depletion from HeLa 
cells by RNAi leads to failure in establishing a proper microtubule attachment to the 
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kinetochores, which in turn causes a checkpoint-dependent mitotic delay in the G2 phase 
of the cell cycle (Loiodice et al., 2004; Orjalo et al., 2006; Zuccolo et al., 2007). 
The Nup93 complex is assembled by the nucleoporins Nup205, Nup155, 
Nup35/53 and most likely Nup188 (Grandi et al., 1997; Hawryluk-Gara et al., 2005; 
Miller et al., 2000). The yeast homologue of this complex consists of Nic96p as well as 
Nup188p, Nup192p, Nup157p and Nup170p (see Figure 1.2)(Aitchison et al., 1995; 
Grandi et al., 1995; Kosova et al., 1999; Nehrbass et al., 1996; Zabel et al., 1996). 
Immunodepletion of the Nup93 complex from Xenopus egg extracts showed that 
assembled nuclei are lacking proper NPCs, indicating that the Nup93 subcomplex is 
required for NPC assembly (Grandi et al., 1997). Biochemical data showed that the 
Nup93 complex is anchored in the NE through the binding of Nup35 to the integral 
membrane protein Ndc1 (Mansfeld et al., 2006). Ndc1 (Chial et al., 1998) is an important 
player in NPC assembly (Lau et al., 2004; Madrid et al., 2006; Mansfeld et al., 2006; 
Marelli et al., 2001; Stavru et al., 2006a), since depletion of Ndc1 from mammalian cells 
by RNAi caused a severe reduction in NPC staining, indicating defects in NPC assembly 
and/or stability (Mansfeld et al., 2006). The loss of Ndc1 function in C. elegans also 
causes, besides severe NPC defects, high larval and embryonic mortality (Stavru et al., 
2006a).  
Another important integral membrane protein is POM121, which interacts with 
the Nup107-160 complex (Antonin et al., 2005). POM121 is restricted to vertebrates and 
its depletion from Xenopus egg extracts leads to early block in NE assembly (Antonin et 
al., 2005). Nonetheless, when POM121 was depleted from human cells, functional NPCs 
and intact NEs were observed (Stavru et al., 2006b). The third metazoen transmembrane 
protein gp210 seems to be redundant in function with Ndc1 as well (Eriksson et al., 2004; 
Mansfeld et al., 2006; Stavru et al., 2006b). Similarly, in yeast, Ndc1 was found to be 
partially redundant with POM152p (Madrid et al., 2006). These observations suggest 
redundancies in protein-protein interactions within NPCs, ensuring that NPC formation is 
a robust process (Kitano, 2004; Stavru et al., 2006a).  
The Nup214/Nup88 subcomplex is localized to the cytoplasmic face of the NPC 
(Bastos et al., 1997; Fornerod et al., 1997b). Interaction between Nup214 and Nup88 is 
likely mediated by their coiled-coil domains (Bastos et al., 1997; Fornerod et al., 1997b). 
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Interdependence of Nup88 and Nup214 for the localization at the NPC has been 
consistently observed in all species analyzed so far. Nup88 is undetectable in cells 
derived from Nup214-deficient mouse embryos (Fornerod et al., 1997b) and RNAi 
inhibition of each of the genes in human tissue culture results in reduced protein levels 
for the other (Bernad et al., 2004). Yeast cells with a temperature-sensitive mutation of 
the Nup88 homologue Nup82p show a reduction of Nup159p, the yeast homologue of 
Nup214, from the nuclear rim (Belgareh et al., 1998). The molecular mechanisms 
underlying this interplay remain unknown.  
The major structural component of the cytoplasmic filaments is Nup358/RanBP2 
(Delphin et al., 1997; Walther et al., 2002). Based on knockdown analysis in cultured 
human cells, Nup88 and Nup214 were proposed to play a key role in recruiting Nup358 
to create the cytoplasmic filaments of the NPC (Bernad et al., 2004). Conversely, Hutten 
and Kehlenbach found that depletion of Nup214 resulted in codepletion of Nup88, but 
not of Nup358 (Hutten and Kehlenbach, 2006). Consistently, cytoplasmic filaments are 
intact in nup214 Drosophila larvae (Xylourgidis et al., 2006) and depletion of Nup214 
from Xenopus egg extracts did not affect Nup358 localization at the NE (Walther et al., 
2002). Furthermore, high-resolution FEISEM images of the cytoplasmic face of Nup214 
deficient NPCs showed that cytoplasmic filaments were present (Walther et al., 2002). 
Together these data indicate that the Nup214/Nup88 complex does not play a major role 
in maintaining Nup358 on the cytoplasmic filaments. 
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Figure 1.2: Subcomplex organization of the NPC. 
Schematic overview on subcomplex organization in the NPC. (A) Subcomplex organization in 
metazoan NPC. (B) Subcomplex organization in yeast NPC. Adapted from (Schwartz, 2005). 
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1.4 Vertebrate nucleoporins 
 
1.4.1 Nup153 
The nucleoporin Nup153 is asymmetrically located on the nuclear side of the 
NPC and it consists of three distinct domains (Figure 1.3A). The N-terminal domain 
contains a nuclear envelope targeting cassette (NETC; 2-144), a RNA binding domain 
(RBD; 250-400) and the NPC assembly region (NPAR; 39-339), which directs Nup153 
incorporation into the NPC and includes a M9-like nuclear localization signal (NLS; 247-
290) (Bastos et al., 1996; Enarson et al., 1998; Nakielny et al., 1999). In the central 
domain, four zinc fingers of the C2-C2 type can be found that interact with DNA, 
RanGDP and the COPI complex (Liu et al., 2003; Nakielny et al., 1999; Sukegawa and 
Blobel, 1993). The C-terminus consists of natively unfolded FG-repeats, is highly mobile 
and mediates interactions with the soluble transport receptors importin-β and CRM1 
(Denning et al., 2003; Nakielny et al., 1999; Shah et al., 1998; Sukegawa and Blobel, 
1993). Immuno-electron microscopy revealed that the N-terminus of Nup153 is anchored 
at the nuclear ring moiety of the NPC, whereas the central zinc-finger domains are 
located at the distal ring (Fahrenkrog et al., 2002). The localization of the C-terminal 
domain is highly variable and can be detected at the nuclear basket and at the cytoplasmic 
ring of the NPC, depending on the nucleocytoplasmic transport state of the NPC 
(Fahrenkrog et al., 2002; Paulillo et al., 2005).  
Nup153 is an essential protein as RNA interference (RNAi) studies showed that 
its depletion affects both the viability of C. elegans embryos and growth of tissue culture 
cells (Galy et al., 2003; Harborth et al., 2001). Furthermore, depletion of Nup153 by 
RNAi revealed that Nup153 is required for maintaining the structural integrity of the 
nuclear basket and incorporation of Nup153 itself depends on the Nup107-160 complex, 
which has an essential role in overall pore formation (Boehmer et al., 2003; Krull et al., 
2004; Walther et al., 2003). Moreover, Nup153 provides an important link between the 
NPC and the nuclear lamina and it is critical for pore anchoring, as Nup153 deficient 
NPCs become mobile within the NE (Smythe et al., 2000; Walther et al., 2001). Nup153 
also plays a role in NE breakdown (NEBD) in Xenopus nuclei through the recruitment of 
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the COPI coatomer complex (Liu et al., 2003; Prunuske et al., 2006). The COPI complex 
plays a major role in membrane remodeling at the Golgi apparatus and has been 
implicated in the process of NEBD, involving the dispersal of the nuclear membrane as 
well as disassembling of the NPCs (Bonifacino and Glick, 2004; Prunuske et al., 2006). 
Three members of the COPI coatomer complex (α, β and β’) were reported to specifically 
interact with the zinc finger domains of Nup153 and Nup358 (Liu et al., 2003). These 
nucleoporins appear to be involved in the recruitment of COPI to the vicinity of the NE 
during mitosis, however, many questions remain about how the recruitment of COPI is 
regulated (Prunuske et al., 2006). 
Recently, chromosomal rearrangements of NUP153 have been identified that are 
associated with Nup153’s increased expression in urothelial and retinoblastoma cancer 
(Heidenblad et al., 2008; Orlic et al., 2006). Furthermore, Nup153 is a positive regulator 
of Hedgehog signaling, which is crucial for developmental processes in many organisms 
(Nybakken et al., 2005). Moreover, Nup153 directly associates with adenomatous 
polyposis coli (APC) protein, a tumor suppressor, which promotes the association of 
microtubules with the nuclear membrane in neurons and this interaction is required for 
centrosome reorientation during cell migration (Collin et al., 2008). Taken together, these 
results suggest that Nup153 is involved in differentiation and tissue development and 
deficiencies in Nup153 function are related to human disease. Recently, Nup153 was 
implicated in both early mitotic defects and in a delay of late stages of mitosis in a dose-
dependent manner (Mackay et al., 2009). Furthermore, the finding that Nup153 affects 
spindle checkpoint due to Mad1 hypophosphorylation suggests that Nup153 is an 
important regulator of mitotic events, which might be related to Nup153’s role in 
development and cancer (Lussi et al., 2010). 
 
1.4.2 Nup88 
Nup88 was found to be localized on the cytoplasmic side of the NPC in a 
complex with Nup214, NUP358 and the protein export factor CRM1 (Bastos et al., 1997; 
Fornerod et al., 1997b). However, recent evidence suggests that a pool of Nup88 localizes 
to the nucleoplasmic side as well (Lussi et al., submitted, see Chapter 3). Based on its 
amino acid sequence, Nup88 is organized into two distinct domains: an N-terminal 
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domain, which is predicted to fold as a β-propeller, and a C-terminal domain that contains 
predicted coiled-coil segments (Fornerod et al., 1997b; Schwartz, 2005) (Figure 1.3 B). 
Interaction between Nup88 and Nup214 is likely mediated by their coiled-coil domains, 
and it seems that Nup88 and Nup214 are interdependent on each other for NPC 
localization, as one partner is unstable in the absence of the other (Bernad et al., 2004). 
However, Nup88 can be overexpressed relative to Nup214 and under these conditions it 
accumulates in the cytoplasm of both cultured human cells and Drosophila melanogaster 
larvae (Bernad et al., 2004; Xylourgidis et al., 2006).  
Nup88 seems to play an important role in recruiting the FG nucleoporin 
Nup358/RanBP2, the major component of the cytoplasmic filaments of the NPC and the 
binding site for the Ran GTPase activating enzyme RanGAP (Bernad et al., 2004; 
Delphin et al., 1997; Walther et al., 2002). However, the amount of Nup358 in the cells 
appears not to be linked to the protein levels of Nup88, indicating that only the 
recruitment, but not the stability of Nup358 depends on Nup88 (Bernad et al., 2004).  
Another interaction partner of Nup88 is Nup98, a nucleoporin localizing to both 
sides of the NPC (Griffis et al., 2003). Nup98 interacts via its C-terminal NPC-targeting 
domain with the β-propeller domain of Nup88 (Griffis et al., 2003). Nup98 seems to play 
a role in the assembly of Nup88 and other cytoplasmic nucleoporins into the NPC, as 
Nup88 relocates from the NE to annulate lamellae in Nup98 deficient mouse cells (Wu et 
al., 2001).  
 
 
Figure 1.3: Domain organization of the nucleoporins Nup153 and Nup88 
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(A) Nup153 domain organization. The domain architecture of Nup153 is depicted. The N-terminal 
region of Nup153 contains the nuclear envelope targeting cassette (NETC; 2-144), which is 
required for targeting to the inner nuclear envelope, the nuclear pore assembly region (NPAR; 39-
339), which is needed for the incorporation into the nuclear pore complex and an RNA binding 
domain (RBD; 250-400). The central zinc finger region (650-880) is comprised of four C2-C2 type 
zinc fingers. The C-terminal region (881-1475) contains FG-rich motifs that are thought to be 
natively unfolded. Adapted from (Ball and Ullman, 2005). (B) Nup88 domain organization. The 
domain architecture of Nup88 is shown. The N-terminal region of Nup88 folds into a predicted β-
propeller, and the C-terminal domain contains predicted coiled-coil segments (Fornerod et al., 
1997b; Schwartz, 2005). 
 
1.4.2.1 Nup88 in nucleocytoplasmic transport 
Nup88, together with Nup214, has been implicated in CRM1-mediated nuclear 
export. The FG-repeat domain of Nup214 and the N-terminal β-propeller of Nup88 
directly interact with CRM1/exportin, the export factor for many nuclear export signal 
(NES)-containing proteins from the nucleus (Roth et al., 2003; Takahashi et al., 2008). 
However, the contribution of the Nup214/Nup88 complex in export of NES-containing 
cargo varies between systems. In Drosophila larvae, it was found that members only 
(mbo), the Drosophila Nup88 homologue, regulates the nuclear accumulation of Dorsal 
and Dif, members of the Rel/NF-κB family of transcription factors (Roth et al., 2003; Uv 
et al., 2000). Therefore, it is assumed that, in Drosophila, the Nup214/Nup88-complex 
controls the recruitment of CRM1 to the NPC and the export of CRM1-dependent 
proteins, such as Dorsal and Dif, in a concentration-dependent manner (Xylourgidis et al., 
2006) and Nup88 is hence assumed as nuclear export attenuator for NES-dependent 
export. Similarly, selective depletion of Nup88 by small interfering RNA (siRNA) 
inhibited the nuclear translocation of NF-κB and NF-κB-dependent reporter gene 
activation in human cells (Takahashi et al., 2008), suggesting that Nup88 is regulating the 
activity of NF-κB at the level of nucleocytoplasmic transport. This notion is confirmed by 
the finding that nuclear accumulation and constitutive activation of NF-κB in metastatic 
melanoma cells overexpressing Nup88 can be reduced by Nup88 depletion (Takahashi et 
al., 2008). Thus, overexpression of Nup88 in tumor cells might be involved in 
constitutive NF-κB activation and in NF-κB mediated malignancy. 
In mammalian cell culture, the Nup214/Nup88 subcomplex was furthermore 
shown to be required for CRM1-mediated nuclear export of the 60 S pre-ribosomal 
subunits (Bernad et al., 2006). Further, depletion of the Nup214/Nup88 complex in HeLa 
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cells leads to greatly diminished export of the nuclear transcription factor NFAT, a 
transcription factor containing two classical NLS and one NES (Klemm et al., 1997). 
Interestingly, a study in Drosophila S2 cells implicated Nup88 in nuclear import 
(Takano and Gusella, 2002). In this study, Nup88 was shown to be involved in the 
regulation of the transport of the huntingtin protein, the major determinant protein of 
Huntington’s neurodegenerative disorder (Takano and Gusella, 2002). The NF-κB/Rel 
family of transcription factors associates with huntingtin to form complexes for its 
nuclear import, which seems to be Nup88-dependent (Takano and Gusella, 2002). 
However, Nup88 has not been involved in import of any other cargoes than huntingtin so 
far. 
 
1.4.2.2 Nup88 in disease 
Nup88 was found to be overexpressed in a wide variety of human tumors 
(Emterling et al., 2003; Gould et al., 2000; Gould et al., 2002; Martinez et al., 1999; 
Schneider et al., 2004). In 75% of ovarian tumors, Nup88 is overexpressed in malignant 
tissue compared to adjacent healthy tissue (Martinez et al., 1999). In an analysis with an 
extended variety of tumor types, Nup88 was found to be overexpressed in a broad 
spectrum of neoplasias. Immunohistochemistry revealed overexpression of Nup88 
especially evident in carcinomas, but was also observed in sarcomas, lymphomas and 
mesotheliomas (Gould et al., 2000; Gould et al., 2002). Overexpression of Nup88 was not 
associated with overexpression of other nucleoporins, i.e. Nup214 and Nup153, 
suggesting that overexpression in tumor tissues seems to be specific for Nup88 (Gould et 
al., 2002). 
Nup88 can be found in the cytoplasm of tumor cells, what correlates with studies 
in cultured cells, where Nup88 accumulates in the cytoplasm when overexpressed (Bastos 
et al., 1997). Nup88 protein levels correlate to tumor development, aggressiveness and 
differentiation in breast, colorectal and hepatocellular carcinomas, melanoma, ovarian 
tumors and other neoplastic disease (Agudo et al., 2004; Emterling et al., 2003; Gould et 
al., 2000; Gould et al., 2002; Knoess et al., 2006; Martinez et al., 1999; Zhang et al., 
2002; Zhang et al., 2007). Benign tumors and mild hyperplasia showed no 
overexpression, whereas Nup88 overexpression increased in more advanced tumors. In 
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colorectal cancer, highest expression was detected in invasive margins of tumors and in 
metastasis, suggesting a putative function in invasion (Emterling et al., 2003). Nup88 
overexpression seems to increase with the progression of tumors and is associated with 
poorly differentiated tumors. Therefore, Nup88 was suggested as tumor marker and 
potential indicator for tumor prognosis.  
How Nup88 overexpression is involved in tumorigenesis is not clear yet, but the 
notion that Nup88 is also overexpressed in fetal tissue supports the idea that Nup88 might 
play a role in proliferation (Gould et al., 2000; Schneider et al., 2004). A possible 
mechanism of how Nup88 influences proliferation might be through transport of 
transcription factors and its impact on signal transduction pathways, since it is known that 
Nup88 is involved, both in Drosophila and human cells, in the nuclear export of NF-κB 
transcription factors (Takahashi et al., 2008; Uv et al., 2000). In Drosophila, active NF-
κB accumulates in the cytoplasm due to increased nuclear export in the absence of Nup88 
(Uv et al., 2000). Conversely, Nup88 overexpression in cancer cells might lead to a 
decreased export of transcription factors, leading to an accumulation in the nucleus. 
Indeed, in breast, pancreas and colon carcinomas, NF-κB is predominantly found in the 
nucleus where it could contribute to constitutive upregulation of target genes (Kau et al., 
2004). Alternatively, Nup88 overexpression might be a cellular stress response, as its 
overexpression can be induced by UVA light in melanoma cells or by hypertonic stress in 
mice and human kidney cells (Andres-Hernando et al., 2008; Zhang and Rosdahl, 2003).  
 
1.4.3 Nup214 
The Nup214-Nup88 subcomplex is localized to the cytoplasmic face of the NPC 
(Bastos et al., 1997; Kraemer et al., 1994). Nup214 is dispensable for in vitro NPC 
assembly and protein import, but it is essential in vertebrate cells, and its depletion causes 
a strong mRNA export defect (van Deursen et al., 1996; Walther et al., 2002). Nup214 is 
organized in three distinct domains: an N-terminal domain, which is predicted to fold into 
a β-propeller (Weirich et al., 2004), a central domain with a leucine zipper motif and two 
predicted coiled-coil segments known to interact with Nup88 (Bastos et al., 1997; 
Fornerod et al., 1997a), and a long C-terminal FG-repeat that interacts strongly with the 
transport factor CRM1 in vitro in a RanGTP- and cargo-stimulated fashion (Askjaer et 
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al., 1999; Fornerod et al., 1995; Fornerod et al., 1997a; Kehlenbach et al., 1999). These 
data suggest that Nup214 plays an essential role in CRM1-mediated nuclear export. 
Interestingly, recent studies showed that the FG-rich domain of the asymmetric nuclear 
Nup153 and cytoplasmic Nup214 can cross the NPC to bind transport receptors and 
escorting transport complexes through the NPC (Fahrenkrog and Aebi, 2003; Fahrenkrog 
et al., 2002; Paulillo et al., 2005). However, it remains to be elucidated as to whether and 
how NPC asymmetry influences transport processes that are initiated on the opposite side 
of the NPC. 
 
1.4.4 Nup98 
Nup98 is located on both the nuclear and cytoplasmic side of the NPC, where it 
associates with the structural Nup107-160 complex or with Nup88, respectively, as the 
two interactions seem to be mutually exclusive (Griffis et al., 2003; Hodel et al., 2002; 
Vasu et al., 2001). Nup98 is expressed in two forms as a result of alternative splicing. 
The first splice variant encodes the 920 amino acid protein Nup98, which is 
posttranslationally cleaved into the 90 kDa N-terminal Nup98 and an 8 kDa C-terminal 
fragment. The second variant encodes a Nup98-Nup96 polyprotein that is also 
posttranslationally cleaved to form the N-terminal Nup98 and the C-terminal Nup96 
(Fontoura et al., 1999).  
The N-terminal domain of Nup98 contains FG and GLFG repeat motifs that are 
intersected by a small coiled-coil domain. Interestingly, Nup98 is the only vertebrate 
nucleoporin with GLFG-type repeats (Powers et al., 1995; Radu et al., 1995). The C-
terminus is a domain with a unique β-sandwich structure with autoproteolytic activity, 
and it is important for directing Nup98 to the NPC and mediates the binding to the 
Nup107-160 complex and to Nup88 (Fontoura et al., 1999; Griffis et al., 2003; Hodel et 
al., 2002; Vasu and Forbes, 2001).  
Nup98 interacts with the β-propeller nucleoporin Rae1/Gle2 through its coiled-
coil domain (Pritchard et al., 1999). Rae1 is implicated in mRNA export, functions in cell 
cycle regulation and has a role in mitotic spindle function (Babu et al., 2003; Blower et 
al., 2005; Jeganathan et al., 2006; Pritchard et al., 1999). Both Nup98 and Rae1 are 
dynamic components of the NPC, that is, they can move on and off the NPC. Nup98 can 
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also be found within the nucleoplasm, where it is associated with intranuclear bodies 
termed GLFG bodies, as this domain is required for association with these structures. The 
mobility of Nup98 in the nucleoplasm can be blocked by inhibitors of transcription, 
suggesting a role for Nup98 in transcription and/or RNA shuttling to the NPC (Griffis et 
al., 2002).  
 
1.5 FG-nucleoporins in nucleocytoplasmic transport 
About one third of the nucleoporins contain FG-repeat domains, which mediate 
the interaction between transport receptor-cargo complexes and the NPC. These FG-
repeat domains also likely contribute to the selective barrier that limits diffusion through 
the NPC. Crystal structures of importin-β or the mRNA export factor TAP in complex 
with FG-repeat peptides showed that the interaction interface involves primarily the 
phenylalanine rings of the FG-repeat domain and hydrophobic residues on the surface of 
the transport receptor (Bayliss et al., 2000; Fribourg et al., 2001). The length and 
composition of hydrophilic linker between individual FG-motifs seem to influence the 
affinity of the binding and allow simultaneous binding of several FG-repeats to the 
transport receptor (Liu and Stewart, 2005). Biochemical and biophysical measurements 
demonstrated that the FG-repeats are natively unfolded, i.e. they do not adopt any 
secondary structure (Denning et al., 2003; Denning et al., 2002). This notion was 
confirmed by the use of atomic force microscopy on single molecules, which revealed 
that the FG-repeat domain of Nup153 resembles a 180nm long unfolded polypeptide 
chain if spread on a surface (Lim et al., 2006). Along this line, immuno-EM studies on 
two FG-repeat nucleoporins Nup153 and Nup214 furthermore showed that FG-repeat 
domains adopt highly variable locations within the NPC (Fahrenkrog et al., 2002; Paulillo 
et al., 2005). Interestingly, systematic deletion of FG-repeat regions in yeast nucleoporins 
revealed a high level of functional redundancy, since yeast NPCs are able to compensate 
the loss of 50% of their FG-repeats with only little effect on nucleocytoplasmic transport 
(Strawn et al., 2004; Zeitler and Weis, 2004).  
 
While the main function of the NPC and its constituents is to control 
nucleocytoplasmic transport of macromolecules in and out of the nucleus, it became 
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evident in the past few years that individual nucleoporins play important roles in other 
cellular processes, such as chromatin organization, gene expression and kinetochore 
organization during mitosis. We will concentrate here on novel functions of nucleoporins 
in transcription and mitosis, which will be discussed in sections 1.6 and 1.7, respectively. 
 
1.6 Nucleoporins in transcription 
The nuclear periphery and the NPCs were generally considered as region of gene 
repression, despite Blobel's gene gating hypothesis that proposed NPCs as anchoring sites 
for active genes (Blobel, 1985). Heterochromatin and gene poor sequences were found 
enriched at the periphery of the nucleus (Brown and Silver, 2007) and in yeast the two 
nucleoporins Nup60p and Nup145Cp are involved in repression of the silent mating type 
loci HML and HMR and in silencing telomeres (Brown and Silver, 2007; Feuerbach et 
al., 2002; Galy et al., 2000). Evidence for Blobel's theory came from studies on the 
nucleoporin Nup2p, which, together with several proteins of the nuclear transport 
machinery, exhibits boundary activity and can recruit actively transcribed genes to the 
NPC (Cabal et al., 2006; Casolari et al., 2005; Ishii et al., 2002; Luthra et al., 2007; 
Menon et al., 2005; Schmid et al., 2006). 
NPC association of transcribed genes might increase the efficiency of mRNA 
processing and export through, for example, recruitment of the SAGA and TREX 
complex (Cabal et al., 2006; Taddei et al., 2006). Accordingly, Sus1p, a member of the 
SAGA chromatin-remodeling complex in yeast that is also present in the mRNA export 
complex TREX, interacts with Nup1p (Fischer et al., 2002; Rodriguez-Navarro et al., 
2004). Similarly, Nup153, the vertebrate homologue of Nup1p, and Nup98 are thought to 
be involved in the link between transcription and mRNA export (Griffis et al., 2004). 
Moreover, the yeast myosin-like proteins Mlp1p and Mlp2p, both homologous to human 
Tpr (Cordes et al., 1997), appear to link these two processes (Vinciguerra et al., 2005). 
Loss of Mlp1p/Mlp2p is rescuing lacZ reporter mRNA levels and enhances their export 
to the cytoplasm in a yeast strain defective for mRNA export (Vinciguerra et al., 2005). 
Microarray analysis further showed that Mlp2p reduces a subset of cellular transcripts, 
such as RNase P RNA (RPR1) or proteins involved in fatty acid biosynthesis, in the 
mRNA export mutant strain (Vinciguerra et al., 2005), indicating that loss of Mlp 
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proteins negatively affects transcription of several genes when mRNA export is 
disturbed. 
Nup2p and the Nup84p complex can exhibit repressive and activating behavior in 
gene expression (Dilworth et al., 2005; Ishii et al., 2002; Menon et al., 2005; Schmid et 
al., 2006; Therizols et al., 2006), although it is not understood how this switch is 
regulated. Nup2p is furthermore involved in epigenetic regulation of transcription 
(Brickner et al., 2007). Nup2p interacts with the histone variant H2A.Z (Dilworth et al., 
2005) and tethers genes to it (Brickner et al., 2007). H2A.Z in turn is inserted at inducible 
promoters after activation (Brickner et al., 2007), which leads to a heritable memory of 
transcriptional activation through epigenetic information, i.e. the localization at the 
nuclear periphery.  
Nucleoporins are also involved in transcription regulation in higher eukaryotes, 
e.g. in dosage compensation in the fruit fly Drosophila melanogaster (Lucchesi et al., 
2005; Mendjan and Akhtar, 2007; Mendjan et al., 2006). Dosage compensation ensures 
the equalization of X-linked gene expression, which in mammals is achieved by an 
inactivation of one X chromosome in female cells (reviewed in (Royce-Tolland and 
Panning, 2008), whereas in D. melanogaster X-linked genes in males are 2-fold 
upregulated (Mendjan and Akhtar, 2007). In Drosophila Nup153 and Mtor, the 
homologue of the human Tpr, are essential for the correct localization of dosage 
compensation complex proteins on the X chromosome and dosage compensation is 
abolished in male cells when Nup153 or Mtor are depleted (Mendjan et al., 2006). 
Similarly, knockdown of Tpr, but not Nup153, lead to impaired dosage compensation in 
human cells (Tullio-Pelet et al., 2000). 
Human Nup93 was shown to directly associate with chromosomes 5, 7, and 16 at 
the nuclear periphery (Brown et al., 2008). Nup93 interacts with regions of transcriptional 
repression and enriched heterochromatin in HeLa cells. Upon global histone acetylation 
mediated by the histone deacetylase inhibitor trichostatin A, Nup93 binding sites are 
highly enriched in several factors including the histone variant H2A.Z and active histone 
methylation marks (Brown et al., 2008), corresponding to an exchange of silent for active 
chromatin at the NPC. The presence of H2A.Z at sites of NPC-chromatin interaction 
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indicates a similar form of transcriptional memory in human nuclei, as found in yeast due 
to Nup2p and H2A.Z binding.  
Taken together, these studies indicate that gene targeting to the NPC is 
evolutionary conserved from yeast to human. Targeting of genes to the NPC can lead to 
their silencing or activation and NPCs are also acting as epigenetic mark, underlying the 
decisive role of NPCs in the control of gene expression. 
 
1.7 Nucleoporins in mitosis 
 A hallmark of eukaryotic cells is the compartmentalization of the genetic 
material inside the nucleus. By restricting the accessibility of cytoplasmic proteins to 
DNA with the physical barrier of the NE, eukaryotic cells have achieved a complexity in 
transcriptional regulation not found in prokaryotes. Higher eukaryotes undergo an open 
mitosis during which the NE and NPCs disassemble into soluble subcomplexes that 
disperse throughout the mitotic cytoplasm (Burke and Ellenberg, 2002; Suntharalingam 
and Wente, 2003; Vasu and Forbes, 2001). After the chromosomes are segregated, the 
nuclei are reassembled and cytokinesis is completed by abscission of the two daughter 
cells. The whole scenario is tightly controlled by several checkpoints, including the 
spindle assembly checkpoint (SAC). The SAC prevents chromosome mis-segregation and 
aneuploidy by delaying the metaphase-anaphase transition until all chromosomes are 
properly attached to the mitotic spindle and aligned at the metaphase plate (Musacchio 
and Salmon, 2007).  
Nucleoporins were originally thought to be stored inertly once released from the 
NPC at the entry of mitosis and incorporated into NPCs during late mitosis. However, 
recent evidence suggests that certain nucleoporins perform important mitotic functions 
independently of their roles during interphase. For example, the Nup107-160 as well as 
Nup358 localize in part to kinetochores after their release from the NPC, where they exert 
functions in chromosome segregation (Dawlaty et al., 2008; Joseph et al., 2004; Salina et 
al., 2003; Zuccolo et al., 2007). On the other hand, important regulators of the spindle 
assembly checkpoint, namely Mad1 and Mad2, localize to the NPC in interphase cells 
(Campbell et al., 2001; Iouk et al., 2002). The function of the SAC proteins at the NPC 
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has remained largely elusive although it has been suggested that the NPC may play a role 
in the duration of the SAC (Kastenmayer et al., 2005; Scott et al., 2005).  
 
1.7.1 The spindle assembly checkpoint 
The spindle assembly checkpoint (SAC), alternatively referred to as the mitotic 
checkpoint, is a molecular system that ensures accurate segregation of mitotic 
chromosomes by delaying anaphase onset until each kinetochore has properly attached to 
the mitotic spindle and aligned at the metaphase plate (Kops et al., 2005; Musacchio and 
Salmon, 2007; Rieder et al., 1995; Rieder et al., 1994). Kinetochores that are not yet 
attached to mitotic microtubules and chromosome pairs that lack tension across sister 
chromatids generated by the spindle poles activate the SAC (Rieder and Maiato, 2004; 
Yu, 2002). Various mitotic checkpoint proteins, including Mad1, Mad2, Bub1, BubR1 
and Bub3, bind to kinetochores that lack attachment or tension to signal that not all 
chromosmomes are properly attached and to stop progression of the mitotic program 
(Kops et al., 2005; Shah and Cleveland, 2000; Sharp-Baker and Chen, 2001; Taylor et al., 
2001; Yu, 2002). The SAC inhibits the anaphase promoting complex/cyclosome 
(APC/C), a multisubunit E3 ubiquitin ligase that marks target proteins for degradation by 
the proteasome (Hwang et al., 1998; Kim et al., 1998). Specifically, the SAC negatively 
regulates the ability of the cell-division cycle protein Cdc20 to activate the APC/C-
mediated polyubiquitylation of two key substrates, cyclin B and securin, thereby 
preventing their degradation. When the last chromosome is captured by the spindle 
microtubules, the inhibitory SAC proteins are released from the APC/C, which allows 
progression into anaphase. 
 
1.7.2 Mad1 and Mad2 
Mad2 appears to have the most direct role in inhibiting the activity of the APC/C-
activating protein Cdc20. Mad2 binds directly to Cdc20 when the SAC is active, and this 
binding is sufficient to block ubiquitylation of securin or cyclin B by the APC/C in vitro 
(Fang et al., 1998; Li et al., 1997). Protein levels of Mad2 do not change much during 
mitosis, and it is thought that Mad2 in its monomeric form is inactive and not capable to 
stably bind Cdc20. However, oligomerized Mad2 inhibits activation of APC/C and blocks 
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cell cycle progression (Fang et al., 1998). Therefore, a change in Mad2 structure, which 
facilitates oligomerization, might play a role in transducing the checkpoint signal. 
However, it is suggested that Mad2’s activity is stimulated by kinetochores that are 
unoccupied by microtubules and that the association with other checkpoint proteins, 
including Bub3 and the kinase BubR1, enhances the ability of Mad2 to inhibit the APC/C 
(Sudakin et al., 2001). How the kinetochores of chromosomes that have not yet bioriented 
can trigger Mad2 to adopt a form capable of inhibiting Cdc20 is not exactly clear. 
Mad2 directly interacts with Mad1, which is crucial for the recruitment of Mad2 
to kinetochores (Chen et al., 1998). The recruitment of Mad1 to the kinetochores is one of 
the first events in activating the SAC and depends on its phosphorylation by the Polo-like 
kinase 1 (Plk1) (Chi et al., 2008). Attenuation of Mad1 phosphorylation by depleting 
Plk1 using siRNAs inhibits Mad1’s kinetochore association and cells with reduced Mad1 
phosphorylation levels due to overexpression of Nup153 show defective SAC function 
(Chi et al., 2008)(Lussi et al., 2010). 
 
1.7.3 Nup153 
Nup153 is phosphorylated throughout the cell cycle and hyperphosphorylated 
during mitosis (Favreau et al., 1996). Studies performed in Xenopus egg extract, a system 
to reconstitute cell division and nuclear assembly in vitro, have implicated Nup153 in NE 
breakdown (Liu et al., 2003; Prunuske et al., 2006), indicating that Nup153 plays a role in 
mitosis. Increased expression of Nup153 in urothelial and retinoblastoma cancer and its 
requirement for centrosome reorientation through interaction with the adenomatous 
polyposis coli (APC) protein during cell migration in neurons suggests a role for Nup153 
in tissue development and differentiation, probably by regulation of the cell cycle (Collin 
et al., 2008; Heidenblad et al., 2008; Orlic et al., 2006). Interestingly, a study showed that 
reduction of Nup153 causes a delay in cytokinesis in a dose-dependent manner without 
affecting global nucleocytoplasmic transport (Mackay et al., 2009), indicating a role for 
Nup153 in mitotic events. However, the exact mechanism of how Nup153 functions in 
mitosis remained largely elusive. A possible link between Nup153 and mitosis constitutes 
the SAC protein Mad1, since Nup153 is required for the localization of Mad1 to NPCs in 
interphase cells (Hawryluk-Gara et al., 2005). The exact role of Mad1 at the NPC during 
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interphase is not clear, but it is suggested that the tethering of SAC proteins to the NPC in 
interphase plays a role in the timing of the SAC (Kastenmayer et al., 2005; Scott et al., 
2005). However, it was shown recently that overexpression and deletion of Nup153 
exhibits strong mitotic defects due to a misregulation of Mad1 phosphorylation (Lussi et 
al., 2010, see Chapter 2). 
 
1.7.4 The Nup107-160 complex 
A fraction of the Nup107-160 complex has been shown to localize dynamically 
to kinetochores from prophase to late anaphase (Belgareh et al., 2001; Loiodice et al., 
2004) and to reconstituted spindles from Xenopus laevis egg extracts (Orjalo et al., 2006). 
The recruitment of the human Nup107-160 complex to kinetochores is dependent on the 
NDC80 complex and the centromere protein F (CENP-F), which is also involved in 
microtubule-kinetochore interaction (Zuccolo et al., 2007). At the kinetochores, the 
Nup107-160 complex is required for chromosome congression, maintenance of tension 
between sister kinetochores and the attachment of microtubules to the kinetochores 
(Zuccolo et al., 2007). In human cells, depletion of the Nup107-160 complex by RNAi 
from kinetochores affects proper microtubule attachment and is leading to a mitotic delay 
(Zuccolo et al., 2007).  
Only recently, the transcription factor ELYS/Mel-28 has been identified as a new 
binding partner of the Nup107-160 complex at both the NPC and the kinetochores 
(Rasala et al., 2006). ELYS/Mel-28 and Nup107-160 complex also act together in NPC 
assembly in C. elegans and human cells (Fernandez and Piano, 2006; Galy et al., 2006; 
Rasala et al., 2006). Therefore, both ELYS/Mel-28 and Nup107-160 complex are 
required for NPC assembly and proper cell division.  
 
1.7.5 Nup358 
Nup358, together with RanGAP and the protein export factor CRM1, is recruited 
by the Nup107-160 complex to the kinetochores (Zuccolo et al., 2007). RanGAP1 is a 
substrate of the ubiquitin-like protein SUMO-1 (Matunis et al., 1996) and sumoylation is 
needed for its association with kinetochores (Joseph et al., 2002). Nup358 and RanGAP1 
are involved in chromosome congression and segregation, stable kinetochore-microtubule 
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association and kinetochore assembly (Askjaer et al., 2002; Joseph et al., 2004; Salina et 
al., 2003) and it is CRM1 that provides an anchoring site for the Nup358/RanGAP1 
complex at the kinetochores (Arnaoutov et al., 2005). 
 
1.7.6 Nup98 
Nup98 and the nucleocytoplasmic transport factor Rae1 function in anaphase 
onset via regulation of the anaphase promoting complex/cyclosome (APC/C) (Jeganathan 
et al., 2005). APC/C drives the cells into anaphase by inducing degradation of cyclin B 
and the anaphase inhibitor securin, an inhibitor of the separase enzyme. To prevent 
chromosome missegregation, APC/C activity directed against these mitotic regulators 
must be inhibited until all chromosomes are properly attached to the mitotic spindle. 
Rae1 and Nup98 act together to regulate the timely destruction of securin by APC/C 
(Jeganathan et al., 2005). The functional significance of the interaction between 
Nup98/Rae1 and the APC/C is highlighted by the notion that knockdown of Nup98 and 
Rae1 leads to premature separation of sister chromatids and severe aneuploidy in mice 
splenocytes (Jeganathan et al., 2006).  
 
1.8  NPCs and diseases 
The main function of NPCs is to mediate the passage of molecules between the 
nucleus and the cytoplasm. Alterations in NPC components and/or nucleocytoplasmic 
transport have a strong impact on cell growth and survival. Therefore, it is not surprising 
that nucleoporins are implicated in many diseases, such as Triple A syndrome, cancer and 
autoimmune diseases.  
 
1.8.1 Triple A syndrome 
Triple A syndrome (also called Allgrove syndrome) is a rare, autosomal, 
recessive disorder characterized by alacrima, neurological abnormalities, achalasia and 
adrenocorticotropic hormone (ACTH) resistant adrenal failure (Allgrove et al., 1978; 
Clark and Weber, 1998; Gazarian et al., 1995; Khelif et al., 2003; Kimber et al., 2003; 
Moore et al., 1991; Prpic et al., 2003; Tsao et al., 1994). These four major syndromes are 
often highly variable in severity and age of onset and usually are progressive. Triple A 
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syndrome is caused by mutations in the AAAS gene, which encodes a protein known as 
ALADIN (alacrima-alachasia-adrenal insufficiency neurologic disorder) or adracalin 
(Handschug et al., 2001; Tullio-Pelet et al., 2000). ALADIN is thought to localize to the 
cytoplasmic side of the NPC and contains four WD (tryptophan-aspartic acid) repeats 
(Cronshaw et al., 2002; Cronshaw and Matunis, 2003; Handschug et al., 2001; Tullio-
Pelet et al., 2000). Most of the mutations causing triple A syndrome are truncations of the 
C-terminus of ALADIN, which delete a domain essential for NPC targeting, leading to 
mislocalization of ALADIN to the cytoplasm (Cronshaw and Matunis, 2003). In addition, 
four point mutations have been identified in patients, three of which are within the WD-
repeat domain, whereas the fourth is close to the N-terminus of ALADIN (Goizet et al., 
2002; Handschug et al., 2001; Houlden et al., 2002; Persic et al., 2001; Sandrini et al., 
2001; Schmittmann-Ohters et al., 2001; Tullio-Pelet et al., 2000).  
Characterization of a mutant ALADIN cell line indicates that the absence of 
functional ALADIN does not result in morphological abnormalities in nuclei, NPCs or 
NE, indicating that the effect is functional rather than structural (Cronshaw and Matunis, 
2003). As a member of the WD-repeat family of proteins, which are thought to be 
involved in assembly of macromolecular complexes (Smith et al., 1999), ALADIN could 
be involved in mediating the assembly of subdomains of the NPC or the formation of 
transport complexes through its WD-domain (Cronshaw and Matunis, 2003). The tissue–
specific expression of the AAAS gene in both neuroendocrine and cerebral structures 
points to a role for ALADIN in the normal development of the peripheral and central 
nervous systems (Tullio-Pelet et al., 2000). Together this suggests that ALADIN might 
play a cell type-specific role in regulating nucleocytoplasmic transport and this might be 
essential for the proper maintenance and/or development of certain tissues.  
 
1.8.2 Nucleoporins in cancer 
Nucleoporins are involved in several cases of acute myeloid leukemia and a few 
other hematological malignancies as well as rare cases of other tumors (Cronshaw and 
Matunis, 2004). For Nup88, its overexpression is associated with malignant tumors 
(Agudo et al., 2004; Emterling et al., 2003; Gould et al., 2000), whereas in most other 
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cases the involvement of nucleoporins originates from chromosomal rearrangements that 
result in oncogenic fusion proteins. 
Several nucleporin genes, such as Nup98 and Nup214, are involved in 
chromosomal translocations that lead to oncogenic fusion proteins. Nup98 was found 
fused to more than 20 different partners and these fusion proteins are associated with 
leukemic transformations giving rise to myeloid and lymphoid malignancies (Lam and 
Aplan, 2001; Panagopoulos et al., 2003; Rosati et al., 2002; Suzuki et al., 2002; Taketani 
et al., 2002a; Taketani et al., 2002b; Taketani et al., 2002c). Nup98 fusion partners 
include nine members of the homeobox (HOX) family of transcription factors, which are 
fused to the FG-repeat-domain of Nup98 (Panagopoulos et al., 2003; Suzuki et al., 2002; 
Taketani et al., 2002a; Taketani et al., 2002b; Taketani et al., 2002c). Homeobox 
transcription factors are involved in early embryonic development and regulate 
hematopoiesis and the fusion of the FG-repeat domain of Nup98 to the DNA binding 
domains of these transcription factors appears to enhance their transcriptional activity 
(Ghannam et al., 2004; Kasper et al., 1999). However, more recently it became evident 
that Nup98 containing fusion proteins exhibit repressive function on transcription 
(Bagley et al., 2000). Whether Nup98 is exhibiting transcriptional regulation activity only 
in oncogenic fusion or it is related to a role of endogenous Nup98 is not known so far. 
However, it is known that human Nup98 is able to stimulate transcription of reporter 
genes at the nuclear periphery in yeast suggesting that transcription activation by Nup98 
also occurs in a normal context of the NPC (Menon et al., 2005). 
The nucleoporin Nup214 (earlier named CAN) was for the first time discovered 
as DEK-CAN fusion protein in acute myeloid leukemia (Fornerod et al., 1995). Since 
then, the NUP214 gene was found in two other chromosomal translocations that fuse it to 
genes encoding SET (von Lindern et al., 1992) and ABL1 (Graux et al., 2004; Li et al., 
1996). Fusions to DEK and SET contain the FG-repeat domain of Nup214 and are 
thought to act as transcriptional activator (Kasper et al., 1999). Fusions of Nup214 to 
ABL contain the N-terminal domain of Nup214 and are thought to increase the kinase 
activity of ABL (Allen et al., 1996; Graux et al., 2004). 
A rare chromosomal translocation fuses the N-terminus of Nup358 to the protein 
kinase domain of ALK, which was identified in three reported cases in inflammatory 
1.8 NPCs and diseases 
 40 
myofibroblastic tumors (IMTs) (Ma et al., 2003; Patel et al., 2007). It is speculated that 
the N-terminal domain of Nup358 promotes oligomerization and constitutive activation 
of the ALK protein kinase domain. Interestingly, Nup358 was found to be required for 
sumoylation of topoisomerase IIα through its SUMO E3 ligase activity in mitosis 
(Dawlaty et al., 2008). Mice with low amounts of Nup358 develop severe aneuploidy in 
the absence of obvious transport defects and are highly sensitive to tumor formation. 
Therefore, Nup358 seems to play an important role in tumor suppression. Accordingly, 
reduced Nup358 transcription levels were found in human non-small cell lung cancers 
(Beer et al., 2002; Garber et al., 2001). 
Tpr (translocated promotor region) was originally identified in a chromosomal 
rearrangement found in a human sarcoma cell line (Park et al., 1986). Subsequently, 
chromosomal translocations which fuse the N-terminal coiled-coil domain of Tpr to the 
protein kinase domains of the MET (Park et al., 1986), RAF (King et al., 1988) and TRK 
(Greco et al., 1992) protooncogenes were identified, which are involved in osteosarcoma, 
adenocarcinoma or fibroblastoma and papillary thyroid carcinoma, respectively. 
Biochemical studies indicate that the N-terminal coiled-coil domain of Tpr can activate 
the protein kinase domain of MET by mediating protein oligomerization (Hays and 
Watowich, 2003; Rodrigues and Park, 1993). The resulting constitutive protein kinase 
activity is believed to be involved in cellular transformation. Whether specific defects in 
NPC function are also involved is currently unknown. 
The NUP153 gene, among other proteins, was found to be amplified in 
chromosomal translocations leading to 6p22 genomic gain in retinoblastoma and 
urothelial carcinomas (Heidenblad et al., 2008; Orlic et al., 2006). Interestingly, 
chromosomal translocation leads to an amplification of the NUP153 gene and subsequent 
overexpression of the Nup153 mRNA transcript (Heidenblad et al., 2008; Orlic et al., 
2006). However, protein levels of Nup153 were not altered relative to normal adult 
human retina (Orlic et al., 2006). 
Additionally to oncogenic chromosomal translocations, Nup88 was found to be 
overexpressed in a wide variety of human tumors (Emterling et al., 2003; Gould et al., 
2002; Martinez et al., 1999). In normal cells, Nup88 is found on the cytoplasmic side of 
the NPC in a subcomplex with Nup214 and is involved in CRM1 mediated nuclear export 
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(Bernad et al., 2006; Bernad et al., 2004; Fornerod et al., 1997b; Roth et al., 2003). When 
Nup88 is overexpressed in tumor cells, it accumulates in the cytoplasm. The functional 
significance of this mislocalization is not known yet, but overexpression of Nup88 is 
clearly associated with tumor development and aggressiveness (Agudo et al., 2004; 
Emterling et al., 2003; Gould et al., 2000; Gould et al., 2002; Martinez et al., 1999; 
Zhang et al., 2002; Zhang et al., 2007). The exact mechanism as of how Nup88 is 
involved in tumorigenesis is still obscure, but it is suggested that Nup88 might play a role 
in proliferation as it is not only overexpressed during tumorigenesis but also during 
development in the earliest stages of embryological differentiation in chicken embryos 
(Schneider et al., 2004). Alternatively, Nup88 might be involved in DNA repair 
mechanism and stress response as its expression can be induced by UVA light in 
melanoma cells (Zhang and Rosdahl, 2003). Furthermore, Nup88 is involved in the 
nuclear export of NF-κB transcription factors, both in Drosophila and human cells 
(Takahashi et al., 2008; Uv et al., 2000), indicating that its involvement in tumorigenesis 
might be related to specific signal transduction pathways. 
 
1.8.3 Nucleoporins in autoimmune disease 
The NPC is one of many intracellular targets in patients with autoimmune 
disease. Autoantigen targets include gp210, proteins of the Nup62 complex, Tpr and 
Nup153. 
Primary biliary cirrhosis (PBC) is a poorly understood autoimmune disease that 
slowly destroys the bile ducts and can lead to cirrhosis of the liver (Worman and 
Courvalin, 2003). Autoantibodies against gp210 and Nup62 are found in  25% of 
individuals with PBC and appear to be associated with a poor outcome of PBC 
(Invernizzi et al., 2001; Itoh et al., 1998). Tpr antibodies were found in a variety of 
autoimmune disease, e.g. autoimmune liver disease (ALD), systemic lupus erythematosus 
(SLE), motor and/or sensory neuropathy, anti-phospholipid syndrome (APS), systemic 
sclerosis (SSc), Sjogren's syndrome (SjS), and others with a variety of diagnoses. This 
indicates that Tpr is a common target of human autoantibodies (Ou et al., 2004). Two 
other nucleoporins have been identified as targets for human autoantibodies. Antibodies 
from a patient with an overlap connective tissue disorder bound to Nup358 (Wilken et al., 
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1993) and Nup153 has been identified as autoantigen in chronic hepatitis B and C viral 
infection, in Wilson’s disease and other autoimmune diseases (Gregorio et al., 1999).  
Although the list of antigens is growing, little is known about the mechanism of 
activation of autoimmune response. A possible mechanism might be molecular mimicry, 
where similarities between proteins from a pathogen and self-protein are sufficient 
enough to result in the cross-activation of autoreactive T or B cells and trigger 
autoimmune-response. Nup153, for example, displays sequence similarity to the Hepatitis 
B virus DNA polymerase (HBV-pol), and could therefore trigger the autoimmune 
response after HBV infection (Gregorio et al., 1999). Another evidence for molecular 
mimicry comes from studies with gp210 (Greber et al., 1990), where it was shown that 
the transmembrane domain of gp210 had significant sequence similarities to the topology 
of the envelope glycoproteins of different animal viruses. Therefore, molecular mimicry 
might be the mechanism leading to a loss of tolerance to nucleoporins and the subsequent 
production of autoantibodies.  
 
1.9  The nuclear lamina 
The nuclear lamina is a filamentous meshwork at the inner NE and supports 
stabilization of the nuclear architecture and is involved in the anchoring and spacing of 
NPCs (Aaronson and Blobel, 1975; Akey, 1989; Liu et al., 2000; Maeshima et al., 2006). 
The major components of the nuclear lamina are lamins, nuclear specific type V 
intermediate filament (IF) proteins, and various lamin-binding proteins (Burke and 
Stewart, 2002; Herrmann and Aebi, 2004; Stuurman et al., 1998) (Figure 1.4). Lamins 
bind to integral membrane proteins, such as LAP2, emerin and MAN1, proteins 
containing the so-called LEM-domain, through which they interact with the barrier-to-
autointegration protein (BAF) and DNA. Those integral membrane proteins associate the 
nuclear lamina with the INM, thereby providing mechanical stability for the nuclear 
envelope. Lamins can interact directly with DNA and with chromatin proteins, e.g. the 
heterochromatin protein HP1, and organizing the chromatin structure at the nuclear 
periphery (Schirmer and Foisner, 2007). Several nucleoporins have been identified to 
interact with lamins, mainly Nup153, which is interacting with both A- and B-type lamins 
(Al-Haboubi et al., submitted)(Smythe et al., 2000). Lamin B has been shown to interact 
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with Nup53, and more recently, Nup88 has been identified as novel lamin A binding 
partner (Hawryluk-Gara et al., 2005) (Lussi et al., submitted). Moreover, lamins interfere 
with the assembly and distribution of NPCs and clustering of NPCs is associated with 
lamin mutations (Schirmer et al., 2001; Smythe et al., 2000). In recent years, however, it 
became more and more evident that lamins are involved in cellular processes like DNA 
replication, transcription, cell survival and cell cycle regulation (Broers et al., 2006; 
Dechat et al., 2009; Dechat et al., 2008).  
 
 
Figure 1.4: The nuclear lamina. 
The nuclear lamina is engaged in the organization of chromatin and nuclear architecture and in 
anchoring and spacing of NPCs. The main components of the nuclear lamina are A- and B-type 
lamins. Different proteins bind to the lamins, anchor the lamina to the nuclear membrane and 
interact with chromatin. HP1: heterochromatin protein 1; LEM: LAP2, emerin, MAN1; BAF: 
barrier-to-auto-integration factor. Figure from Elsevier, Pollard et al.: Cell Biology 2e. 
 
1.9.1 Nuclear lamins 
According to their sequence homology and their biochemical behaviour, lamins 
can be classified in A- and B-type lamins. A-type lamins, mainly lamin A and lamin C, 
are encoded by the LMNA gene, arise through alternative splicing and are only expressed 
in differentiated cells. B-type lamins are encoded by two different genes, LMB1 and 
LMB2, giving rise to two major isoforms lamin B1 and lamin B2 and they are 
ubiquitously expressed and essential for cell viability and development (Harborth et al., 
2001; Lenz-Bohme et al., 1997; Liu et al., 2000; Osouda et al., 2005; Vergnes et al., 
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2004). Lamins are organized in three distinct domains: a N-terminal head domain, a 
central α-helical coiled-coil rod domain and a C-terminal tail domain (Figure 1.5). The 
rod domain can be divided into four coiled-coil segments 1A, 1B, 2A and 2B, which are 
separated by linker segments. The C-terminal domain contains a NLS and an 
immunoglobulin-like (Ig)-fold domain (Dhe-Paganon et al., 2002; Krimm et al., 2002). 
Furthermore, B-type lamins carry a motif in their C-terminus, referred to as the CAAX 
box (C = cysteine, A = aliphatic, X = any amino acid), which is posttranslationally 
modified through farnesylation, tethering the protein to the inner nuclear membrane 
(Prufert et al., 2004; Ralle et al., 2004). A-type lamins, except for lamin C, also contain a 
CAAX-motif and are farnesylated post-translationally, which is later on removed to 
produce the mature lamin A. The removal of the farnesylation renders the A-type lamins 
more soluble and they can therefore also be found distributed throughout the nucleoplasm 
(Bridger et al., 1993; Hozak et al., 1995; Moir et al., 2000b).  
 
 
Figure 1.5: Structural model of a lamin A dimer based on structural data and structure 
predictions. 
The central α-helical rod domain is subdivided into the coil segments 1A, 1B, 2A, 2B1 and 2B2. 
Linker segments that connect the individual α-helical segments are indicated: L1, L12 and L2. 
Left-handed coiled-coil segments are shown in green. Regions that are predicted to form nearly 
parallel α-helical bundles are represented in yellow. Non-α-helical linkers are shown in grey. The 
non-α-helical N- (head) and C-terminal (tail) domains are colored in blue and red, respectively. 
Adapted from (Herrmann et al., 2007). 
 
1.9.2 Nucleoplasmic lamin A and the lamina-associated polypeptide 2α  (LAP2α) 
In the nucleoplasm, A-type lamins appear in tight foci or in general 
nucleoplasmic distribution (Broers et al., 1999; Moir et al., 2000b). The distribution of 
lamin A seems to be cell cycle dependent, as the most nucleoplasmic lamin A 
accumulates in G1 phase (Bridger et al., 1993; Dechat et al., 2004; Moir et al., 2000b). 
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How the pool of nucleoplasmic lamin A is recruited to the nucleoplasm was not clear 
until recently. Several possibilities were discussed, one is that lamins are only transiently 
localizing to the nucleoplasm during their postttranslational modification before they 
assemble into the more peripheral filamentous lamina (Barrowman et al., 2008; Pendas et 
al., 2002). However, different observations speak for the existence of mature lamin A in 
the nucleoplasm (Barrowman et al., 2008; Dechat et al., 2000a). Another possibility is 
that lamin A might be posttranslationally modified to be targeted to the nucleoplasm, but 
the relevance of known lamin A modifications, such as phosphorylation and 
ubiquitination, regarding nucleoplasmic targeting has not been elucidated yet 
(Gruenbaum et al., 2003; Zhang and Sarge, 2008).  
Several studies addressed the question of how lamin A is targeted to the 
nucleoplasm and found the lamina-associated polypeptide 2α (LAP2α) to be involved in 
lamin A nucleoplasmic targeting (Berger et al., 1996; Dechat et al., 2000a; Dechat et al., 
2000b). LAP2α is a splice variant of the LAP2 gene. Up to six isoforms exist in humans 
(α, β, χ, δ, ε and ζ), generated by alternative splicing from a single gene (Berger et al., 
1996; Foisner and Gerace, 1993; Harris et al., 1994). Most LAP2 isoforms have a closely 
related N-terminal nucleoplasmic domain of variable length with a NLS sequence, a 
single-membrane spanning region, and a short luminal domain at their C-terminus. At 
their N-terminus, LAP2 proteins share a LEM (LAP2, emerin, MAN1) domain, which 
binds the DNA binding protein BAF (Furukawa, 1999; Lin et al., 2000; Shumaker et al., 
2001), and a LEM-like domain, which binds to DNA and chromosomes (Cai et al., 2001). 
Five of the LAP2 isoforms are integral proteins of the inner nuclear membrane and 
predominantly bind B-type lamins at the nuclear periphery. LAP2α is structurally and 
functionally unique. It shares the N-terminal 187 residues with all other LAPs but 
contains a unique C-terminal domain of 506 residues, which lacks a membrane-spanning 
domain. As a result, LAP2α is distributed diffusely throughout the interphase nucleus 
except for nucleoli (Dechat et al., 1998), where it interacts with lamin A and chromatin in 
a cell cycle dependent manner (Dechat et al., 2004; Dechat et al., 2000a). LAP2α -
deficient mouse fibroblasts have greatly reduced nucleoplasmic A-type lamins in G1 
phase (Naetar et al., 2008), suggesting that LAP2α is targeting or stabilizing 
nucleoplasmic lamin A in G1 phase of the cell cycle. In S phase, however, there is an 
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unknown LAP2α-independent pathway that leads to recruitment of nucleoplasmic lamins 
A and C to the nuclear periphery.  
 
1.10  The lamin A- LAP2α  complex and the retinoblastoma 
protein (pRb) 
Several observations have implicated the lamin A-LAP2α complex in cell cycle 
regulation. During myoblast differentiation in vitro, nucleoplasmic lamins A/C and 
LAP2α expression is lost when cells stop to proliferate and fuse to myotubes 
(Markiewicz et al., 2005). Similarly, cells going from a proliferating to a permanently 
arrested, senescent state, loose nucleoplasmic lamin A and downregulate the expression 
of LAP2α (Pekovic et al., 2007). Both lamin A and LAP2α have been shown to interact 
with the tumor suppressor retinoblastoma protein (pRb), a major cell cycle regulator, 
which provides a potential mechanism as to how the lamin A-LAP2α complex can affect 
cell cycle progression (Dechat et al., 2000a; Mancini et al., 1994; Markiewicz et al., 
2002; Ozaki et al., 1994).  
pRb is involved, besides many other functions, in the control of E2F transcription 
factors and is itself regulated by cyclin-dependent kinase (Cdk)-mediated 
phosphorylation (Kitagawa et al., 1994; Suzuki-Takahashi et al., 1995). In early G1, 
hypophosphorylated Rb is tethered in the nucleus and is capable of binding transcription 
factor E2F-1, which prevents the transcriptional activation of S phase-specific genes and 
cell cycle progression to S phase. By binding to the transcription factor, pRb blocks the 
transactivation domain of E2F-1, inhibits recruitment of preinitiation complexes and 
represses genes directly by recruiting chromatin-modifying proteins, including histone 
deacetylase HDAC1 (Brehm, 1998), methyl transferase Suv39h, and heterochromatin 
protein HP1 (Nielsen, 2001; Ait-Si-Ali, 2004). Hyperphosphorylation of pRb during late 
G1 phase by cyclin D and E-dependent kinases (Mittnacht 1998) releases it from E2F-1, 
causing its activation as a transcription factor, which leads to expression of cell cycle 
genes and to passage through S phase. LAP2α was found to localize to E2F-dependent 
promotor sequences and to maintain E2F in a repressed state (Dorner et al., 2006). In 
human cells, depletion of LAP2α accelerates G1-S transition, leads to impaired cell cycle 
arrest and upregulation of E2F target genes, whereas overexpression of C-terminal pRb-
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binding domain of LAP2α causes a cell cycle arrest in interphase, and overexpressed 
LAP2α inhibits E2F/pRb-dependent reporter gene activity and leads to cell cycle exit and 
initiates differentiation (Dorner et al., 2006; Naetar et al., 2008; Vlcek et al., 2002). 
Similarly, lamin A-deficient murine fibroblast cells proliferate faster and have an 
impaired cell cycle arrest upon DNA damage (Nitta et al., 2006; Van Berlo et al., 2005).  
One study in mouse fibroblast cells showed that cells lacking lamin A have decreased 
pRb levels and that the remaining pRb is mislocalized, which might explain the disturbed 
proliferation control (Johnson et al., 2004). However, a different study suggests an altered 
pRb phosphorylation that underlies the observed proliferation defects. Altogether, lamin 
A-LAP2α complexes have a role in regulating pRb activity during the cell cycle, and 
whether the lamin A-LAP2α complex regulates stability or phosphorylation of pRb or 
both, needs to be further elucidated.  
 
1.11  Laminopathies 
Mutations in LMNA have been discovered in a variety of human disease 
syndromes including forms of muscular dystrophy, lipodystrophy and premature aging, 
so called laminopathies (Burke and Stewart, 2002; Hutchison and Worman, 2004; 
Mounkes and Stewart, 2004; Worman and Bonne, 2007). These laminopathies can be 
broadly divided into two group: first, neuromuscular disorders affecting directly the 
skeletal muscle, cardiac muscle and peripheral nervous system, e.g. Emery-Dreifuss 
muscular dystrophy (EDMD), dilated cardiomyopathy (DCM) or limb-girdle muscular 
dystrophy 1B (LGMD1B), characterized by skeletal muscle wasting and striated and 
smooth muscle defects and subsequent heart failure (Bonne et al., 1999); second, partial 
lipodystrophy syndromes with or without developmental abnormalities and premature 
aging, such as mandibuloacral dysplasia (MAD) and Dunnigan-type familial partial 
lipodystrophy (FPLD) characterized by aberrant adipose tissue distribution (Boguslavsky 
et al., 2006) and Hutchinson-Gilford progeria Syndrome (HGPS) a well as atypical 
Werner’s syndrome, which are characterized by loss of subcutaneous fat, decreased bone 
density, osteoporosis and growth retardation. How lamin A mutations lead to these tissue-
specific syndromes is not exactly clear, and it is an ongoing discussion on how lamin A 
contributes to healthy tissue differentiation. It is known that lamin A interacts with the 
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sterol regulatory element-binding protein (SREB), a transcription factor, which is 
involved in adipogenesis (Lloyd et al., 2002), raising the possibility that lamin-associated 
lipodystrophies might be caused by altered interaction between SREB and lamin A. 
Given that lamin A, together with LAP2α, controls stability and function of pRb, which 
is required for the differentiation of muscle and adipose tissue (Haigis et al., 2006; 
Hansen et al., 2004; Huh et al., 2004; Korenjak and Brehm, 2005; Lipinski and Jacks, 
1999; Ruiz et al., 2004; Smith et al., 2005), it is possible that dystrophic syndromes 
arising from LMNA mutations may result, as least in part, from deregulation of pRb 
function. Indeed, analysis of biopsies from laminopathy-type muscular dystrophy patients 
revealed an impairment of the Rb/MyoD pathway, which is required for muscle 
generation (Bakay et al., 2006). Whether pRb misregulation plays a role in other 
laminopathic disease needs to be further elucidated. 
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2.1 Abstract 
The nucleoporin Nup153 is known to play pivotal roles in nuclear import and 
export in interphase cells and as the cell transitions into mitosis, Nup153 is involved in 
nuclear envelope breakdown. In this study, we demonstrate that the interaction of Nup153 
with the spindle assembly checkpoint protein Mad1 is important in the regulation of the 
spindle checkpoint. Overexpression of human Nup153 in HeLa cells leads to the 
appearance of multinucleated cells and induces the formation of multipolar spindles. 
Importantly, it causes inactivation of the spindle checkpoint due to hypophosphorylation 
of Mad1. Depletion of Nup153 using RNA interference results in the decline of Mad1 at 
nuclear pores during interphase and more significantly causes a delayed dissociation of 
Mad1 from kinetochores in metaphase and an increase in the number of unresolved 
midbodies. In the absence of Nup153 the spindle checkpoint remains active. In vitro 
studies indicate direct binding of Mad1 to the N-terminal domain of Nup153. 
Importantly, Nup153 binding to Mad1 affects Mad1's phosphorylation status, but not its 
ability to interact with Mad2. Our data suggest that Nup153 levels regulate the 
localization of Mad1 during the metaphase/anaphase transition thereby affecting its 
phoshorylation status and in turn spindle checkpoint activity and mitotic exit.  
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2.2 Introduction 
Nuclear pore complexes (NPCs) are macromolecular assemblies that bridge the 
double membrane of the nuclear envelope (NE) and control nucleocytoplasmic transport 
in interphase cells (D'Angelo and Hetzer, 2008; Lim et al., 2008; Lim and Fahrenkrog, 
2006; Tran and Wente, 2006). The vertebrate NPC is composed of ~30 different proteins, 
called nucleoporins (Nups), which include Nup153. Nup153 resides on the nuclear side 
of the NPC and immuno-electron microscopy (EM) analysis revealed that the N-terminal 
and central zinc-finger domains of Nup153 are anchored to different sites within the 
NPC's nuclear basket (Fahrenkrog et al., 2002). The localization of the Nup153 C-
terminal domain, which mediates interactions with soluble nuclear transport receptors, is 
variable and dependent on the nucleocytoplasmic transport state (Fahrenkrog et al., 2002; 
Paulillo et al., 2005). Through its interactions with various nuclear transport receptors, 
Nup153 is known to be critical for both nuclear import and export (Bastos et al., 1996; 
Nakielny et al., 1999; Shah et al., 1998; Ullman et al., 1999; Walther et al., 2001). 
Further support for the importance of Nup153 has resulted from RNA 
interference (RNAi) studies showing that it is required for maintaining the structural 
integrity of the nuclear basket and the survival of both tissue culture cells and C. elegans 
(Galy et al., 2003; Harborth et al., 2001; Walther et al., 2001). Nup153 also plays a role 
in NE breakdown in Xenopus nuclei (Liu et al., 2003; Prunuske et al., 2006) and in 
dosage compensation in Drosophila (Mendjan et al., 2006). In addition, chromosomal 
rearrangements of NUP153 are associated with its increased expression in urothelial and 
retinoblastoma cancer (Heidenblad et al., 2008; Orlic et al., 2006). Furthermore, Nup153 
is a positive regulator of Hedgehog signaling (Nybakken et al., 2005) and it is required 
for centrosome reorientation during cell migration in neurons (Collin et al., 2008). These 
results suggest that Nup153 is involved in differentiation and tissue development and that 
altering either the amount of Nup153 or its function is related to human disease. The 
mechanistic basis for Nup153 function in these different cellular processes has remained 
largely elusive. Many of these functions, however, point to a role in cell cycle regulation. 
A putative role for Nup153 in cell cycle regulation is further supported by the notion that 
Nup153 appears to be required for the localization of the spindle assembly checkpoint 
(SAC) protein Mad1 to NPCs in interphase cells (Hawryluk-Gara et al., 2005). 
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The SAC acts to prevent chromosome mis-segregation and aneuploidy by 
delaying the metaphase-anaphase transition until all chromosomes are properly attached 
to the mitotic spindle and aligned at the metaphase plate (Musacchio and Salmon, 2007). 
Two SAC proteins, Mad1 and Mad2, are located at NPCs in interphase cells (Campbell et 
al., 2001; Iouk et al., 2002). Mad2 is thought to play a key role for mitotic checkpoint 
because of its inhibitory effect on the anaphase promoting complex/cyclosome (APC/C) 
(Musacchio and Salmon, 2007; To-Ho et al., 2008). The binding of Mad2 to Mad1 and 
Cdc20, a co-factor of APC/C, is thought to be crucial for Mad2 function. Loss of the 
interaction between these proteins results in an impaired SAC, aneuploidy and failed 
cytokinesis (Musacchio and Salmon, 2007; To-Ho et al., 2008). The role of Mad1 during 
metaphase/anaphase transition on the other hand appears regulatory as the depletion of 
Mad1 results in SAC deficiency without significantly altering the duration of mitosis 
(Musacchio and Salmon, 2007). 
The function of the SAC proteins at the NPC has remained largely elusive, 
although it has been suggested that the NPC may play a role in the duration of the SAC 
(Kastenmayer et al., 2005; Scott et al., 2005). Here, we have examined the effect of 
altering Nup153 expression in HeLa cells and found that Nup153 levels affect spindle 
checkpoint activity due to binding of Nup153 to the SAC protein Mad1.  
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2.3 Results 
 
2.3.1 Enhanced levels of Nup153 lead to multinucleation and multilobulation of 
cells 
To gain further insights into Nup153 function, we analyzed the effects of altering 
Nup153 levels in HeLa cells. Following transfection with GFP-human Nup153 (GFP-
Nup153), cells with low to moderate expression levels displayed typical nucleoporin 
staining patterns at the NE (Figure 2.1a), while higher expression levels resulted in 
dramatic alterations in nuclear architecture. These alterations include misshapen nuclei 
and the accumulation of GFP-Nup153 in intranuclear foci that are frequently associated 
with the NE (Figure 2.1b and c) as has been previously described (Bastos et al., 1996). 
Moreover, enhanced levels of GFP-Nup153 cause highly lobulated nuclei (Figure 2.1, d-
f) with some similarities to so-called flower cells (Jin et al., 1998). Most strikingly, the 
accumulation of GFP-Nup153 induces the formation of multinucleated cells (Figure 2.1, 
f-m). The NEs of nuclei in multinucleated cells have an abnormal nuclear shape and are 
more invaginated than NE's in cells containing a single nucleus. In addition, nuclei in 
multinucleated cells frequently appear to be closely apposed to each other, lending to the 
impression that their envelopes are fused in certain regions (Figure 2.1, g and k, arrows). 
These fusions are also detectable on electron microscopy levels (Figure S7.1). Further 
work will be needed to elucidate the actual nature of these fusions. 
Overexpression effects of Nup153 were not restricted to HeLa cells as the same 
phenotypes were obtained in HEK293 and Xenopus A6 cells following transfection with 
GFP-Nup153 (Figure S7.2, a and b), while expression of other nucleoporins, i.e. 
Nup358/RanBP2, Nup62, Nup88 (not shown) and Tpr (Figure S7.2, d-f), or GFP alone 
(Figure S7.2c) did not result in nuclear foci, nuclear lobulation or multinucleation. These 
experiments indicate that overexpression of GFP-Nup153 can cause rearrangements in 
the nuclear envelope indicated by lobulation of the nuclei and multinucleation, which 
implies abnormal mitosis.  
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Figure 2.1: Overexpression of human Nup153 causes changes in nuclear shape and aberrant 
mitosis.  
HeLa cells were transfected with GFP-Nup153 and visualized by direct fluorescence microscopy 
48 hours post transfection. (a) At lower expression levels GFP-Nup153 localizes to nuclear pore 
complexes as indicated by a typical rim staining, whereas at higher levels (b- e) GFP-Nup153 
accumulates in the nucleus close to the nuclear envelope and causes strong lobulation of nuclei. (e-
i) Enhanced levels of GFP-Nup153 lead to the appearance of multinucleated cells and in some 
cases micronuclei (e). Arrows in g and k mark nuclei of multinucleated cells, which appear to be 
closely apposed to each other or fused in certain regions. Shown are confocal fluorescence 
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micrographs (a-f, g, k), differential-interference-contrast (h, l) and coincident fluorescence/ 
differential-interference-contrast images (i, m). Scale bars, 5 µm (a-e), 10 µm (f-m). 
 
2.3.2 Enhanced levels of Nup153 lead to multinucleation in live cells 
Multinucleation of cells can be a consequence of various alterations in cell 
division, such as altered chromosome separation or failures of the spindle checkpoint and 
cytokinesis (King, 2008). To determine how cells become multinucleated, we studied the 
effect of GFP-Nup153 overexpression in HeLa cells by live cell imaging. A 
representative series of time-lapse images shows a normal cell division (Figure 2.2a) 
compared with an abnormal mitotic progression without cytokinesis in a cell containing 
an apparent tri-polar spindle culminating in a cell with at least two nuclei (Figure 2.2b). 
Even more striking, progression through mitosis without cytokinesis of a cell with an 
apparent multipolar spindle resulted in a multinucleated cell with more than 10 nuclei 
(Figure 2.2c; see also Figure 2.1f). Multinucleation was not observed in 23 untransfected 
HeLa cells that were followed through mitosis by live cell imaging (data not shown). 
Together these data indicate that multinucleation in the presence of increased GFP-
Nup153 levels in the cells is a consequence of failed cytokinesis rather than abnormal 
chromosome separation. 
To further support this notion, we performed cell sorting and flow cytometric 
analysis to determine the DNA content of nuclei isolated from cells expressing GFP-
Nup153 (nuclei, not the intact cells) as compared to nuclei from untransfected control 
cells. Our analysis revealed changes in ploidy in nuclei expressing GFP-Nup153 
compared to nuclei from untransfected cells (Figure 2.2, d and e). GFP-Nup153 nuclei 
show a strong increase in aneuploidy indicated by both low N nuclei (Figure 2.2e, arrow) 
as well as a substantial increase in high N nuclei (Figure 2.2e, inset) compared to control 
nuclei (15.2 ± 5.1% versus 1.2 ± 0.2% aneuploid cells). In both populations, the 
percentage of nuclei in G1, S and G2 phase of the cell cycle, respectively, and the overall 
G1:G2 ratio were similar (Figure 2.2, d-f), indicating that despite a failure in cytokinesis, 
DNA synthesis and chromosome segregation appear to be unaffected. 
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Figure 2.2: High levels of Nup153 expression interfere with cytokinesis and induce 
aneuploidy. 
GFP-Nup153 (green) and phase contrast time-lapse images of HeLa cells 48 hours post 
transfection and their progression through mitosis are presented. (a) Normal cell division and (b, 
c) nuclear division without cell separation can be observed. Scale bars, 10 µm (a), 5 µm (b, c). 
HeLa cells expressing GFP-Nup153 48 h post transfection were prepared for flow cytometry by 
staining DNA with propidium iodide and control cells not expressing GFP (d) were compared 
with GFP-positive cells (e). Whereas no significant effect on cell cycle progression as 
demonstrated by the G1:G2 ratio was detectable, there was a significant increase in the number of 
aneuploid nuclei in GFP-Nup153 expressing cells. Insets are 6x enlarged in the vertical axis 
showing a substantial increase in high N nuclei in cells expressing GFP-Nup153. (f) Quantification 
of the cell cycle profiles from six independent experiments.  
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2.3.3 Expression of Nup153 induces multipolar spindles 
Our data suggest a possible link between Nup153, mitotic spindle function and 
completion of cytokinesis. To better understand the effect of Nup153 on these processes, 
HeLa cells stably expressing histone H2B-GFP were transfected to express GFP-Nup153 
and immunostained for actin and microtubules, two key players in cell division (Eggert et 
al., 2006). Whereas these cells displayed a normal actin cytoskeleton in interphase and at 
the cleavage furrows in mitosis (not shown), we observed alterations in the microtubule 
networks (Figure 2.3, a-c). Cells expressing GFP-Nup153 displayed a substantial increase 
in the number of aberrant mitoses, shown by multipolar spindles (Figure 2.3, a and b) and 
lagging chromosomes (Figure 2.3c). In controls, 6% (5.8 ± 1.8%) of the mitotic cells 
displayed multipolar spindles, while ~26% (26.2 ± 3.7%; p <0.005) of GFP-Nup153 
expressing cells exhibited multipolar spindles (Figure 2.3g). 
Nup153 is a multi-domain protein and we next aimed to determine which domain 
of Nup153 was responsible for the aberrant mitosis phenotype. To do so, various 
truncations of Nup153 were prepared. The N-terminal domain of Nup153 harbors the 
NPC assembly region (NPAR), residues 39 to 339 (Enarson et al., 1998). The NPAR is 
sufficient to target Nup153 to the NPC, but lacks residues that are required to target 
soluble proteins, such as nuclear transport receptors, to the inner nuclear membrane (Ball 
and Ullman, 2005; Enarson et al., 1998). When fused to GFP and transfected into HeLa 
cells, GFP-Nup153-39-339 associates with NPCs and the nucleoplasm (Figure S7.3a), 
aggregates in intranuclei foci, induces nuclear deformation (Figure S7.3b), and 
multinucleation (Figure S7.3, c and d). Moreover, GFP-Nup153-39-339 causes multipolar 
spindle formation in ~25% of the mitotic cells (24.7 ±2.5%; p <0.005) as revealed by 
staining with an antibody against β-tubulin (Figure 2.3d). Further truncating the NPAR 
into two fragments, residues 39-144 and 145-339, revealed that residues 145-339 induced 
multipolar spindles in ~20% of the mitotic cells (Figure 2.3, e and i; 19.2 ± 5.5%; p 
<0.005) and are targeted to the nucleus (Figure S7.3e-h). GFP-Nup153-39-144 is found in 
the cytoplasm and nucleus (Figure S7.3i-m) and the number of cells with multipolar 
spindles is not significantly increased (12.1 ± 2.2%; Figure 2.3i). Together these data 
show that the NPAR of Nup153 and in particular residues 145-339 interfere with normal 
mitoses. 
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Figure 2.3: Overexpression of the nuclear pore complex assembly region (NPAR) of Nup153 
induces mitotic abnormalities. 
HeLa cells expressing histone H2B-GFP were transfected with GFP-Nup153 (a-c), GFP-Nup153-
39-339 (d; i.e. the NPAR of Nup153), GFP-Nup153-39-144 (e) or GFP-Nup153-144-339 (f) and 
prepared for immunofluorescence 48 hours post transfection using monoclonal antibodies directed 
against β- (e-f). Cells expressing either GFP-Nup153, GFP-Nup153-39-339, or GFP-Nup153-144-
339 showed poor spindle morphology and a strong increase in the frequency of multipolar spindles 
(a, b, d and e) and lagging chromosomes (c). Cells expressing the N-terminal portion of the 
NPAR, GFP-Nup153-39-144, show predominantly normal bipolar spindles (f). Scale bars, 5 µm. 
(g) Quantification of the number of multipolar spindles among mitotic cells. Cells were 
significantly more likely to have multipolar mitotic spindles when expressing Nup153 (26.2 ± 3.7 
%), Nup153-39-339 (24.7 ± 2.5 %), or Nup153-144-339 (19.2 ± 5.5 %) than control cells or cells 
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expressing Nup153-39-144. Spindles were counted from 3-4 independent experiments with 
typically 100-200 spindles per experiment. 
 
2.3.4 Nup153 levels affect the spindle assembly checkpoint 
Abnormal mitoses with lagging chromosomes and multipolar spindles indicated a 
weakened SAC and two SAC factors, Mad1 and Mad2, are known to localize to NPCs in 
interphase cells. In turn, the Mad1- and Mad2-binding nucleoporins may have some 
activity during mitosis. Several nucleoporins appear to mediate the association of the 
Mad1-Mad2 complex to the NPC (Iouk et al., 2002; Lee et al., 2008; Scott et al., 2005) 
and Nup153 has been suggested to be required for Mad1 localization (Hawryluk-Gara et 
al., 2005; Scott et al., 2005). To test if Nup153 function in mitosis is related to the spindle 
checkpoint, we examined the potential interaction between Nup153 and Mad1 by indirect 
immunofluorescence and found that Mad1 in fact colocalizes with NPCs as indicated by a 
punctated nuclear rim staining, typical for nucleoporins (Figure 2.4a, top panels) and 
consistent with previously published data (Campbell et al., 2001). 
To more precisely determine the position of Mad1 within the NPC, we next 
performed immuno-EM using Xenopus oocyte nuclei. Nuclei were isolated manually and 
incubated with an anti-Mad1 antibody directly conjugated to 8-nm colloidal gold and 
processed for thin-sectioning EM. As illustrated in Figure 2.4b, the Mad1 antibody 
recognizes distinct epitopes on the nuclear side of the NPC. Quantification of the gold 
particle distribution with respect to the central plane of the NE revealed the major 
epitope, with about 50% of the gold particles, at distances of -10 to -50 nm from the 
central plane with a peak at -28.8 nm (± 8.5 nm). Together with corresponding radial 
distances of 0 to 30 nm (peak at 19.1 nm ± 14.2 nm) this corresponds to an epitope at the 
nuclear ring moiety of the NPC. 
We have previously mapped the N-terminal domain of Nup153 to the nuclear 
ring moiety of the NPC (Fahrenkrog et al., 2002) and compared the localization of 
Nup153 with the Mad1 epitope at the nuclear ring. As shown in Figure 2.4b (right panel), 
both antibody epitopes are overlapping, indicating that in fact about 50% of Mad1 
colocalizes with Nup153's N-terminal domain. The remaining 50% of Mad1 epitopes are 
found within the nuclear basket of the NPC (Figure 2.4b), consistent with Mad1 having 
multiple binding partners at the NPC (see (Hawryluk-Gara et al., 2005; Lee et al., 2008)). 
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In contrast to Mad1, Mad2 was not found in close proximity to Nup153. Antibodies 
against Mad2 conjugated to 8-nm colloidal gold recognized distinct epitopes in the centre 
as well as on the cytoplasmic face of the NPC (Figure S7.4a). 
 
 
Figure 2.4: Nup153 interacts with the spindle checkpoint protein Mad1.  
(a) Mad1 localizes to nuclear pore complexes (NPCs) in interphase cells. HeLa cells were double 
immunostained with a polyclonal antibody against Nup153 and a monoclonal antibody against 
Mad1. Scale bars, 5 µm. (b) Immuno-electron microscopy localization of Mad1 in Xenopus oocyte 
nuclei. Nuclei were isolated manually and labeled with a monoclonal Mad1 antibody directly 
conjugated to 8nm colloidal gold. Mad1 localizes to the nuclear side of the NPC with several 
epitopes at the nuclear basket (left). Quantification of the gold particle distribution revealed that 
about 50% of the gold particles were associated with the nuclear ring moiety of the NPC (middle). 
The epitope at the nuclear ring moiety that is recognized by the Mad1 antibody overlaps with the 
epitope that is recognized by an antibody against the N-terminal domain of Nup153(Fahrenkrog et 
al., 2002; Walther et al., 2001) as shown schematically by elliptic location clouds (right). Scale 
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bar, 100 nm. (c) Total HeLa extracts from unsynchronized or nocodazole arrested cells were 
immunoprecipitated using either anti-Mad1 or anti-Nup153 antibody. Equivalent amounts of HeLa 
extracts (L), immune supernatants (S) and immune precipitate (P) were separated by SDS-PAGE 
and analyzed by immunoblotting using Mad1 and Nup153 antibodies. Immunoprecipitations 
brought down the corresponding protein. (d) Bacterially expressed GST-Nup153, GST-Nup153-N, 
GST-Nup153-N339 and GST were bound to glutathione beads then incubated with in vitro-
synthesized 35S-labeled Mad1. Expressed and purified GST was unable to bind 35S-Mad1 while all 
truncations of GST-Nup153 containing the NPAR region bound 35S-Mad1. Unbound and bound 
fractions were analyzed by SDS-PAGE and autoradiography. 
 
2.3.5 Nup153 and Mad1 are directly interacting 
To further confirm that Nup153 interacts with Mad1 at NPCs, lysates from HeLa 
cells were immunoprecipitated both with antibodies directed against Mad1 (Figure 2.4c, 
top left panel) and Nup153 (Figure 2.4c, bottom left panel). The HeLa extracts, 
supernatant, and pellet proteins were separated by SDS-PAGE, transferred to a PVDF 
membrane and probed with antibodies to Nup153 and Mad1. This set of experiments 
demonstrated that Nup153 associates with Mad1 in HeLa cells. To elucidate if the 
interaction between Nup153 and Mad1 is maintained during mitosis, we prepared lysates 
from HeLa cells that had been arrested in mitosis after treatment with nocodazole. Mitotic 
lysates that were immunoprecipitated with antibodies against Mad1 co-precipitated 
Nup153 (Figure 2.4c, top right panel), indicating that Nup153 and Mad1 interact 
throughout the cell cycle. Under the same conditions, Mad2 was found to co-precipitate 
with Mad1 antibodies (Figure S7.4b), but not with Nup153 (Figure S7.4c), indicating that 
Nup153 specifically interacts with Mad1. 
To determine which domain of Nup153 interacts with Mad1, we next performed 
solution-binding assays. Purified recombinant Nup153 domains fused to GST were 
attached to glutathione sepharose beads and incubated with in vitro transcribed and 
translated 35S-labeled Mad1. Mad1 interacts with GST-Nup153, with the N-terminal 
domain of Nup153 (GST-Nup153-N, i.e. residues 2 to 610) and a truncation of the N-
terminal domain comprising the first 339 residues of Nup153 (GST-Nup153-N339), but 
not with GST alone (Figure 2.4d). Together, these data indicate that the interaction of 
Nup153 with Mad1 is mediated by Nup153's NPAR. 
 
2.3 Results 
 62 
2.3.6 Nup153 affects the spindle checkpoint 
We next explored the functional significance of the Nup153-Mad1 interaction on 
the spindle checkpoint. To do so, we treated control, Nup153-depleted (see below), 
Mad1-depleted (80% reduction of Mad1 mRNA as determined by qRT-PCR; data not 
shown) and GFP-Nup153 expressing HeLa cells, respectively, with nocodazole to 
activate the spindle checkpoint and analyzed their ability to arrest in mitosis by light 
microscopy. As shown in Figure 2.5a, HeLa cells as well as HeLa cells transfected with 
control siRNA rounded up and became arrested in mitosis upon nocodazole treatment for 
20 hours. Similarly, Nup153 depleted cells were able to arrest in mitosis. In contrast, cells 
overexpressing GFP-Nup153 or depleted for Mad1 failed to arrest in mitosis. Although 
unlikely, a lack of mitotic cells after nocodazole treatment could also be due to a G1 and 
a G2 arrest upon overexpression of Nup153. To exclude this possibility, HeLa cells 
transfected with GFP-Nup153 were subjected to a double thymidine block to study their 
ability to progress into mitosis after release. Cells overexpressing GFP-Nup153 were able 
to enter mitosis, similarly to various control cells (Figure S7.5). 
Together our data therefore indicate that enhanced Nup153 levels disable a 
functional checkpoint. To test if Nup153 in fact directly affects the SAC via Mad1, we 
co-expressed GFP-Nup153 together with GFP-Mad1. GFP-Mad1 was found to localize to 
NPCs in interphase cells and to kinetochores in prometaphase (data not shown), 
indicating that it is functional. HeLa cells that were co-transfected with GFP-Nup153 and 
GFP-Mad1 were found to arrest in mitosis when treated with nocodazole (Figure 2.5a), 
suggesting that Nup153 directly acts on the SAC via Mad1. 
To further examine whether cells were in mitosis following nocodazole 
treatment, cells were immunostained with antibodies directed against histone H3 
phosphorylated on Ser10. Cells expressing GFP-Nup153 were substantially decreased in 
their mitotic index (20%) as compared to control cells (60%). Similarly Mad1-depleted 
cells exhibited a low mitotic index (6%), while Nup153-depleted cells and cells co-
expressing GFP-Nup153 and GFP-Mad1 were more similar to controls (50%; Figure 
2.5b). Together these data indicate that enhanced levels of Nup153 abrogate SAC 
function, while the SAC remains intact in the absence of Nup153. 
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A functional SAC requires the interaction between Mad1 and Mad2. Mad1 is a 
phosphoprotein and hyperphosphorylated when bound to Mad2 in mitosis and 
phosphorylation of Mad1 is critical for SAC function (Chen et al., 1999). To determine if 
Nup153 effects Mad1 phosphorylation, we conducted co-immunoprecipitation 
experiments of cells after nocodazole treatment. We immunoprecipitated Mad1 from 
lysates of nocodazole arrested HeLa cells that were either transfected with GFP-Nup153 
or Nup153 siRNAs using a monoclonal Mad1 antibody. Mad1 phosphorylation was 
assessed by Western blotting using an antibody that recognizes a phosphorylated 
serine/threonine/or tyrosine residue (α-pSTY). Indeed, the α-pSTY antibody detected 
phosphorylated Mad1 in control cells, whereas the levels of phosphorylated Mad1 were 
largely reduced in GFP-Nup153 transfected cells (Figure 2.5c, left panels), but not in 
Nup153-depleted cells (Figure 2.5c, right panels). Neither the Mad1 nor the pSTY 
antibody was found to bind to the protein G-agarose beads alone (Figure S7.6). 
Quantification of the band intensity revealed that about 28% of the precipitated Mad1 was 
phosphorylated in control cells, but only 17.8% in the GFP-Nup153 transfected cells. The 
amount of Mad2 that co-precipitated with Mad1 was not affected in cells expressing 
GFP-Nup153 (Figure 2.5c, left) or Nup153-depleted cells (Figure 2.1c, right). Together 
these data suggest that increased levels of Nup153 abrogate SAC function by diminishing 
Mad1 phosphorylation without affecting its association with Mad2. Reduced levels of 
Nup153 on the contrary do not impair Mad1's phosphorylation status, leaving the SAC 
functional. 
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Figure 2.5: Enhanced levels of Nup153 affect spindle checkpoint activity. 
(a) Phase contrast images of untransfected HeLa cells or cells that were transfected with control 
siRNA, Mad1 siRNA, Nup153 siRNA, GFP-Nup153 or GFP-Nup153 and GFP-Mad1, 
respectively, and treated with nocodazole for 20 hours to activate the spindle checkpoint. Whereas 
untransfected or GFP-Nup153/GFP-Mad1 transfected HeLa cells or cells treated with control and 
Nup153 siRNAs rounded up and arrested in mitosis, cells treated with Mad1 siRNA or expressing 
GFP-Nup153 did not. (b) HeLa cells were transfected with siRNAs or GFP-Nup153, respectively, 
and treated with nocodazole for 20 hours. After nocodazole treatment, cells were stained with a 
phospho-histone H3 antibody and immunofluorescence microscopy was performed. Quantification 
of the mitotic index by counting the population of cells positive for phospho-histone H3 staining 
(n>300). (c) Total HeLa extracts from GFP-Nup153 transfected and untransfected nocodazole 
arrested cells were immunoprecipitated using anti-Mad1 antibody. Equivalent amounts of HeLa 
extracts (L), immune supernatants (S) and immune precipitate (P) were separated by SDS-PAGE 
and analyzed by immunoblotting using an anti-pSTY antibody (αpSTY) that specifically 
recognizes a phosphorylated serine/threonine/or tyrosine residue and an anti-Mad2 antibody. 
Asterisks mark the antibody light chain. Immunoblotting using anti-Mad1 verified the 
immunoprecipitation of Mad1. 
 
2.3.7 Nup153 levels affect Mad1 localization 
To explore how Nup153 might affect Mad1 phosporylation, we tested whether 
Nup153 is important for regulating the localization of Mad1 in interphase and/or mitosis. 
To do so, Nup153 was depleted from HeLa cells using RNA interference. Transfection of 
HeLa cells expressing histone H2B-GFP with short interfering (si) RNAs resulted in an 
80% reduction in Nup153 both at the mRNA and protein levels as determined by 
quantitative real-time PCR (qRT-RCR) and immunoblotting, respectively (Figure S7.7, a 
and b). Under these conditions the HeLa cells remain viable, whereas a more complete 
knock down causes growth arrest of the cells (Harborth et al., 2001). The siRNAs 
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specifically depleted Nup153 from NPCs without co-depleting other nucleoporins, such 
as Nup62 or Tpr as analyzed by Western blotting (Figure S7.7b) and immunofluorescence 
(Figure S7.7d). Additionally, qRT-PCR demonstrated that Tpr mRNA was also not 
reduced (Figure S7.7c). These results are at variance with a recent study, where a near 
complete loss of Nup153 resulted in a Tpr mislocalization and a reduction in its protein 
level (Hase and Cordes, 2003). These discrepancies likely result from the different levels 
of Nup153 depletion (~80% versus ~100%). 
Having determined that our siRNA treatment specifically affected Nup153, we 
studied the effect of Nup153 depletion on Mad1 localization throughout the cell cycle.  
This resulted in a reduced localization of Mad1 at the NPC in interphase (Figure 
2.6a), indicating that Nup153 is in part required for Mad1 binding to the NPC. As cells 
progress through mitosis, Mad1 localization at kinetochores in prometaphase remains 
unchanged in the presence or absence of Nup153 (Figure 2.6a). However, in metaphase, 
Mad1 dissociates from kinetochores and is found dispersed in control cells, whereas it 
remains associated with kinetochores in Nup153-depleted cells. Moreover, in telophase, 
the recruitment of Mad1 to the newly formed NE is inefficient in the absence of Nup153 
(Figure 2.6a). 
We next performed co-localization experiments of GFP-Nup153 with Mad1 and 
determined that by indirect immunofluorescence Mad1 and GFP-Nup153 colocalize at the 
NE and in the intranuclear GFP-Nup153 foci of interphase cells (Figure 2.6b). We have 
not observed colocalization with GFP-Nup153 foci for Tpr (Figure S7.7), other FG-repeat 
nucleoporins recognized by the mAb414 antibody or the nuclear lamina protein lamin A 
and only partially with lamin B2 (not shown), indicating that Nup153 overexpression 
specifically perturbs Mad1 localization. Nup153 overexpression most likely also affects 
Mad1 localization during mitosis, however, our attempts to colocalize GFP-Nup153 and 
Mad1 in mitotic cells were inconclusive likely due to a temporary interaction between 
Mad1 and Nup153. 
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Figure 2.6: Localization of the spindle assembly checkpoint protein Mad1 is dependent on 
Nup153. 
(a) HeLa cells expressing histone H2B-GFP were transfected with control or Nup153 siRNAs, 
fixed and stained with anti-Mad1 antibodies. Control nuclei displayed a significant localization of 
Mad1 at the nuclear rim, while cells depleted for Nup153 lost Mad1 from the nuclear rim. Mad1 
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localizes to kinetochores in prometaphase cells and dissociates from the kinetochores in mitosis, 
before it is recruited back to the NE in telophase (left panels). In the absence of Nup153, Mad1 is 
present at kinetochores in prometaphase, where a significant pool remains during mitosis. Mad1 
recruitment to the reforming NE in telophase is impaired in cells lacking Nup153 (right panels). 
(b) Overexpression of GFP-Nup153 perturbs Mad1 localization in HeLa cells. HeLa cells were 
transiently tranfected with GFP-Nup153 and immuno-stained with a Mad1 antibody. Mad1 
colocalizes with GFP-Nup153 foci in the nucleus (bottom), while both proteins reside at NPCs in 
control cells stained with antibodies against Mad1 and Nup153, respectively. Scale bars, 5µm. 
 
2.3.8 Depletion of Nup153 causes cytokinetic abnormalities 
To further examine the role of Nup153 in mitosis, we studied the effect of 
Nup153 depletion on cell division. Cells transfected with control siRNA underwent 
normal cytokinesis (Figure 2.7a). In contrast, Nup153-depleted cells co-immunostained 
with an anti-β-tubulin antibody frequently showed abnormal midbodies and peripheral 
midbody remnants (Figure 2.7, b and c), prolonged persistence of midbodies in interphase 
cells (Figure 2.7d) and unresolved midbodies between multiple cells (Figure 2.7e). These 
effects are consistent with delayed and abortive cytokinesis (Bruzzoni-Giovanelli et al., 
1999; Li, 2007; Plans et al., 2008). Overall, the number of midbodies in Nup153-depleted 
cells was twice that of control cells (Figure 2.7f). Failed cytokinesis upon Nup153 
depletion does not affect the ploidy of the nuclei or cell cycle progression as monitored 
by flow cytometry of isolated nuclei from Nup153-depleted cells as compared to nuclei 
isolated from cells treated with control siRNA (Figure S7.8). Together, these data 
indicate that Nup153 depletion results in delayed and/or aborted cytokinesis. 
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Figure 2.7: Depletion of Nup153 inhibits cytokinesis.  
 HeLa cells expressing histone H2B-GFP treated with cyclophilin B siRNA and then stained with 
anti-β-tubulin antibodies (a) show a normal mitotic spindle interrupted at the midbody following 
cytokinesis. Knocking down Nup153 gave a variety of phenotypes: peripheral residual midbodies 
(b and d), poorly defined midbody spindles (c), and multipolar midbody spindles (f). (g) 
Quantification of the number of midbodies on random areas of a coverslip. 500-1000 cells per 
coverslip from four independent experiments were analyzed. Scale bars, 10 µm. 
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2.4 Discussion 
NPCs control the trafficking of macromolecules between the nucleus and the 
cytoplasm of interphase cells and the nucleoporin Nup153 is a critical player in both 
nuclear import as well as export. Besides their function in interphase, it has become 
evident that many nucleoporins have important roles in mitosis, such as the nucleoporins 
of the Nup107-160 complex or Nup358 (Chakraborty et al., 2008; Loiodice et al., 2004; 
Salina et al., 2003; Zuccolo et al., 2007). The mitotic function of nucleoporins is often 
associated with their localization to kinetochores in mitosis, while on the other hand 
kinetochore proteins, such as the SAC proteins Mad1 and Mad2 are found at NPCs 
during interphase (Campbell et al., 2001). In this study we show that Nup153 binds 
directly to Mad1 and that Nup153 expression levels regulate Mad1 phosphorylation, 
which in turn modulates checkpoint activity. 
 
2.4.1 Altered Nup153 levels are associated with abnormal mitosis 
To gain further insight into the cellular function(s) of Nup153 we have altered its 
expression levels in HeLa cells and found that enhanced levels of Nup153 coincide with a 
number of nuclear abnormalities, such as intranuclear Nup153 foci, nuclear lobulation 
and multinucleation (Figure 2.1 and Figure 2.2), coinciding with multipolar spindles 
(Figure 2.3). Depletion of Nup153 from HeLa cells by RNAi results in an increase in 
cells with unresolved midbodies, indicative of delayed or aborted cytokinesis (Figure 
2.7). Therefore, both up- and down-regulation of Nup153 causes abnormal mitoses, 
indicating that Nup153 levels need to be tightly controlled to achieve normal cell 
division. Most importantly, the role of Nup153 in mitosis appears independent of its 
ability to recruit soluble nuclear transport receptors to the inner nuclear membrane, since 
overexpression of its NPAR, i.e. residues 39-399 of human Nup153, is sufficient to 
induce the aberrant mitotic phenotype. This region of Nup153 is required for its 
incorporation into NPCs, but an interaction of this domain with nuclear transport receptor 
is unknown (Bastos et al., 1996; Enarson et al., 1998). Based on our data presented here it 
is therefore conceivable to conclude that the role of Nup153 in mitosis is independent 
from its transport role, at least from "conventional" nucleocytoplasmic transport 
pathways, since the role of Nup153 in nucleocytoplasmic transport is due to interactions 
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of Nup153's C-terminal FG-repeat domain with soluble nuclear transport receptors (Ball 
and Ullman, 2005). While this manuscript was in preparation, a study was published that 
supported this notion (Mackay et al., 2009). In this study, the authors showed that 
reduction of Nup153 causes a delay in cytokinesis without affecting global 
nucleocytoplasmic transport. 
 
2.4.2 Nup153 function in mitosis is related to the mitotic checkpoint  
Multinucleation can originate from several malfunctions, such as errors in 
chromosome segregation, incorrect microtubule-kinetochore attachments, failure of the 
spindle checkpoint or cytokinesis (King, 2008). In this context, multinucleated cells have 
been described as a phenotype that is consistent with the loss of Mad1 function (Jin et al., 
1998) or due to mutations in Mad2 (Michel et al., 2001). Impaired Mad1 function does 
not affect cell cycle progression and duration of mitosis (Musacchio and Salmon, 2007). 
Consistent with loss of Mad1 function, overexpression of Nup153 results in 
multinucleation of cells without affecting cell cycle progression (Figure 2.2 and Figure 
2.3). While the ratio of nuclei having G1, S and G2 phase DNA content were similar in 
cells expressing GFP-Nup153 as compared to untransfected control cells, GFP-Nup153 
nuclei exhibited a significant increase in aneuploid cells (Figure 2.2, d-f), corresponding 
to cells undergoing abnormal mitoses.  
The given similarities in the phenotypes that result from Mad1 inactivation and 
enhancing Nup153 levels, respectively, and the known localization of Mad1 to NPCs in 
interphase, prompted us to explore a direct interaction between Nup153 and Mad1. We 
found in fact that both proteins bind to each other in unsynchronised as well as in cells 
arrested in mitosis (Figure 2.4c), indicating that the interaction between Nup153 and 
Mad1 is maintained throughout the cell cycle. Moreover, we could show that Nup153's 
NPAR mediates binding to Mad1, consistent with the observation that expression of this 
domain causes abnormal mitoses (see above). By immuno-EM, we furthermore found 
Mad1 to colocalize with the N-terminal domain of Nup153 on the nuclear face of the 
NPC (Figure 2.4b). Our findings therefore strongly suggest that an interaction between 
the NPAR of Nup153 and Mad1 contributes to the regulation of the Mad1 and spindle 
checkpoint activity.  
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During the course of our study, a recent report has implicated Tpr, another 
component of the NPC and a known interacting partner of Nup153 (Hase and Cordes, 
2003), in proper spindle checkpoint activation due to direct binding of Tpr to Mad1 and 
Mad2 (Lee et al., 2008). The function of Nup153 and Tpr in SAC regulation appear 
independent from each other, as we found that the loss of Nup153 neither affect mRNA 
nor protein levels of Tpr (Figure S7.7, b-d). Moreover, Nup153 and Tpr appear to have 
opposing effects in SAC regulation, as increased levels of Nup153, but reduction of Tpr 
cause multinucleation and impaired checkpoint activity. Evidently both components of 
the NPC's nuclear basket are critically engaged in SAC regulation and further 
investigations are required to more systematically dissect the underlying regulatory 
mechanisms. 
 
2.4.3 Nup153 levels regulate SAC activity 
Challenging HeLa cells that either express GFP-Nup153 or are depleted for 
Mad1 with nocodazole lead to a lowered mitotic index as compared to control cells, in 
contrast to Nup153-depleted cells (Figure 2.5b). This data indicated that Nup153 
overexpression abrogates the mitotic checkpoint to a comparable extend to depletion of 
Mad1, whereas the SAC remains functional in the absence of Nup153. Importantly, co-
expression of Nup153 and Mad1 rescue cells from Nup153-induced SAC impairment, 
indicating that the Nup153-Mad1 ratio is important for proper SAC function. Consistent 
with an impaired SAC, we found phosphorylation of Mad1 to be reduced in the presence 
of enhanced Nup153 levels (Figure 2.5c).  
Decreased concentrations of Nup153, on the other hand, leave the SAC intact and 
may lead to persistent checkpoint activity. A hyperactive spindle checkpoint alters the 
sequence of mitotic events and cells display marked difficulties in completing cytokinesis 
(Brito and Rieder, 2006; Hernando et al., 2004). Consistent with this model, reduction of 
Nup153 causes abnormal cytokinesis (Figure 2.7) and persistent association of Mad1 to 
kinetochores beyond prometaphase (Figure 2.6), but neither Mad1 phosphorylation nor 
the association of Mad2 is compromised. Further studies are required to analyze the 
underlying molecular mechanism as to how varying Nup153 levels affect Mad1 
phosphorylation and SAC activity. 
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In summary, we have shown that the nucleoporin Nup153 is involved in spindle 
checkpoint regulation due to an interaction with the checkpoint protein Mad1. Both, up- 
and down-regulation of Nup153 gives rise to abnormalities in mitosis and cytokinesis. 
Furthermore, our data indicate that Mad1 interacts with the NPAR region of Nup153 and 
that this interaction is likely responsible for localizing Mad1 at the NPCs and its 
translocation to kinetochores in mitosis. Interestingly, Nup153 itself was not found at 
kinetochores (data not shown; see also (Mackay et al., 2009)), indicating that Nup153 
acts to keep Mad1 away from kinetochores and that this regulates SAC activity. 
Interestingly, this role for Nup153 in controlling the mitotic checkpoint appears 
evolutionarily conserved, since its yeast homologue, Nup1p, is also required for the 
association of Mad1p with the NPC (Kastenmayer et al., 2005). Moreover, mutations in 
nup1 result in altered spindle organization with an increase in multinucleate and anucleate 
daughter cells as well as failure to exit from mitosis (Bogerd et al., 1994; Harper et al., 
2008). Given a role for Nup153 in development and cancer (Heidenblad et al., 2008; 
Nybakken et al., 2005; Orlic et al., 2006) it will be interesting to determine how this is 
related to Nup153's novel function in cell division.  
 
 
Figure 2.8: Schematic model of Nup153 function in SAC activity. 
Overexpression of Nup153 causes hypophosphorylation of Mad1, which leads to an impaired SAC 
and consequently chromosome missegregation and failures of cytokinesis. Depletion of Nup153 
does not affect Mad1 phosphorlation (P) leaving the SAC intact, which may cause a persistently 
activated SAC consistent with delayed and/or aborted cytokinesis. Mad1 binding to Mad2 is 
neither affected by enhanced nor by reduced Nup153 levels. 
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2.5 Materials and Methods 
 
2.5.1 Cell culture and transfections 
HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) plus penicillin and streptomycin. HeLa 
cells stably expressing H2B-GFP cells were cultivated in DMEM supplemented with 
10% FBS plus penicillin, streptomycin and blasticidin. 
Cells were transfected using Lipofectamine 2000 (Invitrogen, Pailsey, UK) 
following the instructions of the manufacturer. 
 
2.5.2 Constructs and antibodies 
N-terminally tagged GFP-Nup153 was produced as described previously 
(Fahrenkrog et al., 2002). N-terminally tagged GFP-Nup153-39-339 was subcloned from 
Nup153-39-339 with a N-terminal HA-tag and a C-terminal 6 His-tag from pGEX-4T-3 
(Amersham-Pharmacia, Little Chalfont, England) into BamHI cut pEGFP-C1 (Clontech, 
Palo Alto, CA). The correct orientation of the insert was confirmed by enzymatic 
digestion. pEGFP-Nup153-39-144 and pEGFP-Nup153-144-339 were subcloned 
following the same strategy. 
The polyclonal antibody against the zinc-finger of human Nup153 (anti-Nup153-
Z: 1:1000 for immunofluorescence) was kindly provided by Katie Ullman (University of 
Utah). The monoclonal antibodies SA1 (1:2 for immunofluorescence) and QE5 against 
the C-terminal FG-repeat domain of Nup153 were obtained from Brian Burke (University 
of Florida). Further primary antibodies were the monoclonal antibodies mAB414 
(1:2000; Covance, Berkely, CA), anti-Mad1 (1:50; Santa-Cruz, Santa Cruz, CA), anti-Tpr 
(1:400, Abnova, Taipei, Taiwan), anti-β tubulin (1:2000; Chemicon, Billerica, MA), anti-
phospho-Ser/Thr/Tyr (1:1000, Abcam) as well as polyclonal anti-phospho-histone H3 
(1:50; Santa Cruz). Secondary antibodies include anti-mouse IgG-Alexa 568, anti-mouse 
Alexa 647, anti-rabbit IgG Alexa 488, anti-rabbit IgG-Alexa 568, anti-rabbit Alexa 647 
and anti-human Cy5 are from Molecular Probes (Paisley, UK) and used 1:400 (Alexa 
488), 1:1000 (Alexa 568), 1:350 (Alexa 647), and 1:200 (Cy5). 
 
2.5 Materials and Methods 
 74 
2.5.3 Immunofluorescence  
Cells were grown on coverslips and fixed either in 2% formaldehyde for 15 min 
or -20°C methanol for 5 min, washed three times for 5-10 min with PBS, and 
permeabilized with PBS containing 2% bovine serum albumin (BSA) and 0.2% Triton X-
100 for 10 min. Next the cells were washed three times for 5-10 min in PBS containing 
2% BSA and incubated with the appropriate primary antibodies for 1 hour, washed three 
times in PBS containing 2% BSA and incubated with the appropriate secondary 
antibodies for 1 hour, washed 5x with PBS then mounted with Mowiol and stored at 4°C 
until viewed. Cells were prepared for triple label immunofluorescence as described 
previously (Joseph et al., 2002) and mounted in 50% glycerol in 20 mM Tris (pH 9.0) 
containing 2 mg/ml p-phenylenediamine (PPD). Cells were viewed using a confocal laser 
scanning microscope (Leica TCS NT/SP1 or SP5, Leica, Vienna, Austria). Images were 
recorded using the microscope system software and processed using Adobe Photoshop 
(Adobe Systems, Mountain View, CA, USA).  
 
2.5.4 RNA interference 
HeLa cells were depleted of Nup153 using On-target smart pool duplex siRNA to 
human Nup153 (Dharmacon, Lafayette, CO). Cells were grown on 12 mm diameter 
coverslips and exposed to the Nup153 siRNA in the presence of Lipofectamine 
RNAiMax (Invitrogen, Paisley, UK) following the instructions of the manufacturer. As a 
control cells were exposed to Lipofectamine RNAimax alone or to siRNA against 
cyclophilin B (Dharmacon, Lafayette, CO). Knock down efficiency was determined by 
qRT-PCR and immunoblotting 48 h post transfection. For indirect immunofluorescence, 
cells were prepared as described above. 
 
2.5.5 Quantitative real-time PCR 
Cells were lysed using QIAshreddersTM (Qiagen, Hilden Germany) and total 
RNA was extracted using the RNeasy® Mini Kit (Qiagen, Hilden Germany) according to 
manufacturer’s recommendations. Messenger RNA (mRNA) was purified using the 
GenEluteTM-mRNA Miniprep Kit (Sigma, St. Lois, MO). Reverse transcription was 
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performed using the first-strand cDNA and SuperscriptTMIII reverse transcriptase 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. 
Probes were designed with the Real-Time PCR Primer Design program 
(www.genscript.com). Nup153 probes were 5’-ATT TGG AAC TGG ACC CTC AG and 
5’-TGG GAA ATA ATG CTG TGG AA and β-Actin probes were 5’-AGC ACG GCA 
TCG TCA CCA ACT and 5’-TGG CTG GGG TGT TGA AGG TCT. These probes 
generated 256 and 180 bp replicons, respectively (W. Dietmeier, Rapid cycle real-time 
PCR, Spinger). 
 
2.5.6 Quantitative immunoblotting and gel electrophoresis 
Cells were resuspended in lysis buffer containing 50 mM Tris-HCl pH 7.8, 150 
mM NaCl, 1% Nonidet P-40, and protease inhibitor cocktail tablets (Roche, Basel, 
Switzerland). Sample aliquots were resolved by sodium dodecyl sulfate-polyacrylamide 
(10%) gel electrophoresis (SDS-PAGE). The proteins were transferred onto a PVDF 
membrane and the membrane was incubated in I-Block solution (Tropix, Bedford, MA) 
containing 0.1% Tween-20 (blocking solution) over night at 4°C, then incubated in 
blocking solution containing a primary antibody directed against either SA1 (1:100), QE5 
(1:3) or anti-β-tubulin (1:1000) for 1 hour followed by washing 3x with PBS containing 
0.1% Tween-20. The membrane was then incubated in the dark with anti-mouse IRDye 
800 (1:10000; LI-COR, Biosciences, NE, USA) in blocking solution. Images were 
recorded using the Odyssey infrared imaging system and analyzed by the systems 
software program (LI-COR, Biosciences, NE, USA). 
 
2.5.7 Flow cytometry 
Cells were fixed in ice-cold 70% ethanol for 30 minutes, washed 2x in PBS by 
vortexing and pelleting at 1000 g for 5 minutes, and suspended at 1x106 cells/ml, pelleted 
again and stained with PI stain (50 µg/ml propidium iodide, 180 units/ml RNase A, 0.1% 
Triton-X 100, 4 mM citrate buffer, 0.03g/ml polyethylene glycol 6000) for 20 minutes at 
37°C. An additional PI salt solution (50 µg/ml propidium iodide, 0.1% Triton-X 100, 0.4 
M NaCl, 0.03g/ml polyethylene glycol 6000) was added and the cell preparation was 
stored at 4°C in the dark until flow cytometric acquisition and analysis. 
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2.5.8 Live cell imaging 
For live cell imaging, HeLa cells were transfected with GFP-Nup153 by 
electroporation, seeded onto Lab-Tek chamber (Nunc, Roskilde, Denmark) and 
maintained at 37°C in DMEM. 48 hours after transfection, cells were equilibrated to 
Leibowitz medium complemented with 10% FCS and time-lapse sequences were 
recorded every 60 sec for a maximum of 300 cycles using a 63x N.A. 1.4 objective on a 
Zeiss LSM 510 META confocal microscope (Zeiss, Thornwood, NY) with a heated 
stage. 
 
2.5.9 Immunoprecipitation 
Subconfluent HeLa cells (3x106) were trypsinized, washed with PBS and 
resuspended in 160 µl lysis buffer (50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 0.1 % 
Triton X-100, 2 mM EDTA-Na2, 10% Glycerol and protease inhibitor (Thermo 
Scientific)), vortexed and incubated for 10 min at 37°C. The cells were pelleted at 16,000 
g for 10 min and the supernatant was transferred to a fresh tube. The supernatant was 
cleared with 20 µl of protein G-agarose beads (Santa Cruz) and incubated for 30 min at 
4°C, centrifuged at 1000 g for 30 sec at 4°C, and the supernatant was transferred to a 
fresh tube and 2 µg mouse monoclonal Mad1 antibody or a 1/5 dilution of a hybridoma 
supernatant containing mouse monoclonal Nup153 antibody (SA1) were added and 
incubated for 2 hours on ice. Prewashed protein G-agarose slurry, 40 µl, was added to the 
lysate and incubated at 4°C on a rocker platform for 1 hour. The immunoprecipitate was 
collected by centrifugation at 1000 g for 30 sec at 4°C and the supernatant was carefully 
removed and kept to analyze as unbound fraction. The pellet was washed 3x with lysis 
buffer, resuspended in electrophoresis sample buffer, boiled at 95°C for 5 min and 
subjected to electrophoresis and Western blotting.  
 
2.5.10 Solution binding assays 
The in vitro interaction between Nup153 and Mad1 was tested as described 
previously (Walter et al., 2006). 
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2.5.11 Immuno-EM  
Mature (stage 6) oocytes were surgically removed from female Xenopus laevis, 
and their nuclei were isolated as described (Pante et al., 1994). Colloidal gold particles, 
~8-nm in diameter, were prepared by reduction of tetrachloroauric acid with sodium 
citrate in the presence of tannic acid and antibodies were conjugated to colloidal gold 
particles as described (Baschong and Wrigley, 1990). Isolated nuclei were labeled with 
anti-Mad1 antibodies as described previously (Fahrenkrog et al., 2002). Labeled nuclei 
were fixed and processed for EM as described (Fahrenkrog et al., 2002; Paulillo et al., 
2005). EM micrographs were recorded on a Phillips CM-100 transmission electron 
microscope equipped with a CCD camera. Elliptic location clouds were calculated as 
described (Fahrenkrog et al., 2002). 
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3.1 Abstract 
Nuclear pore complexes (NPCs) are embedded in the nuclear envelope (NE) and 
mediate bidirectional nucleocytoplasmic transport. Their spatial distribution in the NE is 
organized by the nuclear lamina, a meshwork of nuclear intermediate filament proteins. 
Major constituents of the nuclear lamina are A- and B-type lamins. In this work, we have 
identified Nup88 as novel interaction partner of lamin A in pull-down experiments. By 
immunoprecipitation assays, we showed that the interaction takes place in vivo. Further 
characterization of the Nup88-lamin A complex by solution-binding assays revealed that 
the N-terminus of Nup88 specifically binds to the Ig-fold of lamin A, but not the Ig-fold 
of B-type lamins. Additionally, we have localized the nucleoporin Nup88 to the 
cytoplasmic and nuclear face of the NPC by immunoelectron microscopy using Xenopus 
laevis oocyte nuclei. Moreover, we found that overexpression of GFP-tagged lamin A is 
masking the binding site of Nup88 antibodies in immunofluorescence assays, supporting 
the interaction of lamin A with Nup88 in a cellular context. We further demonstrated that 
the epitope masking phenotype is lost in cells overexpressing Ig-fold mutants of lamin A 
that are associated with Emery-Dreifuss muscular dystrophy (EDMD) and Dunnigan-type 
familial partial lipodystrophy (FPLD). Consistently, the interaction of GST-Nup88 with 
the in vitro expressed lamin A Ig-fold mutants was lost in a solution-binding assay. 
Together, our data suggest that a pool of Nup88 is localizing to the nuclear side of the 
NPC, where it provides a novel interaction with lamin A. 
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3.2 Introduction 
In eukaryotic cells, the nuclear envelope (NE) is spatially separating the 
molecular events in the cytoplasm and the nuclear compartment. Nuclear pore complexes 
(NPCs) are embedded in the double membrane of the NE, thereby bridging the nucleus 
and cytoplasm in interphase cells. The vertebrate NPC consists of about 30 different 
proteins called nucleoporins (or Nups) (Cronshaw et al., 2002), which are organized in 
distinct subcomplexes to form the major building blocks of the NPC: the central 
framework, which exhibits octagonal rotational symmetry, and the cytoplasmic and 
nuclear ring moiety (Akey and Radermacher, 1993; Beck et al., 2004; Hinshaw et al., 
1992; Stoffler et al., 2003). Filamentous structures decorate the cytoplasmic and nuclear 
face of the NPC, known as cytoplasmic filaments and nuclear basket, respectively. Nup88 
is associated within a subcomplex with Nup214 and Nup358 on the cytoplasmic side of 
the NPC, which is implicated in CRM1-mediated nuclear protein export (Bernad et al., 
2006; Bernad et al., 2004; Fornerod et al., 1997b; Roth et al., 2003). Nup88 consists of 
two structural domains: the N-terminal two-thirds of the protein (residues 1-584) fold into 
a β-propeller based on secondary structure prediction, and the C-terminal third (residues 
585-742) is predicted to be largely coiled-coil in structure (Fornerod et al., 1997b; 
Schwartz, 2005). The coiled-coil domain is mediating the interaction with Nup214 and 
connects Nup88 to the NPC (Bastos et al., 1997; Bernad et al., 2004; Fornerod et al., 
1997b). The N-terminal β-propeller domain of Nup88 interacts with the NPC-targeting 
domain of Nup98, a nucleoporin that is discussed to localize to both the nuclear and 
cytoplasmic side of the NPC and to interact with distinct subcomplexes, i.e. the Nup88-
Nup214 subcomplex on the cytoplasmic side and the Nup107-160 complex on the 
nuclear side of the NPC (Griffis et al., 2003; Radu et al., 1995).  
The nuclear lamina is a component of the NE, lying between the inner nuclear 
membrane and the peripheral chromatin and is tightly associated with the NPCs (Akey, 
1989; Furukawa et al., 2009). The nuclear lamina has been suggested to be involved in 
maintaining the structural integrity of the NE, the organization of chromatin structure and 
function and the spacing of NPCs (Broers et al., 2006; Lenz-Bohme et al., 1997; Liu et 
al., 2000; Sullivan et al., 1999). The lamina is formed by type-V intermediate filament 
proteins, which are composed of A- and B-type lamins (Aebi et al., 1986; Stuurman et al., 
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1998). The A-type lamins lamin A and lamin C (lamin A/C) arise through alternative 
splicing of a common transcript and differ only in the last 83 amino acids of their C-
terminus, whereas the B-type lamins lamin B1 and B2 are encoded by separate genes 
(Moir et al., 1995; Stuurman et al., 1998). While B-type lamins are constitutively 
expressed in cells throughout development, A-type lamins are only expressed in later 
stages of development and in differentiated cells (Broers et al., 2006; Hutchison et al., 
2001). Both types directly interact with integral proteins of the inner nuclear membrane, 
NPC proteins, chromosomal proteins and DNA, and play roles in nuclear activities 
including gene expression and DNA replication (Broers et al., 2006; Schirmer and 
Foisner, 2007). Several studies in C. elegans, D. melanogaster and cultured mammalian 
cells suggest that B-type lamins are essential for viability (Lenz-Bohme et al., 1997; Liu 
et al., 2003), whereas the targeted disruption of lamin A/C in mice causes muscular 
dystrophy, loss of adipose tissue and early cell death (Sullivan et al., 1999). Mutations in 
lamin A/C as well as several inner nuclear membrane proteins that bind the lamina are 
associated with a diverse array of human diseases, so-called laminopathies. One 
particular point mutation in the immunoglobulin (Ig)-fold domain of lamin A, i.e. the 
missense mutation of an arginine at position 453 to a tryptophan (R453W), is leading to 
Emery-Dreifuss muscular dystrophy (EDMD) in humans, which is characterized by 
muscle weakness and wasting and contractures of certain joints (Burke and Stewart, 
2002; Hutchison and Worman, 2004; Mounkes et al., 2003; Wilson, 2000). R453 resides 
in the Ig-fold domain of lamin A, is involved in a salt bridge formation between two β-
sheets and its mutation leads to abrogation of the salt bridge and to a destabilization of 
the C-terminal domain of lamin A (Dhe-Paganon et al., 2002; Krimm et al., 2002). The 
missense mutation R482W in lamin A results in Dunnigan-type familial partial 
lipodystrophy (FPLD), characterized by variable loss of body fat from the extremities as 
well as from the truncal region (Speckman et al., 2000). Residue R482 locates on the 
surface of the Ig-fold and its mutation destroys a positively charged interaction site of 
lamin A-binding proteins (Dhe-Paganon et al., 2002; Krimm et al., 2002). The most 
common mutation found in Hutchison-Gilford progeria syndrome (HGPS) is the mutation 
of C1824 to a T, a silent mutation, however, it results in the generation of an alternative 
splice site, leading to a truncated version of lamin A lacking 50 amino acids in its Ig-fold 
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neighbored C-terminus, called LAΔ50 or progerin (Broers et al., 2006). LAΔ50 is 
permanently farnesylated and anchored to NE, affecting its localization and overall 
function (Eriksson et al., 2003; Scaffidi and Misteli, 2005).  
To fully understand lamina function as well as the implications of the lamina-
NPC interaction in laminopathies, it is crucial to identify lamin-binding components. In 
this study, we found Nup88 as novel interaction partner of lamin A. We show that Nup88 
and lamin A interact in vitro as well as in vivo. Further characterization of the interaction 
revealed that the N-terminal domain of Nup88 and the Ig-fold of lamin A are mediating 
the binding of the two proteins. Additionally, we show that Nup88 is localizing to both 
sides of the NPC by immunoelectron microscopy using Xenopus laevis oocyte nuclei. 
Furthermore, we show that overexpression of GFP-lamin A leads to a masking of a 
Nup88 antibody epitope in human cells. Moreover, we show that the EDMD-associated 
R453W and the FPLD-associated R482W mutant lamin A abolish the interaction between 
the two proteins, however the progeria mutant lamin AΔ50 is still able to bind Nup88. 
Together, our data describe a new interaction between the nucleoporin Nup88 and the 
nuclear intermediate filament protein lamin A and its loss of interaction with disease-
linked Ig-fold mutants. Understanding the details of this interaction might be essential to 
shed light on the underlying molecular mechanism of lamin-linked diseases.  
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3.3 Results 
 
3.3.1 Lamin A is an interaction partner of Nup88 
In order to identify new interaction partners of Nup88, we performed an in vitro 
binding assay. To do so, a lysate of isolated HeLa S3 nuclei was incubated with purified, 
recombinant glutathione-S-transferase (GST)-tagged Nup88 fusion protein or GST alone 
immobilized on glutathione sepharose beads. Proteins that bound immobilized GST-
Nup88 or GST were separated on SDS-PAGE and detected using colloidal blue staining. 
One protein band of ~74 kDa was identified in the lane corresponding to the GST-Nup88 
bound fraction but not in the GST control (Figure 3.1A). Mass spectrometry analysis of 
peptide fragments derived from this polypeptide revealed that the 74 kDa protein was 
lamin A. Other bands identified were either degradation products of GST-Nup88, linker 
histone H1, ribosomal protein L7a or M-phase phosphoprotein 4. Since connections 
between the NPC and the nuclear lamina were already described before, lamin A was a 
promising candidate as novel interaction partner of Nup88 (Hawryluk-Gara et al., 2005; 
Smythe et al., 2000). By immunoblot analysis using a polyclonal antibody against lamin 
A, we confirmed that lamin A copurified with GST-Nup88, but not with GST. However, a 
protein with slightly higher molecular weight than lamin A is recognized unspecific by 
the lamin A antibody in both samples (indicated with *) (Figure 3.1B). 
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Figure 3.1: Lamin A is a novel interaction partner of Nup88. 
Bacterially expressed GST-Nup88 and GST were bound to glutathione sepharose beads and 
incubated with HeLa cell lysate. Bound fractions were analyzed by SDS-PAGE, colloidal staining 
(A) and mass spectroscopy or by immunoblotting with lamin A antibody (B). Lamin A was bound 
to GST-Nup88, but not to GST. The locations of molecular weight (MW) markers are indicated on 
the left. 
 
3.3.2 Nup88 is interacting with lamin A in vivo and in vitro 
To confirm that Nup88 is interacting with lamin A in vivo, HeLa cell lysates 
were immunoprecipitated with antibodies directed against Nup88 (Figure 3.2A). The 
HeLa lysate (L), supernatant (S), and pellet (P) proteins were separated by SDS-PAGE, 
transferred to a PVDF (Polyvinylidene Difluoride) membrane and probed with antibodies 
against Nup88 and lamin A, respectively. As shown in Figure 3.2A, lamin A is co-
immunoprecipitated with Nup88, indicating that Nup88 associates with lamin A in vivo 
(Figure 3.2A).  
To test whether Nup88 and lamin A are interacting directly, we performed blot-
overlay assays between Nup88 and lamin A using recombinantly expressed lamin A and 
in vitro transcribed/translated 35S-labeled Nup88 using the rabbit reticulocyte lysate 
system (Figure 3.2B). Equal amounts of bacterially expressed and purified cytoplasmic 
intermediate filament (IF) protein vimentin as a control (Figure 3.2B, lane 1) and lamin A 
(Figure 3.2B, lane 2) were subjected to SDS-PAGE (Coomassie), transferred to a PVDF 
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membrane and overlaid with the 35S-labeled Nup88. As shown in Figure 3.2B (overlay), 
Nup88 was binding to lamin A, but not to vimentin. 
To further determine the domains of Nup88 and lamin A, respectively, that are 
required for the interaction between the two proteins, we performed solution binding 
assays with purified recombinant his-tagged lamin A bound to nickel beads and in vitro 
transcribed and translated 35S-labeled Nup88 fragments, i. e. the full-length protein, the 
N-terminal domain (residues 1-550) or the C-terminal domain (residues 551-741) of 
Nup88 (Figure 3.2C). The bound (B) and unbound (U) fractions to lamin A immobilized 
on nickel beads were separated by SDS-PAGE, transferred to a PVDF membrane and 
analyzed by autoradiography. As shown in Figure 3.2C, full-length Nup88 (left panel) 
and the N-terminal domain (middle panel) were interacting with lamin A, but not so the 
C-terminus of Nup88 (right panel). Together, this data indicate that the interaction of 
Nup88 with lamin A is mediated by Nup88’s N-terminus. 
To further determine which domain of lamin A interacts with Nup88, we next 
performed solution-binding assays using purified recombinant GST-Nup88 and GST as 
control immobilized on sepharose beads and in vitro transcribed and translated 35S- 
labeled domains of lamin A, lamin B1 and B2, respectively. GST-Nup88 interacted with 
the full-length lamin A, the tail domain of lamin A (i.e. residues 386 to 548) and the 
immunoglobulin (Ig)-fold domain of lamin A, but not with the Ig-folds of lamin B1 and 
lamin B2 (Figure 3.2D). None of our different lamin constructs was significantly 
interacting with GST alone. Together, these data indicate that the interaction of lamin A 
with Nup88 is specifically mediated by the Ig-fold of lamin A. 
Nup88 has been implicated in CRM1 mediated protein export, and importin α 
and β appear to act as nuclear import factors for lamin A (Adam et al., 2008; Fornerod et 
al., 1997b; Loewinger and McKeon, 1988). To analyze if the observed Nup88-lamin A 
complex might be associated with nucleocytoplasmic transport, we tested if importin α, 
importin β or CRM1 are associated with the lamin A-Nup88 complex. To do so, we 
immunoblotted reticulocyte lysate used for in vitro expression and 35S-labeling of lamin 
A as well as the fractions bound to GST-Nup88 and GST, respectively with monoclonal 
antibodies against importin α, importin β and CRM1 (Figure S7.9). While CRM1, 
importin α and β are detectable in the reticulocyte lysate, neither importin α, importin β 
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or CRM1 were found to be bound to GST-Nup88 or GST, indicating that the Nup88-
lamin A complex is not part of a nuclear import or export complex. 
 
 
Figure 3.2: Nup88 is interacting with lamin A in vivo and in vitro. 
(A) HeLa cell lysates were immunoprecipitated with Nup88 antibody. Hela cell lysate (L), 
immune supernatant (S) and immune precipitate (P) proteins were analyzed by SDS-PAGE and 
immunoblotted with Nup88 and lamin A antibodies. Lamin A is found to be co-
immunoprecipitated with Nup88. (B) Blot binding assay employing bacterially expressed and 
purified vimentin and lamin A and in vitro expressed and 35S-labeled Nup88. Samples of purified 
vimentin (lane 1) and lamin A (lane 2) were separated by SDS-PAGE, stained with Coomassie 
blue (left panel) or transferred to a PVDF membrane and overlaid with 35S-labeled Nup88 (right 
panel). 35S-labeled Nup88 was visualized by autoradiography. (C) Bacterially expressed his-tagged 
lamin A was bound to nickel beads and incubated with in vitro synthesized 35S-labeled full-length, 
N-terminal (residues 1-550) or C-terminal (residues 551-741) Nup88. Unbound and bound 
fractions were analyzed by SDS-PAGE and autoradiography. 35S-full-length Nup88 and N-
terminal 35S-Nup88 were binding to lamin A-his, whereas C-termianl 35S-Nup88 was not able to 
bind lamin A-his. (D) Bacterially expressed GST-Nup88 and GST were bound to glutathione 
sepharose beads and incubated with in vitro synthesized 35S-labeled full-length lamin A, lamin A 
tail domain (residues 386-548), and the Ig-folds of lamin A, lamin B1 and B2. Unbound and 
bound fractions were analyzed by SDS-PAGE and autoradiography. Whereas full-length lamin A, 
lamin A tail and lamin A Ig-fold were able to bind GST-Nup88 but not GST, the Ig-folds of lamin 
B1 and B2 did not bind to GST-Nup88 or GST. 
 
3.3.3 Nup88 is localizing partially to the nuclear face of the NPC 
An epitope of Nup88 was previously localized to the cytoplasmic side of the 
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NPC in Xenopus oocyte nuclei using an antibody recognizing the C-terminus of Nup88 
(Bernad et al., 2004). However, the novel interaction of Nup88 with lamin A suggests 
that a pool of Nup88 might also be localized on the nuclear side of the NPC. In an effort 
to more precisely determine the position of Nup88 within the NPC, we performed 
immuno-electron microscopy (EM) using Xenopus oocyte nuclei and domain-specific 
antibodies against distinct domains of human Nup88. Xenopus oocyte nuclei were 
isolated manually and incubated with distinct anti-Nup88 antibodies directly conjugated 
to 8-nm colloidal gold and processed for thin-sectioning EM. As illustrated in Figure 
3.3A, the antibody against the N-terminus of Nup88 recognized epitopes on both the 
nuclear and the cytoplasmic side of the NPC. Quantification of the gold particle 
distribution with respect to the central plane of the NE revealed that about 40% of the 
gold particles were associated with the nuclear face of the NPC at a mean distance of  –
31.9 nm +/- 16.7 nm from the central plane (Figure 3.3B). Together with corresponding 
mean radial distance of 25.7 nm +/- 19.6 nm this corresponds to an epitope near the 
nuclear ring moiety of the NPC. The remaining 60% of the gold particles were found on 
the cytoplasmic side of the NPC, with a mean distance of 16.8 nm +/- 8.6 nm from the 
central plane and a mean radial distance of 8.2 nm +/- 8.7 nm.  
Previously, we have shown that recombinant hNup153 incorporates into the NPC 
after microinjection of a plasmid encoding epitope-tagged hNup153 into the nuclei of 
Xenopus oocyte (Fahrenkrog et al., 2002). We therefore aimed to confirm the localization 
of the N-terminus using a N-terminal green fluorescent protein (GFP)-tag (GFP-Nup88). 
Xenopus oocytes were microinjected with the plasmids and the localization of the 
incorporated proteins was determined by using a monoclonal anti-GFP antibody directly 
coupled to 8 nm colloidal gold. The anti-GFP antibody recognized epitopes both on the 
cytoplasmic and the nuclear side of the NPC. As shown in Figure 3.3C, quantification of 
the labeling pattern relative to the central plane of the NPC revealed that 51% of the 
particles were detected at a mean distance of 38.1 nm +/- 12.2 nm and a mean radial 
distance of 27.3 nm +/- 15.4 nm, on the cytoplasmic side and 49% of the gold particles 
were localized on the nucleoplasmic side with a mean distance of -49.8 nm +/- 26.1 nm 
from the central plane and a mean radial distance of 24.2 nm +/- 15.4 nm, consistent with 
the localization data of the untagged N-terminus of Nup88. The bigger vertical distance 
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could be explained by the fact that the GFP-tag extends the Nup88 protein. These data are 
suggesting that indeed a pool of Nup88 is localizing to the nucleoplasmic side of the 
NPC.  
To revise the localization of Nup88’s C-terminus by immuno EM studies, we 
then used an antibody against the C-terminus of Nup88, which recognized an epitope 
exclusively on the cytoplasmic side of the NPC (Figure 3.3D). Quantification of the 
labeling pattern (Figure 3.3E) relative to the central plane revealed that 87.7% of the gold 
particles were detected at a mean distance of 30.7 nm +/- 9.2 nm from the central plane 
with a radial distance of 16.5 nm +/- 12.8 nm, which is consistent with a previous 
ultrastructural localization study of the C-terminus of Xenopus laevis Nup88 (Bernad et 
al., 2004).  
We further localized the position of recombinant Nup88 with a C-terminal myc-
tag (Nup88-myc). Xenopus oocytes were microinjected with the plasmids and the 
localization of the incorporated proteins was determined by using an anti-myc antibody 
directly coupled to 8 nm colloidal gold. Quantification of the labeling distribution (Figure 
3.3F) revealed that 76.3% (n=29) of the gold particles was associated with the 
cytoplasmic side of the NPC (mean distance from the central plane of the NPC 41.6 nm 
+/- 12.2 nm with a corresponding radial distance of 33.2 nm +/- 22 nm). This detection of 
the C-terminal myc-tag is similar, although further away from the central plane and the 
radial axis, to the labeling seen with the domain-specific antibody against the C-terminus 
of Nup88 (Figure 3.3E). Together, the C-terminus of Nup88 seems to be detectable 
almost exclusively on the cytoplasmic side of the NPC. 
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Figure 3.3: Domain topology of endogenous and ectopically expressed Nup88 within the 
NPC.  
Nuclei were isolated manually and labeled with antibodies directly conjugated to 8nm colloidal 
gold. (A) Nup88 localizes to both the cytoplasmic and the nuclear side of the NPC with a 
monoclonal Nup88 antibody directed against the N-terminus of Nup88. Shown are selected 
examples of gold-labeled NPCs in cross-section. c, cytoplasm; n, nucleus. (B) Quantitative 
analysis of the gold particle distribution associated with the NPC using an antibody against the N-
terminus of Nup88. 70 gold particles were scored. (C) Quantitative analysis of the gold particle 
distribution associated with the NPC using an antibody against the N-terminal GFP-tag of Nup88. 
55 gold particles were scored (D) Nup88 is found mainly on the cytoplasmic side of the NPC with 
a monoclonal Nup88 antibody directed against an epitope in the C-terminus of Nup88. Shown are 
selected examples of gold-labeled NPCs in cross-section. c, cytoplasm; n, nucleus. (E) 
Quantitative analysis of the gold particle distribution associated with the NPC using antibodies 
against the Nup88 C-terminus. 57 gold particles were scored. (F) Quantitative analysis of the gold 
particle distribution with anti-myc antibodies. 38 gold particles were scored. Scale bars, 100 nm. 
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3.3.4 The apparent depletion of Nup88 in human embryonic kidney cells 
overexpressing GFP-lamin A is due to epitope masking 
By indirect immunofluorescence, we determined that endogenous lamin A is 
found at the nuclear rim and distributed in the nucleoplasma and Nup88 is localizing to 
the nuclear rim with a partial overlap with lamin A in human embryonic kidney (HEK) 
interphase cells, as described before (Figure S7.10) (Fornerod et al., 1997b; Lehner et al., 
1986). To examine whether ectopic expression of lamin A has any effect on Nup88 in 
HEK cells, we performed a co-immunostaining experiment of HEK cells transfected with 
green-fluorescent protein (GFP)-tagged lamin A and indirectly labeled Nup88 using an 
antibody recognizing an epitope in the N-terminus of Nup88 (residues 314-425). 24 hours 
after transfection, GFP-lamin A was readily expressed and localized to the NE and the 
nucleoplasm as examined by immunofluorescence and immunblot analysis (Figure 3.4A 
+ B). However, HEK cells transfected with GFP-lamin A showed a significant reduction 
of Nup88 staining upon immunolabeling with monoclonal antibody directed against the 
N-terminal Nup88 epitope with the residues 314-425 as compared to non-transfected cells 
(Figure 3.4A). We have not observed any reduction in the staining of Nup88 in cells 
transfected with GFP-lamin B1 nor in the staining of FG-repeat nucleoporins detected 
with the monoclonal antibody mAb414 in cells transfected with GFP-lamin A or GFP-
lamin B1 (Figure 3.4A), indicating that GFP-lamin A overexpression specifically leads to 
a reduction of Nup88 signal. The transfection efficiency in cells transfected with the GFP-
lamin A construct was determined to be 48%, whereof 27.6% showed a masking 
phenotype (57.8% of total transfected cells, 680 cells counted). The quantification of the 
fluorescence intensity revealed a reduction of 35% of fluorescence signal in cells 
transfected with GFP-lamin A compared to non-transfected cells.  
Using a tetracycline inducible expression system based on HEK cells, we induced 
overexpression of Nup88-myc upon presence of tetracycline in the medium, whereupon 
the protein localizes, besides being incorporated into the NPC, to the cytoplasm of the 
cell (Figure S7.11A, upper panel). Expression of recombinant Nup88-myc was verified 
by immunoblot using an anti-myc antibody (Figure S7.11B). In this background, we 
studied the effects of GFP-lamin A overexpression on Nup88 by immunofluorescence 
microscopy. In cells transfected with GFP-lamin A, we observed a reduction of Nup88 
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staining at the nuclear rim and in the cytoplasm, as Nup88 was almost completely 
vanished from the cytoplasm and only a slight rim staining could be observed (Figure 
S7.11A, lower panel). 
Two scenarios can be thought of to explain the observed reduction of Nup88 
staining, one is that either Nup88 protein levels are decreased due to degradation of the 
protein, or second that Nup88 is in fact present in the cells, but the antibody epitope is 
masked by binding of excess GFP-lamin A. To examine whether Nup88 protein levels 
are decreased in cells overexpressing GFP-lamin A, we analyzed Nup88 protein levels by 
Western blotting. Quantification of the Western blot in Figure 3.4B revealed that the 
levels of Nup88 in GFP-lamin A and mock transfected cells are not significantly altered 
(104% versus 100%, respectively), indicating that Nup88 is not depleted in GFP-lamin A 
overexpressing cells and suggests that the antibody epitope in Nup88 is masked in theses 
cells. We have then reinvestigated this problem by using a polyclonal antibody 
recognizing a different epitope in the N-terminus of Nup88, i.e. residues 27-45 (Figure 
S7.12A). Immunofluorescence analysis of GFP-lamin A overexpressing cells with this 
Nup88 antibody did not show a reduction of Nup88 staining as compared to control cells 
(Figure S7.12B). Together, these findings suggest that GFP-lamin A specifically hinders 
the Nup88 antibody directed against residues 314-425 to react with Nup88.  
In an effort to extract the antibody epitope, we used an alternative fixation 
method with methanol instead of formaldehyde to precipitate the proteins. Formaldehyde 
fixation crosslinks the proteins with very little extraction, and possibly mutilates or 
sterically blocks an epitope. Methanol, in contrast, does not crosslink the proteins but 
precipitates the proteins what might lead to an extraction of the hidden Nup88 epitope.  
Indeed, in methanol-fixed HEK cells transfected with GFP-lamin A and immunostained 
with the Nup88 antibody recognizing the residues 314-425 epitope, no reduction of the 
Nup88 signal is observed anymore (Figure S7.12C), further supporting the notion that the 
reduction in Nup88 staining is due to epitope masking. These results demonstrate that an 
ectopic expression of lamin A is efficiently masking the Nup88 antibody epitope at 
residues 314-425 and moreover, confirming the in vitro solution binding data showing 
that the interaction site of Nup88 with lamin A lies in the central N-terminus of the 
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protein (Figure 3.2C), which corresponds to the predicted N-terminal β-propeller domain 
(Schwartz, 2005).  
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Figure 3.4: Overexpression of GFP-lamin A is masking an antibody epitope within the N-
terminus of Nup88.  
(A) HEK cells transfected with GFP-lamin A or GFP-lamin B1 were prepared for 
immunofluorescence 24 hours after transfection using monoclonal antibodies directed against 
residues 314-425 of Nup88 or the FXFG-repeat containing nucleoporins (mAb414). Cells 
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transfected with GFP-lamin A, but not with lamin B1, showed a decreased signal for Nup88 
staining, but not for staining with monoclonal antibody mAb414. Scale bar, 10 µm. (B) Protein 
levels of Nup88 were analyzed in HEK cells transfected with GFP-lamin A or mock transfected 
control cells. No changes in protein levels of Nup88 were observed when compared with β-
tubulin. 
 
3.3.5 Nup88 interaction with lamin A is lost in presence of the EDMD-associated 
R453W mutant and the FPLD-associated R482W mutant lamin A 
To further characterize the interaction between Nup88 and lamin A and to assert 
the importance of the lamin A Ig-fold for the binding, we performed solution binding 
assays with recombinantly expressed GST-Nup88 and GST as control and in vitro 
transcribed/translated and 35S-labedeled lamin A mutants.  The Emery-Dreifuss muscular 
dystrophy-associated lamin AIg(R453W) mutant and the Dunnigan-type familial partial 
lipodystrophy (FPLD)-associated mutant lamin A Ig(R482W) were used in this study, 
two mutation lying in the Ig-fold domain of lamin A. Furthermore, we analyzed binding 
with the Hutchison-Gilford progeria syndrome-associated mutant lamin AΔ50, where 50 
residues are deleted in the Ig-fold neighbored C-terminus of lamin A. Purified 
recombinant Nup88 fused to GST or GST as control were attached to glutathione 
sepharose beads and incubated with in vitro transcribed and translated 35S- labeled lamin 
A mutants (Figure 3.5A). Unbound (U) and bound (B) fractions were separated on SDS-
PAGE, transferred to a PVDF membrane and analyzed by radiography (Figure 3.5A). 
The mutant lamin A Ig(R453W) and lamin A Ig(R482W) were not binding to GST-
Nup88 or GST, whereas the HGPS-associated lamin AΔ50 mutant was still binding to 
Nup88 (Figure 3.5A). The loss of interaction of Nup88 with the two Ig-fold mutants is 
further highlighting the importance of the Ig-fold for the interaction between Nup88 and 
lamin A. 
To study the interaction of Nup88 with the lamin A mutants in a cellular context, 
we next performed co-immunostaining experiments of GFP-lamin A(R453W), GFP-
lamin A(R482W), GFP-lamin AΔ50 and wild-type GFP-lamin A with Nup88 by indirect 
immunolabeling Nup88 with the monoclonal antibody recognizing the residues 314-425 
in the N-terminus of Nup88 (Figure 3.5B). In contrast to the effect of wild-type GFP-
lamin A, we could not observe a masking phenotype in cells overexpressing GFP-lamin 
A(R453W) or GFP-lamin A(R482W) (Figure 3.5B), indicating that the interaction of 
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Nup88 with the R453W and the R482W mutation is disrupted in vivo. However, 
overexpression of GFP-lamin AΔ50 had a comparable masking effect as observed for 
wild-type lamin A, suggesting that GFP-lamin AΔ50 is still able to bind Nup88 in vivo 
(Figure 3.5B). 
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Figure 3.5: EDMD-associated lamin A(R453W) and FPLD-associated lamin A(R482W) 
mutants do not interact with Nup88.  
3.3 Results 
 98 
(A) Bacterially expressed GST-Nup88 and GST were bound to glutathione sepharose beads and 
incubated with in vitro synthesized 35S-labeled lamin A Ig(R453W), lamin A Ig(R482W) and 
lamin AΔ50. Unbound and bound fractions were analyzed by SDS-PAGE and autoradiography. 
The interaction of Nup88 with the lamin A (R453W) mutant as well as with the lamin A 
Ig(R482W) mutant was lost, whereas lamin AΔ50 was able to bind Nup88. (B) HEK cells 
transfected with GFP-lamin A(R453W), GFP-lamin A(R482W), GFP-lamin AΔ50 or wild-type 
GFP-lamin A were prepared for immunofluorescence 24 hours post transfection using monoclonal 
antibodies directed against residues 314-425. The epitope masking phenotype, as it is observed in 
cells transfected with wild-type GFP-lamin A, is lost in cells expressing the GFP-tagged lamin 
A(R453W) and lamin A(R482W) mutants, whereas it is still observed in cells expressing GFP-
lamin AΔ50. Scale bar, 10 µm. 
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3.4 Discussion 
In this work, we report that lamin A is a novel interaction partner of Nup88. We 
could show that the two proteins interact in vitro and in vivo by solution-binding, overlay 
and immunoprecipitation assays. We could characterize the interaction between lamin A 
and Nup88 insofar that it is the N-terminus of Nup88 binding to lamin A and Nup88 
interaction is specifically with the lamin A Ig-fold domain, but not with the Ig-fold of 
lamin B1 or B2. We could show by immunogold localization studies that a pool of Nup88 
is localizing to the nucleoplasmic side of the NPC. Furthermore, GFP-lamin A is masking 
an antibody epitope of Nup88 in immunofluorescence assays, supporting the finding that 
the two proteins interact in vivo. However, interaction of Nup88 with lamin A is lost 
when mutations in the Ig-fold are present, supporting the notion that the lamin A Ig-fold 
domain is mediating the interaction with Nup88. Taken together, our data indicate that, 
besides being involved in building the cytoplasmic Nup88/Nup214 subcomplex, Nup88 is 
localizing to the nucleoplasmic side of the NPC, where it provides a novel connection 
between the NPC and the nuclear lamina by interacting with lamin A.  
 
3.4.1 Lamin A is a novel interaction partner of Nup88 
By biochemical analysis, we have shown for the first time that the nucleoporin 
Nup88 and the nuclear intermediate filament protein lamin A interact in vivo and in vitro 
(Figure 3.1 and Figure 3.2A-D). The observed interaction seems to be specific for nuclear 
lamin A, since Nup88 is not interacting with the cytoplasmic intermediate filament 
protein vimentin in a blot overlay assay (Figure 3.2B). Furthermore, Nup88 interacts 
specifically with the lamin A Ig-fold but not with the Ig-folds of lamin B1 and B2, what 
makes Nup88 a novel A-type lamin binding partner (Figure 3.2D). We find that the 
interaction with lamin A is mediated by the N-terminal domain of Nup88, which folds 
into a predicted β-propeller (Figure 3.2C). It is therefore possible that the C-terminal 
coiled-coil domain of Nup88 mediates its interaction with an unknown partner on the 
nuclear side of the NPC, as it is observed for the cytoplasmic interaction with Nup214 
(Bastos et al., 1997; Fornerod et al., 1997b), whereas the N-terminal β-propeller binds to 
lamin A. 
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Using RNA interference to deplete endogenous lamin A, we find that reducing 
the cellular levels of lamin A produced a corresponding decrease in Nup88 protein levels 
in an immunoblot analysis (Figure S7.13A). Nup88 protein levels were reduced for 40% 
percent in cells treated with siRNA against lamin A compared to Nup88 protein levels in 
cells treated with control siRNA (cyclophilin B) or untreated cells (Figure S7.13B). A 
likely explanation for this observation is that reduced lamin A protein levels lead to 
unstable free Nup88 that is then more rapidly degraded. Similar results have been 
observed for other protein complexes, where the stability of the complex is decreased by 
depletion of individual members (Bernad et al., 2004). However, it cannot be excluded 
that the observed reduction of Nup88 protein levels is due to a change in transcription 
caused by reduced lamin A levels, as lamin A has been implicated in transcriptional 
regulation (Andres and Gonzalez, 2009). 
Nup88 has been implicated in CRM1-mediated export and lamin A is imported 
into the nucleus in an importin α/β dependent manner. However, we could rule out an 
nucleocytoplasmic transport-associated interaction of Nup88 with lamin A, as CRM1, 
importin α and β from the reticulocyte lysate did not associate with the Nup88-lamin A 
complex in solution binding assays, suggesting a new type of interaction apart from 
Nup88 transport function (Figure S7.9). 
 
3.4.2 Nup88 is localizing to both sides of the NPC 
Consistent with previous localization experiments, we localized the C-terminus 
of Nup88 to the cytoplasmic side of the NPC, whereas for the N-terminus, we observed a 
cytoplasmic and nuclear localization pattern (Figure 3.3). It is rather unlikely that Nup88 
is anchored to the cytoplasmic side by its C-terminus and that the N-terminus can reach 
through the NPC to the nucleoplasmic side, as Nup88 does not contain any FG-repeat 
domain found in nucleoporins which are more flexible and can reach through the pore 
(Fahrenkrog et al., 2002; Paulillo et al., 2005). The difference in N-and C-terminal 
location lies more likely in their epitope accessibility so that the C-terminus is more 
readily accessible on the cytoplasmic side of the NPC, but hidden for an antibody access 
on the nuclear side, whereas the N-terminus seems to be similar accessible on both sides. 
The idea that a pool of Nup88 is cytoplasmic and a pool of Nup88 resides at the nuclear 
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ring moiety of the NPC is consistent with the idea that Nup88 interacts with lamin A on 
the nuclear side of the NPC. Notably, another lamin interacting nucleoporin, Nup153, is 
located at the nuclear ring moiety, and the location therefore appears to be a good 
prerequisite for lamin A interaction (Fahrenkrog et al., 2002; Smythe et al., 2000). 
Nup153 depends on the nuclear lamina for its recruitment to the NE and the 
nuclear lamina itself is involved in NPC assembly and spacing within the NE (Smythe et 
al., 2000; Walther et al., 2001). Therefore, it is feasible that Nup88 as a novel lamin A-
binding protein plays a role in maintaining nuclear architecture. However, lamin A exists 
in at least two forms in the cell: in a filamentous form incorporated in the nuclear lamina, 
and in a more soluble form distributed throughout the nucleoplasm. Hence, a possibility 
could be that Nup88 interacts with the soluble fraction lamin A, which is further 
supported by the idea that only soluble lamin A co-precipitated with the Nup88 
antibodies in the immunoprecipitation experiment, as the immunoprecipitation conditions 
we used in our experiment seem to extract more the soluble lamins than the lamina 
filaments (Moir et al., 2000b; Muralikrishna et al., 2004). Further indication for this 
scenario provides the finding that Nup88 interacts with lamin A and LAP2α in a trimeric 
complex in a GST-solution binding assay (Lussi et al., data not shown). LAP2α is a 
known interaction partner of soluble nucleoplasmic lamin A. Future studies will be 
directed towards understanding the nature and function of the interaction between Nup88 
and lamin A. 
Until now, it is unclear which binding partner Nup88 possesses within the 
nuclear side of the NPC. A putative nuclear binding partner is Nup98, as Nup98 localizes 
to both sides of the NPC and furthermore, it was shown to interact with Nup88 (Griffis et 
al., 2003). Moreover, it was shown that overexpression of GFP-Nup98 leads to active 
relocation of Nup88 into the nucleus, suggesting an import mechanism similar to Nup96, 
where Nup98 has been described to be responsible for the import of Nup96 into the 
nucleus, after which Nup96 is incorporated into the nucleoplasmic side of the NPC 
(Fontoura et al., 1999). A similar mechanism could be imagined for Nup88. 
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3.4.3 Nup88 interaction is lost with disease-associated lamin A Ig-fold mutants 
Characterization of the interaction between Nup88 and lamin A showed that 
Nup88’s N-terminus is required to interact with lamin A, and that it is the Ig-fold domain 
of lamin A mediating the binding to Nup88 (Figure 3.2C and D). Many laminopathy-
associated mutations were identified within the Ig-fold domain of lamin A (Worman and 
Bonne, 2007). Here, we examined the nature of interaction between Nup88 and two Ig-
fold-related mutants, lamin A(R453W) and (R482W) causing Emery-Dreifuss muscular 
dystrophy and Dunnigan-type lipodystrophy, respectively, and a mutant affecting the 
very C-terminus of lamin A leading to Hutchison-Gilford progeria syndrome, lamin 
AΔ50. Our results show that the interaction of Nup88 with the Ig-fold-related mutations 
is abrogated, whereas the lamin AΔ50 mutant is still able to bind Nup88 in vitro and in 
vivo (Figure 3.5). This implicates that the overall Ig-fold structure, and more specifically 
the site around R482W, which has been shown to be a binding site for lamin A-binding 
partners, is critical for Nup88 binding as well (Dhe-Paganon et al., 2002; Krimm et al., 
2002). This is in agreement with the in vivo finding that wild-type lamin A and lamin 
AD50 are masking a Nup88 epitope through interaction with its N-terminus, whereas the 
masking phenotype is lost with the Ig-fold mutants, and, accordingly, in vivo interaction 
of Nup88 with theses mutants (Figure 3.4 and Figure 3.5). However, the implications of 
Nup88 in laminopathies concerning the abrogated interaction with the Ig-fold lamin A 
mutants needs to be elucidated. 
 
3.4.4 Overexpression of GFP-lamin A is masking the Nup88 antibody epitope 
We have shown that the reduced Nup88 staining observed with antibodies against 
the residues 314- 425 in HEK cells transfected with GFP-lamin A is due to epitope 
masking, rather than an absence of the protein antigen (Figure 3.4, Figure 3.5, Figure 
S7.11 and Figure S7.12). Antigen masking can occur as a result of conformational 
changes in the antigen, post-translational modification or interaction with other 
macromolecules that physically block the epitope. Nup88 epitope masking takes place 
when GFP-lamin A is overexpressed, suggesting that the abundant lamin A is binding 
more Nup88 than under native conditions in these cells, leading to the observed 
phenomenon. We could overcome this occurrence can by the use of a different epitope of 
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Nup88 or a different fixation method in the immunofluorescenec assay (Figure S7.12). 
Normally, a high affinity antibody would be capable of displacing interacting proteins 
from an antigen by mass action. Chemical cross-linking can prevent such displacement 
and might explain why the masking is observed in formaldehyde-fixed samples but not in 
methanol-fixed samples. Interestingly, the masking phenotype is lost with the lamin 
A(R453W) and the lamin A(R482W) mutant, suggesting that the interaction between the 
two proteins is lost in vivo, strengthening our in vitro findings that interaction between 
Nup88 and the lamin A Ig(R453W) and lamin A Ig(R482W) mutants is abolished in 
solution binding assays and confirming that the Ig-fold is crucial for Nup88 binding in 
vitro an in vivo (Figure 3.2 and Figure 3.5). 
Altogether, with this work on the interaction of Nup88 and lamin A, we provide 
evidence for a novel link between the NPC and the nuclear lamina. It will be interesting 
to determine the functional significance of this interaction, and its pathological 
implications in laminopathies. 
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3.5 Materials and Methods 
 
3.5.1 Preparation of nuclei from HeLa cell suspension cultures by osmotic 
swelling 
HeLa S3 cells were grown in suspension culture and harvested by centrifugation 
at 600g for 5 min. The pelleted cells were washed in 5 volumes of prechilled Earle’s 
balanced salt solution. The pelleted cells were then resuspended in 10 volumes of RSB 
buffer (0.01 M NaCl, 1,5 mM MgCl2, 0.01 M Tris-HCl, pH 7.4) and incubated for 10 min 
on ice. Cells with swollen cytoplasm were homogenized in a prechilled glass Douncer 
and examined in the phase contrast microscope. The homogenized cell suspension with a 
free nuclei: intact cell ratio of 9 or greater was centrifuged at 1000g for 3 min to pellet the 
nuclei. The nuclear pellet was washed in 10 volumes of RSB.  
 
3.5.2 Cell culture and transfections  
 HEK cells were grown in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) plus penicillin and streptomycin. Cells 
were transfected using TransIt®-293 transfection reagent (Mirus Bio LLC, Madison, 
USA) following the instructions of the manufacturer.  
A stable cell line based on HEK cells was generated expressing a myc-tagged 
Nup88 upon addition of tetracycline to the medium (Invitrogen). Nup88-myc HEK cells 
grown in the absence of tetracycline expressed only endogenous Nup88. Upon addition of 
1 µg/ml tetracycline to the medium, the cells express Nup88-myc as analyzed by 
immunofluorescence microsocopy and immunoblot (Figure S7.11A, upper panel and B).  
 
3.5.3  Constructs  
 N-terminally tagged GST-Nup88 was cloned into NcoI/KpnI cut pGEX-CS 
vector (Amersham-Pharmacia, Little Chalfont, England). N-terminally tagged GFP-lamin 
A and GFP-lamin B1 were kindly received from Prof. Robert D. Goldman (University of 
Chicago). The pET-lamin A Ig was constructed with HindIII and XhoI restriction sites. 
The lamin A Ig(R453W) and GFP-lamin A(R453W) constructs were made by Dr. Teba 
Al-Haboubi by site-directed mutagenesis with primers (5’- GAG GGC AAG TTT GTC 
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TGG CTG CGC AAC AAC TCC) and (3’- (GGA GTT GTT GCG CAG CCA GAC 
AAA CTT GCC CTC) on pET-lamin A Ig and pEGFP-lamin A and the lamin A 
Ig(R483W) and GFP-lamin A(R482W) with primers (5’-CCC TTG CTG ACT TAC 
TGG TTC CCA CCA AAG TTC) and (3’-GAA CTT TGG TGG GAA CCA GTA AGT 
CAG CAA GGG) on pET-lamin A Ig and pEGFP-lamin A. The pET-lamin AΔ50 and 
pEGFP-lamin AΔ50 were kindly received from Harald Herrmann (German Research 
Center, DKFZ, Heidelberg). 
 
3.5.4 Antibodies 
The polyclonal antibody against the residues 27-45 of human Nup88 (1:1000 for 
immunofluorescence) was kindly provided by Prof. Ulrike Kutay (ETH, Zürich) and the 
polyclonal anti-lamin A antibody (1:500) was kindly received from Prof. Robert D. 
Goldman. The monoclonal antibodies against the amino acids 314-425 of human Nup88 
(1:500, BD Biosciences, Pharmingen) and against the amino acids 509-741 (Novocastra 
Laboratories, Newcastle) were used in this study. Further primary antibodies were the 
monoclonal antibodies mAB414 (1:2000; Covance, Berkely, CA), anti-β tubulin (1:2000; 
Chemicon, Billerica, MA), anti-importin α (1:1000; Sigma Aldrich) and anti-importin β 
(1:1000; BD Biosciences, Pharmingen). Secondary antibodies include anti-mouse IgG-
Alexa 568, anti-rabbit IgG-Alexa 488 and anti-rabbit IgG-Alexa 568 from Molecular 
Probes (Paisley, UK) and used 1:1000.  
 
3.5.5 Immunofluorescence   
 Cells were grown on poly-lysine coated glass coverslips and fixed either in 2% 
formaldehyde for 15 min or - 20°C methanol for 5 min, washed three times for 10 min 
with PBS, and permeabilized with PBS containing 1% bovine serum albumin (BSA) and 
0.2% Triton X-100 for 5 min on ice. Next, the cells were washed three times for 10 min 
in PBS containing 1% BSA and incubated with the appropriate primary antibodies for 1 
hour, washed three times in PBS containing 1% BSA and incubated with the appropriate 
secondary antibodies for 1 hour, washed 4x 10 min with PBS, mounted with a drop of 
Mowiol and stored at 4°C until viewed. Cells were viewed using a confocal laser-
scanning microscope (Leica TCS NT/SP5, Leica, Vienna, Austria). Images were recorded 
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using the microscope system software and processed using Adobe Photoshop (Adobe 
Systems, Mountain View, CA, USA).  
 
3.5.6 Gel electrophoresis and immunoblotting 
 Cells were resuspended in lysis buffer containing 50 mM Tris-HCl pH 7.8, 150 
mM NaCl, 1% Nonidet P-40, and protease inhibitor cocktail tablets (Roche, Basel, 
Switzerland). Sample aliquots were resolved by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE; 10%). The proteins were transferred onto a PVDF 
membrane and the membrane was incubated in I-Block solution (Tropix, Bedford, MA) 
containing 0.1% Tween- 20 (blocking solution) over night at 4°C, then incubated in 
blocking solution containing a primary antibody directed against either Nup88 (1:800) or 
anti-β-tubulin (1:1000) for 1 hour followed by washing 3x with PBS containing 0.1% 
Tween-20. The membrane was then incubated in the dark with anti-mouse IRDye 800 
(1:10000; LI-COR, Biosciences, NE, USA) in blocking solution. Images were recorded 
using the Odyssey infrared imaging system and analyzed by the systems software 
program (LI-COR, Biosciences, NE, USA).  
 
3.5.7 Colloidal blue staining 
Colloidal blue staining (Invitrogen, Pailsey, UK) was performed according to 
manufacturer’s instructions. 
 
3.5.8 Immunoprecipitation  
 Subconfluent HeLa cells (3x106) were trypsinized, washed with PBS and 
resuspended in 160 µl lysis buffer (50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 0.1 % 
Triton X-100, 2 mM EDTA-Na2, 10% glycerol and protease inhibitor (Thermo 
Scientific)), vortexed and incubated for 10 min at 37°C. The cells were pelleted at 16,000 
g for 10 min and the supernatant was transferred to a fresh tube. The supernatant was 
cleared with 20 µl of protein G-agarose beads (Santa Cruz) and incubated for 30 min at 
4°C, centrifuged at 1000 g for 30 sec at 4°C, and the supernatant was transferred to a 
fresh tube and 1 µg mouse monoclonal anti-Nup88 antibody was added and incubated for 
2 hours on ice. 40 µl prewashed protein G- agarose slurry was added to the lysate and 
3.5 Materials and Methods 
 107 
incubated at 4°C on a rocker platform for 1 hour. The immunoprecipitate was collected 
by centrifugation at 1000 g for 30 sec at 4°C and the supernatant was carefully removed 
and kept to analyze as unbound fraction. The pellet was washed 3x with lysis buffer, 
resuspended in electrophoresis sample buffer, boiled at 95°C for 5 min and subjected to 
electrophoresis and Western blotting.  
 
3.5.9 In vitro transcription and translation 
Nup88, Nup88 (1-550) and Nup88 (551-741), lamin A, lamin A (386-548), lamin 
A Ig, lamin A Ig (R453W), lamin A Ig (R482W), lamin AΔ50, lamin B1 Ig and lamin B2 
Ig were obtained by in vitro transcription and translation with the TNT-coupled 
reticulocyte lysate system (Promega, Madison, USA) in the presence of residue L-
[35S]methionine-cysteine (Amersham Bioscience, Uppsala, Sweden) following the 
instructions of the manufacturer. 
 
3.5.10 Expression of recombinant Nup88 and lamin A 
GST, GST-Nup88 and lamin A-his were expressed in E. coli BL21 (DE3) cells. 
Protein expression was induced with 0.5 mM isopropyl-beta-D-thiogalactopyranoside 
(IPTG) for 5 hours at 25°C. Cells were lysed by sonication (Branson Digital Sonifier, 
Branson Ultrasonics Corporation, Danbury, CT, USA) in 2xPBS containing 1% Triton X-
100 and protease inhibitor (Thermo Scientific). Lysed cells were spun at 60,000 g for 1 
hour, and the cleared lysates were stored at -80°C.  
 
3.5.11 In vitro binding assays 
The in vitro interaction between Nup88 and lamin A was tested by binding GST 
and GST-Nup88 to glutathione-sepharose beads (Amersham Bioscience, Uppsala, 
Sweden) or lamin A-his to Ni-sepharose 6 fast flow beads (GE Healthcare, formerly 
Amersham Biosciences, Sweden) for 1 hour at 4°C. Beads were washed twice with 
2xPBS containing 1% Triton X-100 and protease inhibitor (Thermo Scientific). In vitro 
translated Nup88, Nup88 (1-550) and Nup88 (551-741), lamin A, lamin A (386-548), 
lamin A Ig, lamin A Ig (R453W), lamin B1 Ig and lamin B2 Ig were allowed to bind for 
16 to 20 hours at 4°C. After binding, the beads were washed twice in 2xPBS containing 
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1% Triton X-100 and protease inhibitor (Thermo Scientific) followed by two washes in 
2xPBS. Samples were eluted in 50 µl SDS sample buffer, analyzed on a 10% SDS 
polyacrylamide gel and detected by autoradiography. 
 
3.5.12 Expression and purification of lamin A and vimentin 
Purified human vimentin in urea was a kind gift of Prof. Harald Herrmann 
(German Cancer Research Center (DKFZ), Heidelberg, Germany). Purified human lamin 
A in urea was a kind gift of Prof. Robert D. Goldman (Northwestern University, Chicago, 
IL). 
 
3.5.13 Blot-overlay assay 
Purified vimentin and lamin A were separated on SDS-PAGE, transferred to a 
PVDF membrane, blocked with I-block o/n at 4°C and then incubated with in vitro 
transcribed/translated 35S-labeled Nup88. After washing, binding of Nup88 was 
visualized by autoradiography. 
 
3.5.14 Immuno-EM   
Mature (stage 6) oocytes were surgically removed from female Xenopus laevis, 
and their nuclei were isolated as described (Pante et al., 1994). Colloidal gold particles, 
~8-nm in diameter, were prepared by reduction of tetrachloroauric acid with sodium 
citrate in the presence of tannic acid and antibodies were conjugated to colloidal gold 
particles as described (Baschong and Wrigley, 1990). Isolated nuclei were labeled with 
monoclonal Nup88 antibodies (BD Biosciences, Pharmingen; Novocastra Laboratories, 
Newcastle) as described previously and labeled nuclei were fixed and processed for EM 
as described (Fahrenkrog et al., 2002; Paulillo et al., 2005). EM micrographs were 
recorded on a Phillips CM-100 transmission electron microscope equipped with a CCD 
camera. 
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4.1 Abstract 
Nuclear pore complexes (NPCs) are embedded in the nuclear envelope (NE) and 
mediate bidirectional nucleocytoplasmic transport. Besides the control of macromolecule 
transport, it became evident that individual nucleoporins play important roles in other 
cellular processes, including cell cycle regulation. In this work, we identified the 
nucleoporin Nup88 as putative regulator of cell cycle progression. By pull-down 
experiments, we identified lamin A and LAP2α to be in a complex with Nup88. The 
lamin A- LAP2α complex was previously shown to control cell proliferation by binding 
to the retinoblastoma protein (pRb), and repressing the expression of pRb/E2F-dependent 
cell cycle regulatory genes important for G1-S phase transition. Misregulation of the 
lamin A- LAP2α complex is leading to impaired pRb repressor activity and 
hyperproliferation of mice fibroblasts. Here, we found that Nup88 overexpression 
interferes with the normal distribution of lamin A and LAP2α in G1, furthermore 
disrupting the lamin A- LAP2α complex. Consistently, we show that Nup88 
overexpression leads to an inefficient cell cycle arrest in G0 by serum starvation and 
slightly accelerates cell cycle progression from G1 to S. In contrast, stable 
downregulation of Nup88 by RNA interference does not affect the association of the 
lamin A- LAP2α complex, but delays progression from G1 to S phase in a synchronized 
cell culture. The effects of Nup88 on cell cycle progression might be relevant for the 
Nup88 overexpression phenotype observed in many human tumors.
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4.2 Introduction 
Nuclear pore complexes (NPCs) are macromolecular structures that are 
embedded in the double membrane of the nuclear envelope (NE) and mediate 
bidirectional nucleocytoplasmic transport. The vertebrate NPC consist of about 30 
nucleoporins (Nups), one of which is Nup88. In a previous study, we have shown that 
Nup88 is localized to both the cytoplasmic and nuclear side of the NPC, where it interacts 
with distinct subcomplexes; the Nup214 subcomplex on the cytplasmic side and lamin A 
on the nuclear side (Bernad et al., 2004) (Lussi et al., submitted). Nup88 was found to be 
overexpressed in a wide range of human tumors and Nup88 levels have been correlated to 
tumor development and aggressiveness (Agudo et al., 2004; Emterling et al., 2003; Gould 
et al., 2000; Gould et al., 2002; Martinez et al., 1999; Zhang et al., 2002; Zhang et al., 
2007). Although the exact function of Nup88 in tumorigenesis remained elusive, it was 
suggested that Nup88 might play a role in proliferation, as it is not only expressed during 
tumorigenesis but also in fetal tissue of the lung and during embryological differentiation 
in chicken embryos (Gould et al., 2000; Schneider et al., 2004). 
The nuclear lamina is a major structural element of the NE and is closely 
associated with the inner nuclear membrane (INM) and attached to the periphery of NPCs 
and to chromatin (Aaronson and Blobel, 1975; Fawcett, 1966; Patrizi and Poger, 1967). 
The nuclear lamina is involved in nuclear architecture, NPC spacing and was found to be 
involved in many cellular processes, including gene regulation (Hutchison, 2002). The 
major constituents are type V intermediate filament (IF) proteins, the nuclear lamins, 
which can be classified in A- and B-type lamins, according to their homology. A-type 
lamins are also found distributed throughout the nucleoplasm and have been implicated in 
chromatin organization (Gruenbaum et al., 2005), DNA replication (Moir et al., 2000a), 
RNA Pol II-dependent transcription (Spann et al., 2002) and gene regulation (Bridger et 
al., 1993; Hozak et al., 1995).  
The organization of lamins at the nuclear periphery as well as within the 
nucleoplasm is influenced by numerous lamin-binding proteins (Dorner et al., 2007; 
Schirmer and Foisner, 2007; Wagner and Krohne, 2007). One of those is the lamina-
associated polypeptide 2α, LAP2α, which is found in a stable complex with lamin A/C in 
the nucleoplasm (Dechat et al., 2000a). LAP2α is a splice variant of the LAP2 gene, from 
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which up to six isoforms exist in humans (α, β, γ, δ, ε and ζ) (Berger et al., 1996; Foisner 
and Gerace, 1993; Harris et al., 1994). LAP2 proteins have a closely related N-terminus, 
but the C-terminus in LAP2α is structurally and functionally unique: it lacks a 
membrane-spanning domain found in the other LAP2 proteins, and is, as a result, 
distributed diffusely throughout the interphase nucleus (Dechat et al., 1998). LAP2α is 
targeting a pool of lamin A to the nucleoplasm, where the two proteins form a stable 
complex (Dechat et al., 2004; Dechat et al., 2000a; Markiewicz et al., 2002).  
The lamin A- LAP2α complex was previously shown to control cell proliferation 
by binding to the hypophosphorylated form of the retinoblastoma protein (pRb) (Dorner 
et al., 2006; Mancini et al., 1994; Markiewicz et al., 2002; Mittnacht and Weinberg, 
1991; Ozaki et al., 1994), which is the predominant form of pRb in G1 phase of 
proliferating cells or in G0 of resting cells. Hypophosphorylated Rb is tethered in the 
nucleus and blocks transition into S phase by inhibiting the activity of E2F transcription 
factors that are essential for the expression of S phase–specific genes (Bracken et al., 
2004; Classon and Harlow, 2002; Dyson, 1998; Kaelin, 1999). Hyperphosphorylation of 
Rb during late G1 phase releases it from nuclear tethers, which in turn releases and 
derepresses E2F and leads to transition through S phase. Misregulation of the lamin A- 
LAP2α complex impairs pRb repressor activity and leads to hyperproliferation of mice 
fibroblasts, failure in efficient cell cycle arrest or impaired myoblast differentiation (Frock 
et al., 2006; Nitta et al., 2006; Van Berlo et al., 2005). 
We have recently identified the nucleoporin Nup88 as novel lamin A interacting 
partner. In this study, we further identified the lamin A-binding protein LAP2α to be 
associated with Nup88. The lamin A-LAP2α complex is known to repress pRb and to 
regulate G1-S transition. We then investigated whether Nup88 affects the lamin A-
LAP2α complex and cell cycle progression. We can show that overexpression of Nup88 
leads to a disruption of the lamin A-LAP2α complex, leading to an inefficient G0/1 arrest 
and accelerated progression through G1-S transition in a human cell culture. Knockdown 
of Nup88 leaves the lamin A- LAP2α complex intact, but, however, slows down S-phase 
progression significantly, indicating a hyperrepression of pRb. This data suggest that 
Nup88 regulates lamin A- LAP2α repressor activity by influencing the stability of the 
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lamin A-LAP2α complex. Together, we identified the nucleoporin Nup88 as a novel 
regulator of the lamin A- LAP2α complex and of cell cycle progression.
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4.3 Results 
 
4.3.1 Nup88 associates with lamin A and LAP2α  
In a previous study, we have localized Nup88 on the cytoplasmic and nuclear 
side of the NPC and identified lamin A as novel interaction partner of Nup88 on the 
nuclear face of the NPC (Lussi et al., submitted). In order to elucidate the functionality of 
this interaction, we aimed to identify other proteins in this complex. For this experiment, 
recombinant glutathione-S-transferase (GST)-tagged Nup88 fusion protein or GST alone 
was expressed in E. coli, purified, immobilized on glutathione sepharose beads and 
incubated with a lysate of isolated HeLa S3 nuclei. Proteins that bound GST-Nup88 or 
GST were separated on SDS-PAGE and detected by immunoblot analysis (Figure 4.1). 
We confirmed that lamin A co-purified with GST-Nup88, but not with GST (Figure 4.1) 
(Lussi et al., submitted). Furthermore, we found that the lamina associated protein 2 
alpha, LAP2α, an interaction partner of lamin A, coprecipitated with GST-Nup88, but not 
with GST alone (Figure 4.1). Therefore, the three proteins Nup88, lamin A and LAP2α 
can build a complex in vitro.  
 
 
Figure 4.1: Nup88 associates with lamin A and Lap2α . 
HeLa S3 nuclei lysate was incubated with purified, recombinant glutathione-S-transferase (GST)-
tagged Nup88 fusion protein or GST alone immobilized on glutathione sepharose beads. Proteins 
bound to GST-Nup88 or GST were separated on SDS-PAGE and detected by immunoblot analysis 
with polyclonal lamin A antibody or polyconal LAP2α antibody. 
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4.3.2 Nup88 overexpression disrupts the lamin A-LAP2α  complex and accelerates 
G1 to S transition 
The lamin A-LAP2α complex binds hypophosphorylated pRb in the nucleus and 
it is suggested that nucleoplasmic lamin A-LAP2α complexes may regulate its repression 
activity on the E2F family transcription factors during G1 phase of the cell cycle by either 
increase pRb’s repressor function or delay its deactivation (Dorner et al., 2006; Dyson, 
1998; Markiewicz et al., 2002; Nitta et al., 2006). To analyze if the overexpression of 
Nup88 influences the stability of the lamin A- LAP2α complex, we performed co-
immunoprecipitation experiments with lysates of HEK cells overexperessing Nup88-myc 
in a tetracycline inducible manner or of control cells (Figure 4.2A). Overexpression of 
Nup88-myc was assessed by immunoblotting of cell lysates using an anti-myc antibody 
(Figure 4.2A). We immunoprecipitated lamin A/C from lysates of HEK cells that were 
treated with tetracycline (tet) to overexpress Nup88-myc (+ tet) or from control cells (- 
tet) using a monoclonal lamin A/C antibody. Co-immunoprecipiation of LAP2α was 
assessed by immunoblotting using a polyclonal LAP2α antibody. As shown in Figure 
4.2A, LAP2α could be co-immunoprecipitated with LA/C in control cells, whereas it was 
not detectable in the co-immunoprecipitate of Nup88-myc overexpressing cells. Neither 
lamin A nor LAP2α were found to bind unspecifically to the protein G-agarose beads 
alone (Figure 4.2A). Together, our data indicate that Nup88 overexpression abrogates the 
association of the lamin A-LAP2α complex.  
The lamin A-LAP2α complex localizes to the nucleoplasm in a cell cycle 
dependent manner, and highest concentrations of the complex in the nucleoplasm can be 
found in early G1 (Naetar and Foisner, 2009). To examine the effect of ectopic Nup88 
expression on the distribution of lamin A and LAP2α during G0/1 phase of the cell cycle, 
we performed a co-immunostaining experiment with human telomerase immortalized 
primary fibroblast cells (BJ1-hTERT) transiently transfected with green-fluorescent 
protein (GFP)-tagged Nup88 or GFP as control. Expression of the proteins was verified 
by immunoblot analysis using a GFP antibody (Figure S7.14). 24 hours after transfection, 
the cells were arrested in G0 phase of the cell cycle by serum starvation and were 
indirectly labeled with antibodies against lamin A and LAP2α (Figure 4.2B). Cell 
transfected with GFP showed the typical rim staining for lamin A and a diffuse lamin A 
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distribution within the nucleoplasm and LAP2α was localized in patches at the nuclear 
periphery and in the nucleoplasm (Figure 4.2B, upper panel). Cells expressing GFP-
Nup88 showed a less uniformly distribution of lamin A in the nucleoplasm and the 
nucleoplasmic patches of LAP2α were significantly reduced (Figure 4.2B, lower panel). 
These data suggest that excess Nup88 is delocalizing lamin A and LAP2α and possibly 
affecting the stability of the lamin A- LAP2α complex in vivo. 
To further investigate if the disrupted interaction of lamin A and LAP2α had any 
impact on pRb repression and E2F-dependent cell cycle gene transcription, we performed 
flow cytometric analysis to determine the cell cycle distribution of cells overexpressing 
GFP-Nup88 or GFP. For this analysis, we utilized BJ1-hTERT cells that were transiently 
transfected to express GFP or GFP-Nup88 and that were arrested in G0 by serum 
starvation. After labeling with propidium iodide, cell cycle distribution was analyzed by 
flow cytometry. Interestingly, cells overexpressing GFP-Nup88 were not as efficiently 
arrested in G0 phase as control cells after 3 days of serum starvation. DNA flow 
cytometry analysis revealed that GFP-Nup88 expressing cells showed a decrease in the 
relative number of cells in G1 phase (61.4 to 74.5%) and an increase of cells in S phase 
(31.1 to 18.6%) compared to GFP expressing cells at time point 0 hours after serum 
addition to the growth medium (Figure 4.2C and D). Moreover, cells expressing GFP-
Nup88 showed a slight but reproducible acceleration of the cell cycle, i.e. more cells in S 
and G2 compared to the control cells after 24 hours of serum addition (41.2% in S phase 
and 12.5% in G2 phase compared to 33.4% (S) and 9.2% (G2), respectively (Figure 4.2C 
and D). Cells were growing asynchronous after 48 h and no significant difference 
between GFP-Nup88 and GFP overexpressing cells was detectable (Figure 4.2C and D). 
Taken together, we concluded that increased GFP-Nup88 levels negatively affect the 
G0/1 arrest and positively affect the G1 to S phase transition. These data suggest that the 
disruption of the lamin A-LAP2α complex by overexpression of Nup88 leads to an 
impairment of pRb repression and to an inefficient arrest in G0.  
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Figure 4.2: Overexpression of Nup88 disrupts the lamin A-LAP2α  complex and accelerates 
cell cycle progression.  
(A) Lysates of HEK cells overexpressing Nup88-myc (I) or control cells (NI) were 
immunoprecipitated with monoclonal lamin A/C antibody. Lysate, unbound and precipitate 
fractions were analyzed by immunoblotting using monoclonal lamin A/C antibody or polyclonal 
LAP2α antibody. Lysates of HEK cells overexpressing Nup88-myc (I) and control cells (NI) were 
analyzed by immunoblotting using monoclonal myc antibodies. (B) BJ1-hTERT fibroblasts were 
transfected with GFP-Nup88 or GFP, arrested in G0 by serum starvation and visualized by indirect 
fluorescence microscopy with antibodies against lamin A and LAP2α. DNA was stained with 
DAPI. Scale bar, 10 µm. (C) BJ1-hTERT cells overexpressing GFP-Nup88 or GFP were arrested 
in G0, labeled with propidium iodide and analyzed by flow cytometry at the indicated timed 
points. (D) Table of cell cycle distribution of GFP-Nup88 and GFP transfected cells at indicated 
time points. 
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4.3.3 Depletion of Nup88 slows down S-phase, leaving the lamin A-LAP2α  
complex intact 
We next investigated the effect of depleting Nup88 on the lamin A-LAP2α 
complex as well as on cell cycle progression. To do so, we depleted Nup88 from HEK 
293 cells using RNA interference (RNAi) and synchronized the cells at the G1/S border 
by applying a double thymidine block. Transfection of HEK cells with siRNA against 
Nup88 resulted in a significant reduction in Nup88 protein levels as determined by 
immunoblotting and compared to control cells transfected with an unrelated control 
siRNA (cyclophilin B) at indicated time points (80% reduction of Nup88 protein levels at 
time point 0h, 73% at 9 and 24h, and 70% at 48 h after double thymidine block release, 
respectively, compared to Nup88 levels in cyclophilin B siRNA treated cells) (Figure 
4.3A). Flow cytometric analysis of synchronized cells that were depleted of Nup88 or 
cyclophilin B and labeled with propidium iodide revealed that Nup88 depleted cells 
progressed significantly slower through cell cycle than the control cells (Figure 4.3B and 
C). At timepoint 0 hours after double thymidine block release, 84% of cells treated with 
cyclophilin B and 84.7% of Nup88 siRNA treated cells were arrested in G1, respectively. 
After 9 hours of release, cyclophilin B treated cells processed through S and G2 phase 
(42.7% in G1, 21.9% in S and 35.4% in G2), whereas Nup88 depleted cells progressed 
through S phase with a delay as compared to control cells (44% in G1, 38.7% in S and 
17.3% in G2). The delay in cell cycle progression was persistent 24 and 48 hours after 
double thymidine block release (Figure 4.3B and C). 
To analyze if Nup88 depletion had any effect on lamin A-LAP2α complex 
stability, we next performed co-immunoprecipitation experiments. We 
immunoprecipitated lamin A/C from lysates of HEK cells transfected with siRNA against 
Nup88 or cyclophilin B using a monoclonal lamin A/C antibody (Figure 4.3D). Co-
immunoprecipiation of LAP2α was assessed by immunoblotting using a polyclonal 
LAP2α antibody. LAP2α was co-immunoprecipitated in control as well as in Nup88 
depleted cells, indicating that Nup88 depletion had no significant influence on the 
stability of the lamin A-LAP2α complex (Figure 4.3D). Neither lamin A nor Lap2α were 
found to bind the protein G-agarose beads alone (Figure 4.3D).  
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Figure 4.3: Depletion of Nup88 slows down S-phase, leaving the lamin A- LAP2α  complex 
intact. 
(A) HEK cells were transfected with Nup88-specific siRNA or with siRNA targeting cyclophilin B 
and arrested in G1 by a double thymidine block. Nup88 protein levels were assessed by 
immunoblotting with monoclonal Nup88 and β-tubulin antibodies at the indicated time points. (B) 
HEK cells were transfected with siRNA against Nup88 or cyclophilin B, arrested in G1 by a 
double thymidine block, labeled with propidium iodide and analyzed by flow cytometry at the 
indicated time points. (C) Table of cell cycle distribution of siRNA treated cells at indicated time 
points. (D) Lysates of HEK cells transfected with siRNA against Nup88 or cyclophilin B were 
immunoprecipitated with monoclonal lamin A/C antibody. Lysate, unbound and precipitated 
fractions were analyzed by immunoblotting using monoclonal lamin A/C antibody or polyclonal 
LAP2α antibody. Lysates of HEK cells transfected with Nup88 or cyclophilin B siRNA were 
analyzed by immunoblotting with monoclonal Nup88 and β-tubulin antibodies.
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4.4 Discussion 
The nucleoporin Nup88 was found to be overexpressed in a wide variety of 
human cancers and Nup88 protein levels were correlated with aggressiveness and tumor 
development, implicating Nup88 in cell proliferation. However, the exact mechanism of 
how Nup88 might influence proliferation was not known so far. We have shown here that 
Nup88 influences cell cycle progression through interaction with the lamin A-LAP2α 
complex.  
 
4.4.1 Nup88 associates with the lamin A- LAP2α  complex 
In a previous study, we have shown that Nup88 is interacting with the nuclear 
intermediate filament protein lamin A (Lussi et al., submitted). In vitro, we have mapped 
the interaction domains of the two proteins in the N-terminus of Nup88 and in the Ig-fold 
domain of lamin A, respectively. The two proteins are interacting in vivo as well, as 
lamin A is co-precipitating with Nup88 antibodies and an excess of lamin A hinders the 
accessibility of Nup88 in human cells. However, it had remained unclear whether Nup88 
interacts with filamentous lamin A or the more soluble nucleoplasmic lamin A.  
To gain more insight into the nature and functional significance of the Nup88 
interaction with lamin A, we have performed a GST-pull down assay with purified GST-
Nup88 and HeLa S3 nuclear lysate and found that lamin A as well as LAP2α bind to 
GST-Nup88, suggesting that the three proteins associate in a complex in vitro (Figure 
4.1A+B). LAP2α is a binding partner of soluble lamin A and lamin A-LAP2α complexes 
can be found distributed throughout the nucleoplasm. Our finding therefore suggests that 
Nup88 interacts with the soluble nucleoplasmic lamin A together in a complex with 
LAP2α. Whether the interaction between Nup88 and LAP2α also takes places in vivo 
and whether the two proteins interact directly or indirectly needs to be further elucidated. 
As we localized a pool of Nup88 to the nuclear side of the NPC (Lussi et al., submitted), 
we speculate that the interaction of the lamin A-LAP2α complex with Nup88 takes place 
at the nuclear periphery. However, it cannot be excluded that the trimeric complex exists 
in the nucleoplasm, since Nup88 has been observed in the nucleoplasm as well (Capelson 
et al.; Kodiha et al., 2008b). 
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4.4.2 Overexpression of Nup88 is associated with the disruption of the lamin A-
LAP2α  complex and impaired G1 cell cycle arrest 
To gain further insight into the cellular significance of Nup88 association with 
the lamin A-LAP2α complex, we overexpressed Nup88 in HEK cells and precipitated the 
lamin A-LAP2α complex with monoclonal lamin A/C antibodies. In control cells, 
LAP2α was co-precipitated with lamin A/C. However, we found that overexpression of 
Nup88 disrupts the lamin A- LAP2α complex, as co-immunoprecipiation of LAP2α with 
lamin A was lost in theses cells (Figure 4.2A). Consistently, overexpression of Nup88 in 
BJ1-hTERT fibroblasts leads to a reduction of nucleoplasmic lamin A and LAP2α, 
indicating that the nuceloplasmic lamin A- LAP2α complex is disrupted in vivo as well 
(Figure 4.2). Furthermore, overexpression of Nup88 weakens the serum starvation 
induced G0/1 arrest in BJ1-hTERT fibroblasts, consistent with the loss of the lamin A-
LAP2α complex and decreased pRb/E2F repression (Dorner et al., 2006) (Figure 4.2C 
and D). Taken together, our data suggest that overexpression of Nup88 leads to 
destabilization of the lamin A-LAP2α complex, possibly by recruiting lamin A to the 
nuclear periphery, and a weakening of its repressor function at pRb/E2F gene loci, 
leading to advanced G1 to S progression (Figure 4.4).  
 
4.4.3 Depletion of Nup88 slows down G1-S transition 
To test whether depletion of Nup88 had opposing effects on the lamin A-LAP2 
complex stability and cell cycle regulation, we performed siRNA experiments targeting 
Nup88. Indeed, we found that Nup88 depleted cells progressed significantly slower 
through S phase than control cells (Figure 4.3A+B). However, the delay in G1-S 
progression was not associated with a change in lamin A-LAP2α association (Figure 
4.3C). Nevertheless, the experiment performed shows a static moment of lamin A-
LAP2α association. Therefore, we hypothesize that loss of Nup88 might positively affect 
lamin A-LAP2α association over time, thereby leading to a more stable complex and 
prolonged repression of pRb/E2F-dependent genes (Figure 4.4). It will be interesting to 
test if the stability of the lamin A-LAP2α complex is changed over time in Nup88 
depleted cells and if the phenotype is associated with a stronger inhibition of pRb/E2F 
dependent cell cycle genes.  
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Although the depletion experiments were performed in HEK cells, where pRb is 
partially inactivated through adenoviral proteins (Graham et al., 1977; Jackson et al., 
2005) (Baus et al., 2003; Moran, 1993), it seems that depletion of Nup88 had a very 
strong negative effect on cell cycle progression, especially on G1-S transition. Whether 
this phenotype is linked to a stronger pRb repression on E2F-dependent cell cycle genes 
needs to be further elucidated by quantification of appropriate E2F target gene products, 
e.g. cyclin D1. 
In summary, we have shown that the mislocalization of lamin A and LAP2α 
caused by Nup88 overexpression is associated with a disruption of the lamin A-LAP2α 
complex and accompanied by an increase in cell cycle progression in BJ1-hTERT 
fibroblasts. On the other hand, depletion of Nup88 from HEK cells results in delayed cell 
cycle progression. Altogether, we found a novel role of Nup88 in cell cycle checkpoint 
regulation and G1 to S transition. Here, we propose that Nup88 is a regulator of the 
pRb/E2F repressor complex lamin A-LAP2α by influencing its stability and the 
localization of lamin A and LAP2α. Recent literature indicates Nup88 as putative 
oncogene, since its overexpression in a wide variety of human tumors is correlated with 
tumor development and aggressiveness. In Rb-deficient cells, a decrease in differentiation 
potential, in addition to an increase in proliferation rates is observed (Kaelin, 1999). 
Therefore, it might be feasible that Nup88 overexpression in those tumors interferes with 
lamin A-LAP2α-dependent E2F repression and might lead to hyperproliferation in those 
cancer cells. 
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Figure 4.4: Model depicting the potential function of Nup88 in the regulation of the lamin A-
LAP2α  complex in pRb-mediated cell cycle progression 
While in S phase cells A-type lamins are found exclusively at the nuclear periphery, LAP2α 
stabilizes a pool of A-type lamins in the nuclear interior during G1 phase. The nucleoplasmic 
lamin A- LAP2α complex binds to pRb at E2F-dependent promoters in G1 phase and helps to 
inhibit E2F-dependent transcription. In S phase, pRb is phosphorylated, causing dissociation of the 
complex, loss of nucleoplasmic lamin A and C and activation of E2F-dependent transcription. (A) 
In Nup88 overexpressing cells, lamin A is more strongly recruited to the nuclear periphery by 
increased Nup88, the lamin A- LAP2α complex is dissociated, and E2F-dependent promoters are 
derepressed, causing progression from G1 to S phase of the cell cycle. (B) In Nup88-depleted 
cells, lamin A does not get recruited to the nuclear periphery, and the lamin A- LAP2α complex is 
longer associated with pRb and E2F-dependent genes stay repressed, causing cells to progress 
much slower through G1-S transition. 
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4.5 Materials and Methods 
 
4.5.1 Cell culture and transfections  
A stable cell line based on HEK 293 cells was generated expressing a myc-
tagged Nup88 upon addition of tetracycline to the medium (Invitrogen) as described 
before (Lussi et al., submitted, Chapter 3). BJ-hTERT cells were kindly received from 
Prof. Dr. Roland Foisner (Max F. Perutz Labor, Vienna). 
 HEK 293 and BJ1-hTERT cells were grown in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS) plus penicillin and 
streptomycin. Cells were transfected using Solution R and Program 024 with the Amaxa 
Nucleofector (Lonza Group Ltd, Switzerland). For a G0/1 block by serum starvation, 
cells were serum starved for 3 days and released by adding 10% fetal bovine serum to the 
medium. For the double thymidine block, cells were synchronized by thymidine block 
(2mM) for 19 h, released for 9 h, blocked a second time with thymidine and released after 
16 h. 
 
4.5.2 Constructs and Antibodies 
N-terminally GFP-tagged Nup88 was produced using the Kpn1-Xba1 restriction 
sites in pEGFP-C1 (Clontech, Palo Alto, CA). The monoclonal antibody against lamin 
A/C (1/200) as well as the polyclonal antibody against LAP2a (1/250) were both 
purchased from Abcam, the monoclonal GFP-antibody is bought from Roche Applied 
Science, the polyclonal lamin A (1/200) antibody was kindly received from Professor RD 
Goldman (University of Chicago). Monoclonal Nup88 antibody was from BD Bioscience 
(1:500, BD Biosciences, Pharmingen). Secondary antibodies include anti-mouse Alexa 
647 and anti-rabbit Alexa 568 from Invitrogen and used 1:350 (Alexa 647) and 1:1000 
(Alexa 568). 4’,6-Diamidino-2-phenylindol (DAPI) was acquired from Sigma. 
 
4.5.3 Immunofluorescence microscopy 
Cells were grown on coverslips and fixed in 2% formaldehyde for 15 min, 
washed three times for 10 min with PBS, and permeabilized with PBS containing 1% 
bovine serum albumin (BSA) and 0.2% Triton X-100 for 5 min on ice. Next the cells 
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were washed three times for 5-10 min in PBS containing 1% BSA and incubated with the 
appropriate primary antibodies for 1 hour, washed three times in PBS containing 1% 
BSA and incubated with the appropriate secondary antibodies for 1 hour, washed 5x with 
PBS then mounted with Mowiol and stored at 4°C until viewed. Cells were viewed using 
a confocal laser-scanning microscope (Leica TCS SP5, Leica, Vienna, Austria). Some 
images were taken with the Zeiss Observer using AxioVision 4.6 with Multichannel 
Fluorescence. Images were recorded using the microscope system software and processed 
using Adobe Photoshop (Adobe Systems, Mountain View, CA, USA).   
 
4.5.4 RNA interference  
 HEK cells were depleted of Nup88 using On-target smart pool duplex siRNA to 
human Nup88 (Dharmacon, Lafayette, CO). Cells were grown on 12 mm diameter  
coverslips and exposed to the Nup88 siRNA in the presence of Lipofectamine 
RNAiMax (Invitrogen, Paisley, UK) following the instructions of the manufacturer. As a 
control cells were exposed to Lipofectamine RNAimax alone or to siRNA against 
cyclophilin B (Dharmacon, Lafayette, CO). Knock down efficiency was determined by 
immunoblotting 48 h post transfection.  
 
4.5.5 Quantitative immunoblotting and gel electrophoresis  
Cells were resuspended in lysis buffer containing 50 mM Tris-HCl pH 7.8, 150 
mM NaCl, 1% Nonidet P-40 and protease inhibitor (Thermo Scientific). Sample aliquots 
were resolved by sodium dodecyl sulfate-polyacrylamide (10%) gel electrophoresis 
(SDS-PAGE). The proteins were transferred onto a PVDF membrane and the membrane 
was incubated in I-Block solution (Tropix, Bedford, MA) containing 0.1% Tween- 20 
(blocking solution) over night at 4°C, then incubated in blocking solution containing a 
primary antibody directed against either lamin A (1:2000), LAP2α (1:250), Nup88 
(1:500) or anti-β-tubulin (1:1000) for 1 hour followed by washing 3x with PBS 
containing 0.1% Tween-20. The membrane was then incubated with secondary antibodies 
in blocking solution, mouse-IgG-alkaline phosphatase (AP) (1/20000) or rabbit IgG-AP 
(1/20000), respectively. After washing twice with assay buffer (200 mM Tris pH 9.8, 10 
mM MgCl2), alkaline phosphatase substrate (CDP-Star solution, Tropic, Applied 
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Biosystems) was added for 5 min on the immunoblot. Images were recorded using the 
Las-4000 imaging system from Bucher Biotec and analyzed by the systems software 
program and Multigauge. 
 
4.5.6 Flow cytometry  
 Cells were fixed in ice-cold 70% ethanol for 30 minutes, washed 2x in PBS by 
vortexing and pelleting at 1000 g for 5 minutes, and suspended at106 cells/ml with PI 
stain (50 µg/ml propidium iodide, 100 µg/ml RNase A, 0.1% Triton-X 100) for 40 
minutes at 37°C. The cell preparation was stored at 4°C in the dark until flow cytometric 
acquisition and analysis.  
 
4.5.7 Immunoprecipitation 
 Subconfluent HEK cells (3x106) were trypsinized, washed with PBS and 
resuspended in 160 µl lysis buffer (50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 0.1 % 
Triton X-100, 2 mM EDTA-Na2, 10% glycerol and protease inhibitor (Thermo 
Scientific)), vortexed and incubated for 10 min at 37°C. The cells were pelleted at 16000 
g for 10 min and the supernatant was transferred to a fresh tube. The supernatant was 
cleared with 20 µl of prewashed protein G agarose beads (Santa Cruz) and incubated for 
30 min at 4°C, centrifuged at 1000 g for 30 sec at 4°C, and the supernatant was 
transferred to a fresh tube and 2 µg mouse monoclonal lamin A/C antibody was added 
and incubated for 2 hours on ice. 40 µl prewashed protein G agarose slurry was added to 
the lysate and incubated at 4°C on a rocker platform for 1 hour. The immunoprecipitate 
was collected by centrifugation at 1000 g for 30 sec at 4°C and the supernatant was 
carefully removed and kept to analyze as unbound fraction. The pellet was washed 3x 
with lysis buffer, resuspended in electrophoresis sample buffer, boiled at 95°C for 5 min 
and subjected to electrophoresis and immunoblotting.  
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5  
Conclusions and Perspectives 
In recent years, it has become more and more evident that nucleoporins and NPC-
associated proteins, such as Nup98 and the Nup107-160 complex, required for 
nucleocytoplasmic transport have important cellular functions independent of their role in 
mediating transport through the NPC (Capelson et al.; Loiodice et al., 2004; Orjalo et al., 
2006). Nucleoporins have been implicated in mitotic events, gene expression and nuclear 
organization. Here, we give insight into novel functions for the two nucleoporins Nup153 
and Nup88, in mitosis and cell cycle regulation, respectively, which appear to be 
independent of their nucleocytoplasmic transport function. 
 
5.1 Nup153 as a novel regulator of the spindle assembly 
checkpoint protein Mad1 
Although Nup153 has been associated with NE breakdown by recruiting the 
coatomer coat protein I (COPI) complex to the NE (Liu et al., 2003), it became only 
recently clear that Nup153 also plays a direct role in mitosis (Liu et al., 2003; Lussi et al., 
2010; Mackay et al., 2009). Recent work by Mackay and coworkers showed that 
depletion of Nup153 in human cells led to defects in both early and late stages of mitosis 
in a concentration-dependent manner and to an accumulation of cells with multilobed 
nuclei (Mackay et al., 2009). The multilobed nuclei phenotype was independent of the 
FG-domain, whereas the FG-domain of Nup153 was required to rescue the late defects, 
indicating two distinct mitotic functions for Nup153 (Mackay et al., 2009). 
Our study employing overexpression and depletion experiments of Nup153 in human cell 
cultures revealed furthermore that overexpression of Nup153 leads to the appearance of 
multinucleated cells and induces the formation of multipolar spindles (Figure 2.1, Figure 
2.2 and Figure 2.3). Importantly, the observed phenotype was linked to residues 39 to 339 
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of Nup153 corresponding to the NPC assembly region (NPAR) (Enarson et al., 1998), as 
overexpression of a GFP-Nup153-39-339 fusion protein caused a similar phenotype as 
observed with full-length Nup153 (Figure 2.3). Residues 39-339 of Nup153 are not 
known to interact with any of the nuclear transport factors, indicating that the observed 
phenotype is independent of its role in nucleocytoplasmic transport.  
Furthermore, we could show that Nup153 and the SAC protein Mad1 are directly 
interacting both in asynchronous and mitotic cell cultures and that the interaction between 
the two proteins is mediated by Nup153’s N-terminus containing the NPAR domain, 
suggesting that the observed mitotic defects induced by Nup153 overexpression is 
mediated through the interaction with Mad1 (Figure 2.4). In addition, Nup153 
overexpresssion affected Mad1 phosphorylation during mitosis, which is critical for 
mitotic function, indicating that Nup153 overexpression affects SAC by impeding Mad1 
phosphorylation (Chen et al., 1999) (Figure 2.5). We could observe a co-localization of 
Mad1 with Nup153 at the NE and in intranuclear foci when Nup153 was overexpressed 
(Figure 2.6). Therefore, we speculate that Nup153 perturbs Mad1 localization in mitosis, 
what might lead to the decreased phosphorylation of Mad1. Together, we show that 
overexpression of Nup153 causes hypophosphorylation of Mad1, leading to an impaired 
SAC and consequently chromosome missegregation and failures in cytokinesis. 
Interestingly, loss of Mad1 function in human cells mimics the phenotype observed upon 
Nup153 overexpression, suggesting that the by Nup153 overexpression mediated 
decrease in Mad1 phosphorylation causes decreased Mad1 activity leading to a weakened 
SAC (Jin et al., 1998).  
During interphase, the SAC proteins Mad1 and Mad2 localize to NPCs 
(Campbell et al., 2001; Iouk et al., 2002) and it has been suggested that NPCs are 
implicated in correct timing of the SAC during mitosis (Kastenmayer et al., 2005; Scott et 
al., 2005). In mitosis, Mad1 and Mad2 localize to kinetochores, where they regulate SAC 
function (Campbell et al., 2001; Musacchio and Salmon, 2007; Suijkerbuijk and Kops, 
2008). In our work we could show that depletion of Nup153 using RNA interference not 
only affects the association of Mad1 at the NPC during interphase, but also causes a 
delayed dissociation of Mad1 from kinetochores in metaphase (Figure 2.6). Depletion of 
Nup153 did not affect phosphorylation of Mad1. However, depletion of Nup153 was 
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associated with increased number of unresolved midbodies, indicating defects in 
cytokinesis (Figure 2.7). Reduced levels of Nup153 might therefore lead to persistently 
activated SAC due to prolonged localization of Mad1 to the kinetochores, consistent with 
the observed delay or aborted cytokinesis.  
 
Taken together, both overexpression and depletion of Nup153 affect the SAC 
mediated by its interaction with Mad1. A model of the effects of Nup153 overexpression 
and depletion on mitosis is depicted in Figure 5.1. Overexpression of Nup153 affects 
Mad1 phosphorylation, possibly by affecting its localization in mitosis, leading to an 
impaired SAC. However, Nup153 depletion affects localization at the kinetochores 
without affecting Mad1 phosphorylation, suggesting that the SAC is functionally intact, 
yet, persistent in time, leading to the observed defects in mitosis.  
It will be interesting to address the question in future as to how exactly Nup153 
affects Mad1 phosphorylation and SAC activity. It is known that the polo-like kinase I 
(PLKI) is involved in the phosphorylation of Mad1 in mitosis and it will be a challenging 
task to examine how Nup153 influences Mad1 phosphorylation by PLK1 (Chi et al., 
2008).  
Weakening of the mitotic checkpoint can promote aneuploidy and a weakened 
checkpoint is prevalent among tumor cells (Kops et al., 2005; Weaver and Cleveland, 
2006). Given that Nup153 expression is increased urothelial and retinoblastoma cancer, 
the here-described findings might give insight in how Nup153 contributes to cancer 
development (Heidenblad et al., 2008; Orlic et al., 2006). Furthermore, the importance of 
Nup153 is highlighted by the fact that it is essential for the viability of C. elegans 
embryos and growth of tissue culture cells, which is not likely explained by its sole 
nucleocytoplasmic transport function, as FG-containing nucleoporins are thought to have 
redundant functions concerning nucleocytoplasmic transport and cells can compensate 
the loss of about 50% of the FG-domains (Galy et al., 2003; Harborth et al., 2001; Strawn 
et al., 2004; Zeitler and Weis, 2004). Therefore, Nup153 is most likely essential for 
viability due to its crucial mitotic function. 
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Figure 5.1: Schematic model depicting the effect of Nup153 overexpression and depletion on 
Mad1, the SAC and mitosis.  
(A) Mitotis in the wild type situation. In prometaphase, Mad1 is recruited to unattached 
kinetochores (brown) and phosphorylated (p). The spindle assembly checkpoint (SAC) is active 
until all chromosmes (blue) are attached to the spindle apparatus (green). Sister chromatids are 
separated in anaphase, resulting in mononucleated cells, normal midbodies and bipolar spindles. 
(B) Overexpression of Nup153 leads to mislocalization of Mad1, subsequent Mad1 
hypophosphorylation, impairment of the SAC, followed by chromosome missegregation, 
aneuploidy and failures in cytokinesis (i.e. multinucleated cells followed by multipolar spindles). 
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(C) Depletion of Nup153 does not affect Mad1 phosphorylation, however to a prolonged 
localization of Mad1 at the kinetochores, leading to a persistently active SAC and delayed and 
aborted cytokinesis (i.e. abnormal midbodies). Adapted from (Musacchio and Salmon, 2007) and 
(Suijkerbuijk and Kops, 2008). 
 
5.2 Nup88 interacts with the lamin A Ig-fold: implications in 
laminopathies? 
An association between the NPC and the nuclear lamina has already been 
documented in 1976 by Dwyer and Blobel (Dwyer and Blobel, 1976). The nucleoporins 
Nup153 and Nup53 have been reported to interact with lamin B, and only recently, it has 
been shown that Nup153 interacts with lamin A as well (Al-Haboubi et al., 
submitted)(Hawryluk-Gara et al., 2005; Smythe et al., 2000). The nucleoporin-lamin 
interactions have been implicated in proper assembly of the NPCs into the nuclear 
envelope, since depletion of lamins lead to NPC clustering and incorporation of certain 
nucleoporins, like Nup153, into the NPC depends on lamina assembly (Furukawa et al., 
2009; Hawryluk-Gara et al., 2005; Smythe et al., 2000). 
Here, we provide a novel molecular link between the nucleoporin Nup88 and 
lamin A (Lussi et al., submitted). By solution-binding, overlay and immunoprecipitation 
assays and by immunofluorescence microscopy, we show that Nup88 and lamin A 
interact in vitro as well as in vivo (Figure 3.1, Figure 3.2 and Figure 3.4). Our studies 
showed that the N-terminus of Nup88 is binding to lamin A in vitro, and that it is the Ig-
fold domain of lamin A which is mediating the binding to Nup88 (Figure 3.2). In solution 
binding assays, the presence of lamin A-associated mutants abrogated the interaction with 
Nup88 and supported the notion that the Ig-fold of lamin A is necessary for Nup88 
binding (Figure 3.5). Our studies showed that the EDMD-associated lamin A mutant 
(R453W), which causes destabilization of the Ig-fold domain, loses its ability to bind 
Nup88 in vitro and in vivo. Another mutation in the Ig-fold domain of lamin A, the 
mutation of R482 to a W, which is responsible for FPLD, also impairs Nup88 binding. 
Interestingly, this mutation lies on the surface of the lamin A Ig-fold and is suggested to 
be a polar interaction site for lamin A-associated proteins (Dhe-Paganon et al., 2002; 
Krimm et al., 2002). In contrast, a lamin A truncation found in HGPS, lamin AΔ50, does 
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not affect binding to Nup88, further indicating the importance of the Ig-fold domain for 
the Nup88 interaction.  
Interestingly, a study with cells from progeria patients showed that Nup88 
mRNA levels decreased in cells derived from progeria patients or from old people 
compared to Nup88 levels in cells from healthy people (Ly et al., 2000). Similarly, we 
could observe a reduction of Nup88 protein levels in lamin A-deficient cells, indicating 
that lamin A might influence Nup88 expression levels (Figure S7.13). How lamin A 
regulates Nup88 expression levels and if Nup88 has a physiological role in aging needs to 
be further elaborated. On the other hand, altered interactions of Nup88 with the above 
mentioned laminopathy-associated mutants might affect Nup88 function in vivo and 
contribute to disease development. 
 
5.3 Implications of Nup88 in nuclear assembly? 
The nuclear lamina has been implicated in proper assembly of the NE and NPCs 
after mitosis (Furukawa et al., 2009; Holaska et al., 2002). Therefore, the interaction of 
Nup88 with lamin A might have a structural role in nuclear architecture and nuclear 
assembly. To study the effects of increased Nup88 levels on nuclear assembly, we used 
the cell-free system based on Xenopus laevis egg extract and demembranated sperm 
chromatin to reconstitute nuclei (Figure 5.2A). Crude extract, sperm chromatin and an 
ATP-regenerating system were incubated for 120 minutes with an excess of either 
purified GST-Nup88 or GST as negative control and assembled nuclei were visualized by 
fluorescence microscopy and DAPI staining. We could observe an abnormal nuclear 
shape in nuclei incubated with an excess of Nup88 compared to control nuclei, 
suggesting that the excess Nup88 interferes with proper nuclear assembly (Figure 5.2A). 
Furthermore, when Nup88-myc is overexpressed in a tetracycline-inducible HEK cell 
line, large nuclear invaginations are observed as compared to control cells, similar to the 
phenotype observed in reconstituted nuclei (Figure 5.2B). Theses observations indicate 
that Nup88 might play a role in nuclear assembly, but whether the observed phenotypes 
are indeed dependent on lamin A needs to be further elaborated. 
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However, lamin A exists in at least two different populations in the cell, as 
filamentous structure near the nuclear envelope and as more soluble fraction in 
association with LAP2α (see Chapter 4). Our findings that Nup88 interacts with lamin A 
together with LAP2α and that Nup88 protein levels influence the lamin A-LAPα 
complex stability and cell cycle progression supports the idea that Nup88 interacts with 
the more soluble lamin A (Figure 4.1, Figure 4.2 and Figure 4.3). Whether the interaction 
takes place at the NPC or in the nucleoplasm has to be further investigated, as Nup88 has 
been observed, beside its peripheral nuclear localization at the NPC, within the 
nucleoplasm, where Nup88 was implicated in gene regulation and cellular stress response 
(Capelson et al.; Chen et al., 2007; Kodiha et al., 2008b)(Lussi et al, submitted). 
 
Figure 5.2: Excess Nup88 leads to aberrant nuclear morphology. 
(A) Reconstituted nuclei from Xenopus oocyte extract display abnormal nuclear shape when 
purified GST-Nup88 is added to the assembly reaction (right panel), compared to nuclei where 
purified GST as control was added (left panel). Nuclei were visualized by Dapi staining and 
immunofluorescence microscopy (B) Stable HEK cells induced with tetracycline to express 
Nup88-myc show large nuclear invaginations (right panel, arrows) compared to non-induced 
control cells (left panel). 
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5.4 Nup88 localizes on both the cytoplasmic and nuclear side of 
the NPC 
Here, we could demonstrate by immuno-EM studies in Xenopus oocyte nuclei 
that Nup88 is localized on both the cytoplsmic and nuclear side of the NPC, 
complementing recent data where Nup88 was shown to be cytoplasmically localized 
(Figure 3.3)(Bernad et al., 2004). Rout and coworkers suggest that the abundance of 
nucleoporins and their localization within the NPC correlates insofar that low abundance, 
i.e. one copy per spoke, correlates with asymmetric distribution within the NPC, and 
higher abundance (several copies per spoke) with a more symmetric distribution within 
the NPC (Rout et al., 2000). This notion supports the idea that Nup88 might be 
symmetrically distributed within the NCP, since Nup88 was found to be a highly 
abundant nucleoporin with 32 copies per NPC, i.e. 4 copies per spoke (Rout et al., 2000). 
Furthermore, the finding that Nup88 is also localized on the nuclear side of the NPC is 
consistent with the novel interaction of Nup88 with lamin A (Lussi et al, submitted). 
 
5.5 Nup88 in proliferation 
Nup88 was implicated in cell proliferation and differentiation, as it was found to 
be overexpressed in developing tissue as well as in different cancer cell lines and tumors 
(Agudo et al., 2004; Emterling et al., 2003; Gould et al., 2000; Gould et al., 2002; 
Martinez et al., 1999; Schneider et al., 2004; Zhang et al., 2002; Zhang et al., 2007). The 
exact mechanism, however, as to how Nup88 influences proliferation was not clear.  
Here, we show that Nup88 associates with the lamin A-LAP2α complex and that 
Nup88 overexpression leads to a destabilization of the lamin A-LAP2α complex, 
followed by a weakened G0/G1 arrest and accelerated cell cycle progression (Figure 4.1 
and Figure 4.2). On the other hand, depletion of Nup88 leaves the lamin A-LAP2α 
complex intact, but significantly decelerates G1-S transition in human cells (Figure 4.3). 
However, the immunoprecipitation experiments give us only a static view of the 
interaction of the two proteins, and it would be possible that LAP2α binding to lamin A is 
not stronger, but longer during the cell cycle. So, loss of Nup88 might lead to a more 
stable lamin A-LAP2α association over time and to a longer repression of E2F-dependent 
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cell cycle genes. To gain more insight into Nup88’s effect on cell cycle progression, it 
will be necessary to analyze expression of endogenous E2F target genes, e.g. cyclin D1, 
thymidine kinase or cyclin E, and an unrelated gene product like actin, by quantitative 
PCR to correlate Nup88 overexpression and depletion defects in cell cycle to pRb/E2F 
gene regulation. E2F genes are differentially expressed during the cell cycle, and gene 
expression needs to be analyzed in a synchronized cell culture in the G1 to S transition 
and during S phase. Additionally to the propidium iodide based cell cycle analysis, it will 
be helpful to analyze the quantity of transcribed DNA by BrdU pulse labeling of actively 
transcribed DNA to make conclusions about the amount of cells in S phase.  
Although the depletion experiments were performed in HEK cells, which is a 
virus-transformed cell line and where pRb is partially inactivated through adenoviral 
proteins (Graham et al., 1977), Nup88 depletion had a very strong effect on cell cycle 
progression. However, to verify the observed phenotype of Nup88 depletion in a non-
transformed cell line, it will be necessary to perform the experiment in BJ1-hTERT 
fibroblasts or a similar non-transformed cell line.  
A possible mechanism of how Nup88 regulates cell cycle progression might be 
by recruiting the lamin A-LAP2α complex away from its inhibitory site of action, and as 
a consequence, decreases pRb’s repressor function or accelerates its deactivation during 
G1-S transition (Figure 4.4). However, we cannot fully exclude the possibility that Nup88 
impacts cell cycle progression via a lamin A or LAP2α independent mechanism. To 
address this question, cell cycle studies in lamin A and LAP2α knockout cells need to be 
performed. These cells should not be responsive to Nup88 overexpression or depletion 
concerning cell cycle progression, and theses finding would indicate a common pathway 
of Nup88 and the lamin A-LAP2α complex in cell cycle regulation. 
For the future, it will be interesting to analyze the question how Nup88 can 
regulate the lamin A-LAP2α complex in a cell cycle–dependent manner. It is known that 
Nup88 is phosphorylated (Kodiha et al., 2008a), and other modifications can be thought 
of to regulate Nup88’s localization or binding with its interaction partners, e.g. 
ubiquitination. 
Alternatively, it has been shown that protein levels of members of the Nup107-
160 complex are regulated during the cell cycle, mainly via the ubiquitin-proteasome 
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pathway, which subsequently regulates cell cycle progression and phase-specific gene 
expression (Chakraborty et al., 2008). Therefore, another scenario might be that protein 
levels of Nup88 itself are regulated in a cell cycle-dependent manner, which further 
regulates the lamin A-LAP2α complexes.  
 
5.6 Implications of nucleoporins in gene regulation 
Only recently, it has been shown for the first time that nucleoporins are involved 
in gene regulatory functions in multicellular organisms (Capelson et al.; Kalverda et al.). 
These findings reveal the nucleoporins as new class of transcription factors, as several 
nucleoporins, such as Nup88, Nup98, Sec13 and FG-containing nucleoporins, have been 
shown to be present in the nuclear interior, where they bind certain genes and regulate 
their expression, including developmentally regulated genes needed for cell 
differentiation and tissue development. These findings support strongly our results that 
Nup88 is implicated in gene expression and cell cycle regulation (Lussi et al., in 
preparation). 
We started to focus on the cellular functions of yet another nucleoporin, Nup98. 
Nup98 is found in leukemia fused to proteins important for gene expression. The best-
studied Nup98 fusion is Nup98/HoxA, where Nup98 is fused to the homeodomain of 
HoxA (Borrow et al., 1996; Nakamura et al., 1996). Nup98/HoxA provides aberrant self-
renewal capacity, blocks myeloid differentiation in vitro and induces AML-like disease in 
vivo (Kroon et al., 2001). NUP98 can also be fused to the hematopoietic homeobox gene 
HHEX also known as proline-rich homeobox (PRH) (Manfioletti et al., 1995; Morgutti et 
al., 2001). The resulting Nup98/HHEX fusion has transforming activity in vitro and in 
vivo, which is dependent on the GLFG repeats of Nup98 and the integrity of the HHEX 
homeodomain. Comparative gene expression analysis revealed a partially overlapping 
target profile of Nup98/HHEX and Nup98/HoxA (Chung et al., 2006; Jankovic et al., 
2008; Palmqvist et al., 2007; Takeda et al., 2006). It is possible that several Nup98 
fusions (and other leukemogenic fusions containing transcriptional regulators) have 
common critical targets that would be interesting as potential targets for therapeutic 
intervention.  
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To illuminate the role of the nucleoporin Nup98 in leukemogenic 
transformations, particularly the fusion of Nup98 to HoxA and HHEX, we analyzed 
interactions partners of Nup98 and its fusion proteins Nup98/HoxA and Nup98/HHEX by 
immunoprecipitation assays with GFP-tagged wild-type Nup98 and Nup98/HoxA and 
Nup98/HHEX fusion proteins using a monoclonal GFP-antibody (Figure 5.3). 
Interestingly, we found that Nup88 is interacting with wild-type Nup98, as it has been 
shown previously (Griffis et al., 2003). However, the interaction was lost with the 
leukemogenic fusion proteins Nup98/HoxA and Nup98/HHEX (Figure 5.3). To 
understand the importance of the loss of interaction between Nup98 and Nup88, it is 
crucial to first understand the physiological function of this interaction in a cellular 
context. Furthermore, we found that lamin A and lamin B1 are binding to Nup98 as well 
as its fusion proteins with HoxA and HHEX. It will be interesting to analyze in future 
whether Nup98 is implicated in gene regulation in a lamin A-dependent manner, similarly 
to Nup88. Insight into Nup98’s involvement in lamin A-mediated gene regulation might 
be important to understand its leukemogenic potential.  
 
Figure 5.3: Immunoprecipitation assays with HEK cells transfected with GFP-Nup98, GFP-
Nup98/HoxA and GFP-Nup98/HHEX fusion proteins using monoclonal GFP-antibodies. 
Nup88 is co-precipitating with GFP-Nup98, whereas the interaction with Nup88 is reduced with 
GFP-Nup98/HoxA fusion protein and almost completely interrupted with the Nup98/HHEX fusion 
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protein. Lamin A and lamin B1 are precipitating with GFP-Nup98, GFP-Nup98/HoxA and GFP-
Nup98/HHEX. 
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Figure S7.1: Electron micrographs of GFP-Nup153 overexpressing cells.  
HeLa cells were transiently transfected with GFP-Nup153 and prepared for thin-sectioning EM 48 
hours after transfection. Cells were fixed in glutaraldehyde, postfixed in osmium tetroxide, 
dehydrated in a series of ethanol and embedded in Epon resin. Electron micrographs were 
recorded on a Philipps CM 100 electron microscope equipped with a CCD camera. Images were 
processed using Adobe Photoshop. Shown are two examples of a multinucleated cell at low 
magnification and a higher magnification of the marked area, highlighting the fusion between the 
two nuclei. 
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Figure S7.2: Over-expression of Nup153 induces cellular multinucleation.  
(a) Xenopus A6 cells and (b) human HEK 293 cells were transiently transfected with GFP-
Nup153 and analyzed by direct epifluorescence 48 hours after transfection. Expression of GFP-
Nup153 resulted in multinucleated cells. (c) HeLa cells transiently expressing GFP do not 
accumulate GFP at the nuclear envelope but is distributed throughout the nucleoplasm. No 
multinucleation of the cells was observed. (d, e, f) GFP-Tpr localizes to the nuclear envelope and 
the nucleoplasm in transiently transfected HeLa cells. No multinucleation of the cells was 
observed. 
7.1 Supplementary Figures 
 163 
 
Figure S7.3: HeLa cells expressing truncations of the N-terminal domain of human Nup153 
cause nuclear lobulations and multinucleation.  
HeLa cells were transiently transfected and analyzed 48 hours later by epifluorescence 
microscopy. GFP-Nup153-39-339 was localized to the nuclear envelope. High levels of expression 
caused nuclear lobulation and multinucleation. Expression of GFP-Nup153-144-339 displayed 
nuclear localization mainly in internal nuclear foci and caused nuclear lobulation. Expression of 
GFP-Nup153-33-144 was localized throughout the cell. 
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Figure S7.4: Mad2 localization and co-precipitation with Mad1 
(a) Immuno-electron microscopy localization of Mad2 in Xenopus oocyte nuclei. Nuclei were 
isolated manually and labelled with a monoclonal Mad2 antibody directly conjugated to 8nm 
colloidal gold. Mad2 localises to the centre of the NPC with additional epitopes on the 
cytoplasmic face of the NPC (left). Quantification of the gold particle distribution from particles 
that were associated with the NPC (right). 
Total HeLa extracts from unsynchronised or nocodazole arrested cells were immunoprecipitated 
using either (b) anti-Mad1 or (c) anti-Nup153 antibodies. Equivalent amounts of HeLa extracts 
(L), immune supernatants (S) and immune precipitate (P) were separated by SDS-PAGE and 
analyzed by immunoblotting using Mad2 antibodies. Mad2 is co-precipitated with Mad1, but not 
with Nup153. 
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Figure S7.5: Enhanced levels of Nup153 do not cause G1 or G2 arrest.  
Phase contrast images of untransfected HeLa cells or cells that were transfected with control 
siRNA, Mad1 siRNA, Nup153 siRNA, GFP-Nup153 or GFP-Nup153 and GFP-Mad1, 
respectively, and treated with thymidine for 16 hours to arrest cells in G1. Cells were released 
from thymidine block by incubation in fresh medium, prior to a second block with thymidine for 
another 16 hours. Cells were released into fresh medium and images 9 hours after release. No G1 
or G2 arrest was observed for any condition. 
 
 
Figure S7.6: Mad1 does not precipitate with protein G agarose beads. 
Protein G agarose beads were incubated with total HeLa extracts from unsynchronised cells were 
analyzed using either (a) anti-Mad1 or (b) anti-pSTY antibodies. Mad1 is detectable in the HeLa 
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extracts (L) and the supernatant (S), but did not bind to the beads (P). The pSTY antibody 
recognised some proteins in the extract, the supernatant, but did not reacted with the beads. 
 
 
Figure S7.7: HeLa cells expressing histone H2B-GFP were transfected either with Nup153 
siRNA or siRNA directed against cyclophilin B as a control.  
Knockdown of Nup153 was verified 48 hours after transfection by (a) real-time PCR with the 
Nup153 signal normalised to the concentration of actin mRNA. (b) In addition, the corresponding 
decrease in Nup153 protein was examined by quantitative Western blotting using cell extracts 
from cells treated with control or Nup153 siRNAs using antibodies directed against Nup153, Tpr, 
Nup62, and tubulin. (d) No changes in Tpr mRNA levels occur upon depletion of Nup153 with the 
Tpr signal normalised to the concentration of actin mRNA. The decrease in the protein level of 
Nup153 was also examined by (c) dual immunofluorescence microscopy after fixation and staining 
for Nup153 and either FG-repeat proteins with mAb414 or Tpr. In the absence of Nup153 Tpr and 
the FG-repeat proteins appeared to be associated with nuclear pore complexes. Expression of 
GFP-Nup153 does not affect (e) Tpr localisation or (f) expression levels in transiently transfected 
HeLa cells. 
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Figure S7.8: Flow cytometric analysis of siRNA treated HeLa cells expressing histone H2B-
GFP. 
Cells were transfected with (a) control siRNA against cyclophilin B and (b) Nup153 siRNAs, 
fixed 48 hours post transfection and stained with propidium iodide to analyze their DNA content. 
Knocking down Nup153 had no effect on cell cycle compared with control treatment. 
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Figure S7.9: Nup88-lamin A complex is not associated with transport. 
Bacterially expressed GST-Nup88 and GST were bound to glutathione sepharose beads and 
incubated with in vitro synthesized 35S-labeled full-length lamin A. The reticulocyte lysate used 
for in vitro expression and 35S-labeling of lamin A and the bound fractions to GST-Nup88 and 
GST were then analyzed by SDS-PAGE and immunoblotting with antibodies against CRM1, 
importin α and importin β. Neither CRM1, importin α nor importin β were found to be associated 
with the Nup88-lamin A complex. 
 
 
Figure S7.10: Localization of endogenous lamin A and Nup88 in HEK cells.  
HEK cells were indirectly immunolabeled with antibodies against Nup88 and lamin A. Scale bar, 
10 µm. 
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Figure S7.11: Expression of GFP-lamin A in Nup88-myc overexpressing HEK cells.  
(A) Stable HEK-hNup88 cells were induced to express Nup88-myc upon tetracycline in the 
medium, transiently transfected with GFP-lamin A, indirectly immunolabeled with a Nup88 
antibody recognizing residues 314-425 and analyzed by fluorescence microscopy. Scale bars, 10 
µm(B) HEK cells were induced to express Nup88-myc upon tetracycline in the medium and 
analyzed by immunoblot analysis using myc-antibodies. Actin antibodies were used as loading 
control. 
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Figure S7.12: Masking can be circumvented by the use of a different antibody epitope or a 
different fixation method.  
(A) Schematic representation of the antibody epitopes in Nup88. (B) HEK cells transfected with 
GFP-lamin A were prepared for immunofluorescence 24 hours post transfection using a polyclonal 
antibody directed against residues 27-45 in the N-terminus of Nup88. (C) HEK cells transfected 
with GFP-lamin A were fixed with 100% ice-cold methanol 24 hours post transfection and 
prepared for immunofluorescence using monoclonal Nup88 antibody against the N-terminal 
residues 314-425. Scale bars, 10 µm. 
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Figure S7.13: Nup88 protein levels are dependent on lamin A.  
(A) HeLa cells were transfected with cyclophilin or lamin A siRNA respectively, or mock 
transfected. Protein levels were analyzed by immunoblot 48 hours after transfection with 
antibodies against lamin A, Nup88 or β-tubulin as loading control. (B) Protein levels of Nup88 
were quantified using MultiGauge (FujiFilm) and normalized with β-tubulin protein levels. Nup88 
protein levels of mock-transfected cells are set to 100%. 
 
 
Figure S7.14: Immunoblot analysis of BJ1 fibroblasts transfected with GFP-Nup88 or GFP, 
respectively. 
BJ1 fibroblast cells were transiently transfected with plasmids encoding GFP-Nup88 or GFP and 
the cells were analyzed for protein expression by immunoblot analysis 24 hours after transfection 
using a monoclonal GFP antibody. 
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